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Abstract 
Many plants form important and beneficial symbioses with microbes including arbuscular 
mycorrhization and the legume-rhizobial interaction. The establishment of both these 
symbioses involves common genes which encode the Sym pathway proteins, of which 
calcium- and calmodulin-dependent protein kinase (CCaMK) is a central component. 
CCaMK has been genetically positioned downstream of a nuclear calcium spiking signal and 
is widely thought to detect and transduce this signal. In the presence of calcium CCaMK 
undergoes a conformational change, but the nature of this was previously unknown. Here I 
show that this change likely corresponds to an elongation of the visinin-like domain and 
this exposes a hydrophobic patch in the full-length protein. This hydrophobic patch could 
facilitate the binding of CCaMK to target proteins. Calcium-binding to the visinin-like 
domain stimulates autophosphorylation, in particular at T271 (in Medicago truncatula 
CCaMK).  However, the molecular mechanism by which this occurs was not well-
established. By contrast, the mechanism of autophosphorylation of CaMKII, a similar 
animal protein, has been determined to be intra-oligomeric and inter-subunit. Work 
presented here shows for the first time that MBP-CCaMK forms an oligomer of 16-18 
subunits when purified from E. coli and experimental evidence is most consistent with an 
intra-oligomeric, inter-subunit mechanism of autophosphorylation. This is expected to 
facilitate the stabilisation of a robust “off-state” of the protein. Finally, CCaMK was 
assessed in planta. Preliminary data suggested the presence of potential alternative splice 
forms of CCaMK, and I undertook an investigation to determine if these were present 
during symbiosis at the RNA and protein level. Very low levels of splice variants were 
detected at the RNA level only, suggesting that they do not play a key role during 
symbiosis. A multi-faceted study is therefore presented, and this provides deeper insights 
into the function of CCaMK in the Sym pathway.  
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Chapter 1: Introduction 
This thesis covers work regarding the Medicago truncatula protein calcium- and 
calmodulin-dependent protein kinase (CCaMK). This protein is a key component of the 
common symbiosis signalling pathway necessary for the establishment of both nodulation 
in legumes and arbuscular mycorrhization. This general introduction places the protein into 
context by describing root symbioses, the common Sym pathway, calcium signalling and 
binding proteins in plants, and previous literature relating to CCaMK. In addition, 
background information on an animal protein which shows significant sequence similarity 
to CCaMK, CaMKII, is detailed. A brief discussion of alternative splicing concludes the 
introduction, which relates to the experimental work in Chapter 6. Finally, the aims of this 
thesis project are detailed in section 1.9.  
 
1.1 Introduction to root symbioses  
 
Many plants form important and beneficial plant-microbe interactions known as 
symbioses. The most ancient form of plant-root symbiosis is the arbuscular mycorrhiza, 
formed between 70-90% of all land plants and the monophyletic fungal phylem, 
Glomeromycota (Parniske, 2008). The more recently evolved plant symbiotic interaction is 
the nitrogen-fixing root nodulation symbiosis. This symbiosis is formed between some 
plants in the orders Fabales, Fagales, Cucurbitalis, and Rosales and the bacterial family 
Rhizobiaceae or the genus Frankia (Popp and Ott, 2011). These plant species form a 
monophyletic nitrogen-fixing clade, in which the root nodulation symbiosis is thought to 
have evolved multiple times (Delaux et al., 2015). In particular, the nitrogen-fixation 
interaction formed between plants of the Fabaceae family and rhizobia bacteria has been 
extensively studied, and is termed the legume-rhizobial symbiosis.  
 
Plants benefit from both mycorrhization and nodulation. From their fungal partners they 
gain enhanced water and nutrient uptake (most notably phosphate but also nitrogen, 
micro and macro-nutrients (Parniske, 2008), (Hodge et al., 2001)) and protection from root 
diseases (Bonfante and Requena, 2011). From bacterial symbionts, plants crucially gain 
nitrogen in the form of ammonia that can be easily utilised (Oldroyd et al., 2011). In return, 
their fungal and bacterial partners gain carbon (Harrison, 2005) and energy in the form of 
di-carboxylic acids (Lodwig et al., 2003), respectively. Therefore mycorrhization and 
nodulation are agriculturally and economically important. Mycorrhization plays a key role 
in the improvement of plant growth because it provides phosphorus which is required in 
16 
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large quantities by plants. Furthermore, since mycorrhization is so widespread amongst 
plants, it also plays a key role in global carbon cycling (Harrison, 2005). 
 
In turn, despite its restriction to a single clade of plants, the nitrogen-fixing root nodulation 
symbiosis impacts the global nitrogen cycle. Moreover, nitrogen is essential for plant 
growth and the presence of nitrogen-fixing bacteria allows the plant to access the 
atmospheric pool of nitrogen which it otherwise cannot use. Crop plants which cannot 
form nodules therefore require the application of large quantities of nitrogenous fertiliser 
for optimum yield. Since nitrogen-availability is therefore growth-limiting, if nitrogen-
fixation could be introduced to key crop plants, for example cereals, this would reduce 
fertiliser-dependency and potentially greatly increase yield. Work has begun to engineer 
the nitrogen-fixing symbiosis in non-legume crops and this will become extremely 
important in the future as one of the ways to feed the ever-increasing world population 
(Rogers and Oldroyd, 2014), (Delaux et al., 2015), (Charpentier and Oldroyd, 2010). 
Therefore, increasing our understanding of symbiotic interactions is an important goal. 
 
1.1.1 Mycorrhization  
 
Mycorrhization is thought to have originated more than 400 million years ago (MYA) in the 
Early Devonian period (Remy et al., 1994). It has been theorised that the development of 
this mutualism played a key role in colonisation of land by green plants because of the 
widespread distribution of mycorrhization, the fossil record and the presence of highly 
conserved key genes required for mycorrhization in the common ancestor of land plants 
(Wang et al., 2010). There are two types of mycorrhiza: ecto- and endo-mycorrhiza. Ecto-
mycorrhization is characterised by the presence of the fungal partner outside of the plant 
cell, and has evolved more recently, approximately 130-180 MYA. This symbiosis is 
observed for example in boreal and temperate forest trees, and assists the plant in the 
uptake of nitrogen, phosphorus and magnesium (Venkateshwaran et al., 2013). The more 
common type of mycorrhization is the endo-mycorrhiza, where the fungus penetrates the 
plant cell. Arbuscular mycorrhization is a type of endo-mycorrhization which is 
characterised by the formation of fungal tree-like projections within plant cells. This is likely 
to be the most common terrestrial symbiosis (Parniske, 2008). 
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Arbuscular mycorrhizal development begins when plant roots exude strigolactones, which 
are plant hormones that stimulates hyphal branching, spore germination and mitochondrial 
activity in the fungal partner (Akiyama et al., 2005), (Besserer et al., 2006). Strigolactones 
break down quickly when released, and this is theorised to indicate the proximity of the 
root to the fungal partner. This is the pre-symbiotic phase. Arbuscular mycorrhizal fungi are 
obligate biotrophs, and therefore to maximise their chance of forming a symbiosis they 
release diffusible compounds called Myc factors. The structure of the Myc factors has 
eluded scientists for many years. However, the structure of several Myc factor has been 
elucidated recently. This is discussed in section 1.2.1. Myc factors induce plant responses 
including symbiotic gene expression, calcium oscillations and root growth and branching 
(Kosuta et al., 2008), (Maillet et al., 2011). The fungus forms a hyphopodium developed 
from mature hyphae and this attaches to the root surface. The plant responds to this by 
migration of the nucleus towards the anticipated fungal entry point and by the formation 
of the pre-penetration apparatus. This consists of a column of cytoplasm across the host-
cell vacuole and this guides the growth of the fungal hyphae through the epidermis to the 
cortex. Here, the fungus branches in the apoplast before re-entering the inner cortical cells 
where it forms developed arbuscules (Figure 1.1) (Parniske, 2008). 
 
 
 
Figure 1.1. Mycorrhizal signalling, fungal penetration and mycorrhizal development. Figure 
adapted from (Oldroyd, 2013). 
 
1.1.2 Nodulation 
 
In contrast, the legume-rhizobial symbiosis forms an entirely new organ on plant roots, 
known as nodules. These specialised plant organs provide the right environment for the 
nitrogen-fixing bacteria; since the rate of ammonia production by the bacterial enzyme 
nitrogenase is inhibited by oxygen and limited by carbon availability, the nodule regulates 
the levels of both in order to maximise the amount of nitrogen that is fixed (Oldroyd and 
Downie, 2004). Two types of nodules can be formed depending on the plant species 
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involved. Indeterminate nodules are formed by, for example, M. truncatula, and are 
characterised by a zonation of the cells within the nodule, including: the meristem, 
infection zone, interzone, fixation zone and the senescence zone. The development of 
these nodules begins with cell divisions in the pericyle and then in the inner cortical cells. 
Alternatively, determinate nodules are formed by, for example, Lotus japonicus, and 
consist of one central nitrogen fixing tissue with no zonation. In contrast to indeterminate 
nodules, they originate by cell divisions which occur in the outer root cortex (Popp and Ott, 
2011). The two types of nodule are further differentiated by the types of meristem present; 
indeterminate nodules have a tip-growing meristem, whereas determinate nodules only 
have a transient meristem, which is lost in mature nodules (Oldroyd et al., 2011). 
 
Root nodule development begins when flavonoids are secreted by the roots of legumes. 
These are plant secondary metabolites that are detected by rhizobial NodD proteins. These 
proteins activate gene expression of nodulation-related (nod) genes, some of which encode 
genes which produce Nod factor proteins (Long, 1996). Nod factors consist of decorated 
lipo-chitooliogsaccharides, which will be discussed in more detail in section 1.2.1. Plants 
perceive these signals at concentrations as low as 10-12 M and symbiotic gene expression is 
activated. In addition, two calcium signals are detected: calcium flux and nuclear-
associated calcium oscillations (Section 1.5). Rhizobia attach to the root, which induces 
root-hair deformation that entraps the bacteria in a root-hair curl. Rhizobia invade the 
plant cells via an infection thread, and as they grow down through the epidermis into the 
cortex they are preceded by calcium oscillations. The direction of this growth is determined 
by the pre-infection thread structure. Nodules initiate by formation of the meristem in the 
cortical cell layer and cell divisions occur to form the nodule. Bacteria divide and 
differentiate in these cells, where they are now able to fix nitrogen and are known as 
bacteroids. Subsequently, when they are surrounded by plant-derived-membranes in the 
developed nodule they are known as symbiosomes (Figure 1.2) (Oldroyd and Downie, 
2004), (Oldroyd, 2013). 
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Figure 1.2. Nodulation signalling, infection and nodule organogenesis. Figure adapted from 
(Oldroyd, 2013). 
 
1.2 Common symbiosis (Sym) pathway  
 
It is widely accepted that the root nodulation symbiosis actually evolved from the more 
ancient arbuscular mycorrhizal symbiosis, and this is thought to have occurred 
approximately 58-65 MYA (Lagunas et al., 2015), (Kistner and Parniske, 2002). 
Mycorrhization is present in all major plant lineages; however, nodulation has only evolved 
in one clade within Eurosid I. Despite the restricted number of species that can form 
nodules, nodulation has actually evolved multiple times within this clade. This implies that 
these species are potentially “pre-disposed to nodulate” (Kistner and Parniske, 2002). 
Recently, evidence has been found in support of this hypothesis by the identification of a 
single precursor to nodulation in the phylogeny of angiosperms. This event most likely 
emerged only once over 100 MYA, and nodulation has subsequently been lost and gained 
several times in the nitrogen-fixing clade. Furthermore, this pre-disposition is further 
thought to have been evolutionarily maintained in some angiosperm species (Werner et al., 
2014). These data suggest that nodulation may have emerged earlier than previously 
theorised. 
 
Interestingly, several pieces of evidence have emerged recently which suggest that 
elements of the signalling pathways for both mycorrhization and nodulation may pre-date 
the e ergence of ycorrhization. First, several co ponents of a “sy biotic toolkit” 
required for the formation of symbiosis have been identified in Charophytes and pre-date 
the colonisation of land by plants (Delaux et al., 2013b). Furthermore, there is evidence 
that the perception of lipo-chitooligosaccharides evolved from earlier plant defence 
signalling due to similarities in receptor structure and phylogenetic analysis (Liang et al., 
2014). Therefore it appears that root nodulation evolved from mycorrhization, which in 
turn utilised more ancient signalling components. 
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There is strong evidence for the evolution of the nodulation symbiosis from mycorrhization, 
the most persuasive of which is the presence of at least seven common genes necessary for 
the establishment of both symbioses. This is known as the common Sym pathway. The Sym 
pathway has been characterised in several different species by mutant analysis including 
Pisum sativum, M. truncatula and L. japonicus. In P. sativum three genes were identified: 
Sym19, Sym8 and Sym9 (Schneider et al., 1999), (Ané et al., 2004), (Schneider et al., 2002). 
In M. truncatula, three components common to both pathways were also identified: DMI1 
(DOES NOT MAKE INFECTIONS 1), DMI2 and DMI3 (Catoira et al., 2000). Interestingly, in L. 
japonicus, seven genes common to both pathways were identified: SYMRK, CASTOR, 
POLLUX, NUP133, CYCLOPS, CCaMK and NUP85 (Kistner et al., 2005). It was later 
determined that the genes identified in P. sativum are homologues of those identified in M. 
truncatula and three genes from L. japonicus. The common Sym pathway, and the 
corresponding nodulation and mycorrhization pathways as currently known, is shown in 
Figure 1.3. 
 
 
 
Figure 1.3. Major components of the signalling pathway for the establishment of 
nodulation and mycorrhization. The common genetic elements of the Sym pathway are 
marked in red. Arrows indicate progression through the pathway and not interactions. 
Elements from M. truncatula are listed where known, and homologues from L. japonicus 
and P. sativum respectively are indicated after a slash. NUP133, NUP85 and CASTOR have 
no known homologues. This is based on data from (Parniske, 2008), (Oldroyd, 2013) and 
personal communication. 
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1.2.1 Nod and Myc factors  
 
Nod factors are lipo-chitooligosaccharides which consist of four or five N-acetyl-D-
glucosa ine residues and are β1-4 linked. An N-acyl group is attached to the sugar at the 
non-reducing end. Interestingly, specificity of the bacterial-plant interaction is encoded in 
specific modifications which can be present on the reducing and non-reducing terminal 
sugar residues. These additions include methyl, fucosyl, acetyl and sulphate groups. Further 
specificity can be conferred by the number of acetyl-glucosamine residues and the mix of 
Nod factors produced by the bacteria (Oldroyd, 2013), (Geurts and Bisseling, 2002). The 
first Nod factor which was characterised was from Sinorhizobium meliloti and consists of 
four glucosamine units with a 16 carbon acyl chain and acetyl and sulphate modifications 
(Figure 1.4) (Lerouge et al., 1990). Nod factors are required for the majority of rhizobia-
legume interactions, however there are some examples of interactions without Nod factor 
including some Bradyrhizobium strains (Giraud et al., 2007). Recently, it was demonstrated 
that a further level of specificity is determined by bacterial exopolysaccharides which are 
recognised after Nod factor perception by a specific receptor-like kinase in L. japonicus, 
Epr3 (Kawaharada et al., 2015).  
 
 
Figure 1.4. The structure of S. meliloti Nod factor. Figure adapted from (Geurts and 
Bisseling, 2002) and (Lerouge et al., 1990). 
 
The structure of Myc factors was elusive for many years, but in 2011 the structure of Myc 
factors from Glomus intraradices were characterised (Maillet et al., 2011). Interestingly, 
these consisted of sulfated and non-sulfated lipo-chitooligosaccharides similar to those 
observed in nodulation signalling. Two of these Myc factors are shown in Figure 1.5. 
Interestingly, further fungal signals have been identified which are non-decorated short-
chain chito-oligosaccharides e.g. tetra-acetyl chitotetraose. These were able to elicit a 
calcium spiking response in M. truncatula root organ cultures, which is a marker of the 
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activation of genes required for mycorrhization (Genre et al., 2013). Therefore, mycorrhizal 
fungi exude a variety of signalling molecules as part of the molecular dialogue. In contrast 
to the legume-rhizobia interaction, mycorrhizal fungi are able to interact with many species 
which this mixture of signals may facilitate. Interestingly, legumes and non-legumes have 
been shown to respond differently to lipo-chitooligosaccharides and chito-oligosaccharides, 
therefore showing potential different functions of these signals in activating mycorrhization 
in different species (Sun et al., 2015). 
 
 
Figure 1.5. The structure of a sulfated and non-sulfated Myc factor from G. intraradices. 
Figure adapted from (Maillet et al., 2011). 
 
1.2.2 Functions of the common Sym pathway components 
 
DMI2 encodes a plasma membrane receptor-like kinase with three extra-cytoplasmic 
leucine-rich repeats (LRR), which was first identified in Medicago sativa as NORK (Endre et 
al., 2002). This gene is a homolog of L. japonicus SYMBIOSIS RECEPTOR-LIKE KINASE 
(SYMRK) (Stracke et al., 2002) which has recently been characterised. SYMRK was 
demonstrated to interact with Nod factor receptor 5 (NFR5) in the absence of a symbiotic 
signal. This was promoted by the cleavage of a malectin-like domain (MLD) in the 
extracellular region SYMRK. The MLD (and LRR) further regulates the protein by enhancing 
its own degradation. The importance of this domain to the regulation of nodulation was 
demonstrated by the deletion of the MLD and LRR region, which initiated excess infection 
thread development (Antolín-Llovera et al., 2014). DMI1 encodes a cation channel which 
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was first characterised in M. truncatula (Ané et al., 2004) and which localises to the nuclear 
membrane (Riely et al., 2007). Interestingly, whilst POLLUX is the putative orthologue of 
DMI1 in L. japonicus, both CASTOR and POLLUX are cation channels. Furthermore, the 
castor pollux double mutant can be rescued by DMI1 alone, whilst both CASTOR and 
POLLUX are required to rescue the dmi1 mutant. This suggests that DMI1 has evolved to 
provide the roles of both CASTOR and POLLUX in M. truncatula (Venkateshwaran et al., 
2012). The role of DMI1 in the generation of the oscillatory calcium signal is discussed in 
section 1.5.2. NUP85 and NUP133 are both nucleoporins and along with NENA form a 
nuclear pore which is required for the generation of the calcium spiking signal (Groth et al., 
2010). It is theorised that this nuclear pore could be involved in the correct localisation of, 
for example, DMI1 (Oldroyd, 2013). 
 
Downstream of these common genes is a nuclear calcium spiking signal (Section 1.5.2) and 
two proteins which are thought to interpret and transduce this signal: CCaMK and 
CYCLOPS. Consistent with this both proteins are nuclear-localised (Takeda et al., 2012), 
(Yano et al., 2008). DMI3 (CCaMK) encodes a calcium- and calmodulin-dependent protein 
kinase and IPD3 (CYCLOPS) is a binding partner and phosphorylation target of CCaMK, and a 
recently characterised transcription factor. These two common Sym pathway components 
are described in detail in Sections 1.7 and 1.7.8, respectively. The nature of the Sym 
pathway requires transduction of the signal from the plasma membrane components (e.g. 
DMI2) to the nucleus (e.g. DMI1). Recently, a secondary messenger, mevalonate, was 
proposed as the signalling component required for this role. Mevalonate can be produced 
by 3-hydroxy-3-methylglutaryl CoA reductase 1 (HMGR1), and HMGR1 has been shown to 
interact with DMI2. Crucially, mevalonate is able to activate both nuclear calcium spiking 
and symbiotic gene expression in a DMI1-dependent manner. Therefore mevalonate (or a 
metabolite of the mevalonate pathway) is a possible candidate to transduce the symbiotic 
signal from the plasma membrane to the nucleus via HMGR1 (Venkateshwaran et al., 
2015). 
 
1.2.3 Nod and Myc pathway genes 
 
In addition to the common Sym pathway components, nodulation- and mycorrhization-
specific genes have also been characterised (Figure 1.3). Two Nod factor receptors have 
been characterised in M. truncatula namely NOD FACTOR PERCEPTION (NFP) and LYSIN 
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MOTIF RECEPTOR-LIKE KINASE3 (LYK3) (Limpens et al., 2003), (Arrighi et al., 2006). NFP and 
LYK3 are LysM-domain containing receptor-like kinases, however only LYK3 possesses an 
active kinase domain. Interestingly, they have recently been shown to form heteromeric 
complexes in planta in cell layers where Nod factor signalling occurs (Moling et al., 2014). 
By contrast, Myc factor receptors are not well characterised. Interestingly, an O. sativa 
receptor kinase known as CERK1 has recently been shown to play both an essential role in 
chitin defence signalling and in mycorrhization (Miyata et al., 2014). Furthermore, MtLYK3 
was demonstrated to be a close homolog of OsCERK1, and LYK3 but not NFP was shown to 
be necessary for mycorrhizal infection in M. truncatula (Zhang et al., 2015). This therefore 
suggests further overlap between nodulation, mycorrhization and even defence signalling 
and thus it is now less clear how specificity of these pathways is achieved. 
 
Downstream of the common Sym pathway are Nodulation Signalling Pathway1 (NSP1) and 
NSP2. These are nuclear-localised GRAS-type transcription factors and were demonstrated 
to function downstream of calcium spiking and CCaMK in nodulation signalling (Smit et al., 
2005), (Kalo et al., 2005). Furthermore, these receptors were shown to form a complex 
which directly binds to the promoters of early nodulin genes (Hirsch et al., 2009). In 
addition, a mycorrhizal-specific GRAS-type transcription factor has been identified: 
Required for arbuscular mycorrhization1 (RAM1). Mutants affected in this gene are unable 
to be colonised by mycorrhizal fungi (Gobbato et al., 2012). Recently, it has been shown 
that there is also crossover in the nodulation and mycorrhization pathways at the 
transcription factor level. NSP1 has been shown to play a role in mycorrhization, because in 
the nsp1 mutant of M. truncatula both the frequency of mycorrhizal colonisations and the 
response to mycorrhizal lipo-chitooligosaccharides were reduced (Delaux et al., 2013a). 
Furthermore, new data reveal a potential role of both NSP1 and NSP2 in addition to RAM1 
in mycorrhization (Maillet et al., 2011), (Leonie Luginbuehl, 2015, personal 
communication). 
 
Many further genetic elements of both nodulation and mycorrhization signalling have been 
identified, including NIN, ENOD11, ERN1, NF-YA1/2, VAPYRIN, CERBERUS, HCL, SYMREM etc 
(Marsh et al., 2007), (Journet et al., 2001), (Cerri et al., 2012), (Laloum et al., 2014), 
(Murray et al., 2011), (Takeda et al., 2013), (Catoira et al., 2001), (Lefebvre et al., 2010). 
However, it is not within the scope of this literature review to cover them all because they 
function downstream, or in conjunction with, the Sym pathway. 
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1.3 Calcium signalling in plants  
 
1.3.1 Calcium as a universal secondary messenger 
 
Calcium ions are an important secondary messenger for both animal and plant cell 
signalling. Calcium ions act as an intracellular messenger for a large number of processes, 
relaying specific information by its ability to produce a wide variety of different signals. In 
animals, calcium ions are involved in processes throughout the life-span of the organism, 
right the way from fertilisation to cell death (Berridge et al., 1998). In plants, calcium ion 
signalling is equally versatile, and occurs via changes in calcium which form distinct 
stimulus-specific “signatures”. Plant calcium signals are involved in a diverse range of 
processes including: stress signalling e.g. osmotic/ salt/ oxidative stresses, pathogen 
signalling, circadian clock regulation, hormonal signalling and of course bacterial/fungal 
signal transduction. Specificity of the signal is therefore extremely important and can be 
conferred in a variety of ways including by the frequency, amplitude, duration and number 
of calcium waves or oscillations (although not all calcium signals are oscillatory).  
Furthermore, specificity can be conferred by comparmentation of the signal, either by 
variation of spatial localisation within the cytosol, or within organelles including the 
nucleus, mitochondria and chloroplast (McAinsh and Pittman, 2009). For example, calcium 
signals in the mitochondria have been implicated in response to touch stimuli in 
Arabidopsis thaliana (Logan and Knight, 2003) and chloroplast calcium signals are involved 
in response to dark as a circadian indicator in Nicotiana plumbaginifolia (Johnson et al., 
1995). Further signal specificity can be conferred by signals in different tissue types, cell 
types and during different developmental stages. 
 
Calcium signals are generated by a number of channels and pumps. Calcium channels in 
plants are, in general, calcium-permeable rather than calcium-selective and include plasma 
membrane channels (e.g. hypersensitive- and depololarisation-activated calcium channels, 
and mechanosensitive channels) and endomembrane channels (e.g. slow-vacuolar, voltage-
gated and cADP-ribose channels). Furthermore, calcium pumps are required for rapid 
removal of calcium because at high levels it is toxic. Calcium efflux transporters include 
high affinity (e.g. ER-type Ca2+-ATPases and autoinhibited Ca2+-ATPases) and low affinity, 
high capacity calcium exchangers. Therefore, these channels and pumps serve to modulate 
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the calcium signal specifically depending on the stimulus and then return calcium ion levels 
back to the resting state after a signal (McAinsh and Pittman, 2009). 
 
Interestingly, oscillations of calcium are theorised to encode pathway-specific information. 
For example, in animal cells, it was demonstrated that calcium oscillations are not just a by-
product of calcium homeostasis but encode information and increase the efficiency of the 
signal. This is because specific gene expression was induced by the frequency of the 
oscillations and oscillations reduced the threshold needed for the activation of particular 
transcription factors (Dolmetsch et al., 1998). This is also the case in plant systems. Calcium 
oscillations have been studied in several systems including pollen tube growth, stomatal 
guard cell regulation and in Nod-factor signalling (section 1.5.2). In stomatal responses, it 
has been shown that the strength of stomatal closure correlates with the stimulus and the 
resultant calcium oscillation (Evans et al., 2001). This system is further discussed in section 
1.3.2. Therefore, calcium is an important secondary messenger in many signalling pathways 
and plants are able to precisely control calcium oscillations to produce a variety of 
downstream responses. 
 
 1.3.2 Case study: Cytosolic calcium changes in stomata 
 
One of the most important pathways involving cytosolic calcium ion signalling is the 
regulation of stomatal opening and closure. Stomata are key to regulating gas exchange 
and water-loss in the plant, therefore stomatal aperture must be tightly regulated. 
Cytosolic calcium oscillations and transients in guard cells are triggered in response to a 
wide variety of stimuli including ABA, H2O2, cold, pathogens and external calcium 
(Hetherington and Brownlee, 2004). Interestingly, different calcium signatures are 
produced in response to these stimuli which are thought to encode information about the 
type and strength of the stimulus perceived. It has been demonstrated in A. thaliana that 
different concentrations of external calcium induce different calcium oscillations. For 
example, oscillations induced by 1 mM external calcium showed an average amplitude of 
160 nM but by contrast, 10 mM external calcium-induced oscillations had an average 
amplitude of 1020 nM (Allen et al., 2000). Furthermore, different stimuli likely access 
different mechanisms for the generation of these different calcium oscillatory signatures. 
For example, the de-etiolated 3 (det3) mutant of A. thaliana corresponds to a 60% 
reduction in the expression of the C-subunit of the V-type H1–adenosine triphosphatase (V-
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ATPase). In the det3 mutant, calcium oscillations and stomatal closure were abolished in 
response to external calcium and oxidative stress. However, stomatal closure and 
corresponding calcium oscillations still occurred in response to cold stress and ABA, 
suggesting different mechanisms for the generation of the calcium signatures (Allen et al., 
2000). 
 
Different stomatal responses are also encoded by the cytosolic calcium signatures. First, 
stomatal closure can occur in either a short-term or long-term manner. Short-term closure 
is encoded in the increase of cytosolic calcium to a required threshold. By contrast, long-
term programmed stomatal closure occurs in response to specific calcium oscillatory 
signals. This was demonstrated to be encoded in the frequency, spike number, duration 
and amplitude of the calcium signature (Allen et al., 2001). Furthermore, calcium has also 
been shown to play a role in stomatal opening in response to low atmospheric CO2 (Young 
et al., 2006). This demonstrates some of the complexity involved in stomatal signalling, 
because calcium signatures can mediate both stomatal opening and closure.  The 
mechanisms involved in these different stomatal responses have begun to be elucidated, 
including the role of calcium-dependent protein kinases (CDPKs). For example, cpk3 and 
cpk6 mutants of A. thaliana show impaired ABA activation of plasma membrane calcium-
permeable channels and slow-type anion channels. Interestingly, the double mutant of 
cpk3 and cpk6 was impaired in only the short-term closure response and not the long-term 
programmed response (Mori et al., 2006). These data demonstrate an important role for 
CDPKs in stomatal calcium signalling and show that the two observed calcium-induced 
closure responses are mediated in different ways. This system is an example of the 
importance of calcium signatures in signalling pathways and the precise control plant cells 
have over calcium oscillations to produce specific downstream responses. 
 
1.4 Calcium signalling in the Sym pathway 
 
Two calcium responses have been observed in legume roots in response to Nod factors: 
calcium flux and calcium oscillations (Figure 1.6). Calcium influx occurs rapidly after the 
signal and is followed by membrane depolarisation (Felle et al., 1999), (Ehrhardt et al., 
1992). Calcium oscillations are observed approximately 10 minutes after the initial signal 
and these oscillations are known as calcium spiking (Wais et al., 2002). Calcium spiking is 
also observed in response to Myc factors (Kosuta et al., 2008). 
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Figure 1.6 Nod factor-induced calcium responses observed in WT M. truncatula root hair 
cells, measured using Cameleon YC3.6. The horizontal black line represents the addition of 
10 nM Nod factor. Figure courtesy of Sarah Shailes. 
 
 1.4.1 Calcium flux 
 
The calcium flux occurs within one minute of Nod factor application and has been observed 
with both ion-specific micro-electrodes and calcium sensitive dyes (Felle et al., 1999), 
(Shaw and Long, 2003). This calcium flux response is widespread amongst legumes and has 
been detected in the root hair cells of M. truncatula, Vicia sativa and P. sativum, amongst 
others. Root hairs have an inherent calcium gradient during growth, with the highest 
concentration present at the tip of the root hair. When Nod factor is applied, a wave of 
calcium influx begins at the tip and moves along the length of the root hair cell towards the 
nucleus. The calcium which participates in this influx is thought to be derived from both 
external and internal stores. Following this, the efflux of chloride and potassium occurs, 
with subsequent cytosolic alkalisation (Oldroyd and Downie, 2004).  
 
Shaw and colleagues (Shaw and Long, 2003) determined that calcium flux and calcium 
spiking are in fact separable. First, different Nod factor requirements are necessary for 
each response. At 1 nM Nod factor, root cells showed only the calcium spiking response 
after approximately 10 min. However, on application of 10 nM Nod factor, calcium influx 
was observed, followed by calcium spiking as expected. These were also differentially 
localised in the cell. Furthermore, mutants which were impaired in calcium spiking were 
still capable of producing the calcium influx response. These included the dmi1 and dmi2 
mutants of M. truncatula (Shaw and Long, 2003) and nup133 and sym24 of L. japonicus 
(Miwa et al., 2006b). This suggests that calcium spiking does not require prior calcium flux. 
It is therefore unclear as to what potential role calcium flux might play in symbiosis 
signalling, since it requires such a high Nod factor concentration. One hypothesis which has 
been proposed is that they could function in the opposite order than they have been 
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observed when Nod factor is artificially applied. When bacteria encounter the legume root 
in the soil, the calcium flux would be activated after calcium spiking and root hair 
deformation had occurred because when the bacteria is encased in the root hair curl the 
concentration of Nod factor experienced by the plant would be sufficiently high. The 
calcium spiking would then play a role in infection thread development, after calcium 
spiking (Miwa et al., 2006b). Consistent with this, Morieri and colleagues (Morieri et al., 
2013) demonstrated the importance of the calcium influx for efficient nodule infection.  
 
 1.4.2 Calcium spiking 
 
Calcium spiking is observed approximately 10 minutes after application of Nod factor or 
rhizobia, and this delay is thought to allow calcium homeostasis changes to occur. 
Individual calcium spikes are characterised by a sharp increase in calcium and a slower 
decline. The calcium spiking response was first characterised by Erhardt and colleagues 
(Ehrhardt et al., 1996) in M. sativa roots injected with dextran-linked calcium-selective 
dyes. They demonstrated that the calcium spiking signal is localised to the nuclear region of 
the cell and that key structural features of Nod factors were essential to stimulating the 
response. Furthermore, the calcium changes were quantified to occur between 
approximately 150 – 800 nM (Ehrhardt et al., 1996), (Felle et al., 1999). Subsequently, the 
localisation of calcium spiking was confirmed as occurring within the nucleus by Sieberer 
and colleagues (Sieberer et al., 2009) in M. truncatula using a nuclear localised form of 
Cameleon (a calcium responsive protein, that undergoes fluorescence resonance energy 
transfer on Ca2+ binding that can subsequently be detected). They also demonstrated that 
some spiking occurs in the nuclear region of the cytosol within the cell. Calcium spiking has 
also been shown to stimulate gene expression, in particular 36 spikes were shown to be 
sufficient to induce ENOD11 expression (Miwa et al., 2006a). All nodulating species, 
present in the nitrogen-fixing clade, have been shown to possess this same calcium 
response (Granqvist et al., 2015). 
 
Calcium spiking has also been characterised in mycorrhization signalling. Nuclear-localised 
Cameleon was again used with M. truncatula and the non-legume Daucus carota. Calcium 
spiking was observed when a root organ culture came into contact with hyphopodia and 
when treated with spore exudate. Therefore this shows that calcium spiking is also present 
in the arbuscular mycorrhizal symbiosis signalling pathway for both legumes and non-
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legumes (Chabaud et al., 2011). The calcium spiking signature in both the nodulation and 
mycorrhization pathway are chaotic in nature, which leads to a robust but flexible signalling 
system (Hazledine et al., 2009). Interestingly, it has previously been theorised that 
specificity in the Sym pathway may be encoded by different calcium spiking signatures in 
the nodulation and mycorrhization pathways. Nod factor-induced calcium spiking was 
shown to have a periodicity of 90 s and Myc factor-induced signals were more variable, 
with a shorter periodicity (30 s) and lower amplitude (Kosuta et al., 2008). However, more 
recent data have called these conclusions into question. Sun and colleagues (Sun et al., 
2015) analysed calcium responses in M. truncatula to various different lipo-
chitoligosaccharides. They concluded that there was in fact a high degree of similarity 
between the Myc and Nod responses detected, but some differences in the frequency of 
spiking were still observed. However, these frequency differences can now be explained by 
work carried out by Sieberer and colleagues (Sieberer et al., 2012). They observed a switch 
in the frequency of calcium oscillations when both microbes infected the cortex, and prior 
to this calcium spiking was less regular. This could therefore account for the differences 
previously observed between mycorrhizal- and rhizobial-induced calcium spiking. Whilst 
calcium-spiking is therefore not likely to show differences relating to mycorrhization or 
nodulation, it has been theorised that differences observed could encode information 
about the specific mix of symbiosis signals which are perceived by the cell (Charpentier and 
Oldroyd, 2013). 
 
The position of calcium spiking in the sym pathway has been determined genetically. This 
was analysed using mutants of dmi1, dmi2 and dmi3 in M. truncatula (Wais et al., 2000). 
Mutants in all three genes do not develop nodules or infection threads, they show 
abnor al root hair responses to Nod factor and they don’t show cortical cell divisions. 
However, whilst both dmi1 and dmi2 mutants are defective for calcium spiking, dmi3 
mutants showed WT calcium spiking responses to Nod factor application. Therefore, this 
places calcium spiking downstream of both DMI1 and DMI2 but upstream of DMI3 (Figure 
1.3). Furthermore, this was confirmed by work using P. sativum mutants (Walker et al., 
2000) and this placed SYM8 (DMI1), SYM10 and SYM19 (DMI2) upstream of calcium spiking 
but SYM2A, SYM7, SYM9 (DMI3) and SYM30 downstream (homologues of the three 
equivalent M. truncatula genes mentioned above are indicated in brackets). Therefore 
CCaMK (DMI3) is well-placed to interpret and transduce the calcium spiking signal in the 
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sym pathway, and it is widely accepted as the decoder of this signal. CCaMK is discussed in 
detail in section 1.7. 
 
The role of different proteins in the generation of the symbiotic calcium spiking signal has 
also been somewhat elucidated. DMI1 is essential for the generation of the calcium spiking 
signal and it encodes an ion channel with similarity to a potassium channel of 
Methanobacterium thermoautothrophicum. It was demonstrated that whilst DMI1 is not a 
calcium channel, it is important for the regulation of calcium release and therefore it 
regulates calcium spiking (Peiter et al., 2007), (Charpentier et al., 2008). It is localised to the 
inner nuclear membrane.  Another component which is essential for calcium spiking is the 
sarco/endoplasmic reticulum calcium ATPase (SERCA) MCA8 (Capoen et al., 2011), which is 
a calcium pump localised to both the inner and outer nuclear membranes and the 
endoplasmic reticulum. Mathematical modelling of the system has revealed how these 
proteins may function together to generate the calcium spiking signal. The store of calcium 
is hypothesised to be the nuclear envelope which is continuous with the endoplasmic 
reticulum. Interestingly, the model predicts a crucial third component in the generation of 
the calcium spiking signal which has not yet been identified: a calcium channel. This 
channel is theorised to be voltage-gated. The model further predicts the importance of 
calcium buffer proteins (for example calmodulin (CaM)) for the shaping of and the 
termination of calcium spiking (Granqvist et al., 2012). Future experimental work will be 
crucial to validate this model; for example, by identification of the calcium channel. 
Furthermore, the role of DMI1 in the generation of the calcium signal requires further 
experimental characterisation. Modelling reveals that it is likely that DMI1 functions as a 
counter ion channel and as an activator of the potential calcium ion channel, in a calcium-
induced manner (Charpentier et al., 2013). Experimental work will also be required to 
validate this theory. 
 
1.5 Calcium-binding proteins in plants 
 
Plants possess a number of different calcium binding proteins, which can be divided into 
two groups: those containing EF-hands and those which do not possess EF-hands. Non EF-
hand proteins show a lower affinity for calcium and are less well characterised in general. 
The calcium binding regions of the protein are structurally varied but possess similar acidic 
amino acids. Examples of non EF-hand proteins include annexins and C2 domain-containing 
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proteins. The annexin family of proteins are characterised by four 70 amino acid annexin 
folds that form a cyclic array. They bind calcium on the convex membrane-binding side of 
the protein. The C2 domain-containing proteins are more thoroughly characterised, and 
these contain the C2 130-145 amino acid region that consists of three conserved 
subdomains. Calcium-binding in the C2 domain occurs at loops in between β-sheets and 
does not confer a conformational change. Instead, binding calcium allows an interaction 
with phospholipids. Examples of C2 domain proteins include phospholipase C, protein 
kinase C and cytosolic phospholipase A2 (Sathyanarayanan and Poovaiah, 2004), (Reddy 
and Reddy, 2004). 
 
EF-hand proteins are much more common and for example the genome of A. thaliana 
encodes over 250 EF-hand-containing proteins (Day et al., 2002). The EF-hand motif is 
highly conserved, and is found in plants as well as animal proteins. They are generally 
found in pairs within proteins and allow calcium ions to bind with a high affinity. Each EF-
hand consists of a helix-loop-helix structure, where one calcium ion is coordinated by the 
loop region, inducing a conformational change. Each helix consists of approximately 10 
residues, and the loop region contains 12. Calcium is co-ordinated by seven ligands, five of 
which are provided by the loop region and two of which are supplied by an amino acid of 
one of the helices. This forms the preferred co-ordination geometry for calcium: a 
pentagonal bipyramid. This means that several of the residues in the EF-hand loop region 
are highly conserved. Sometimes, the coordination sphere of calcium is completed with a 
water molecule. The conformation described corresponds to the canonical EF-hand domain 
structure, but there are also several different non-canonical EF-hand structures (Gifford et 
al., 2007). 
 
There are three main types of EF-hand proteins found in plants: CaM (and CaM-like 
proteins, CML), calcium-dependent protein kinases (CDPKs) and calcineurin B-like (CBL) 
proteins. CaM is found in all eukaryotes, whereas the other types of proteins are unique to 
plants and some protists. These proteins can also be further classified by their function; 
they either function as “sensor relay” or “sensor responder” proteins. For exa ple, CaM 
and CML proteins bind calciu  but don’t have an enzy atic function and therefore are 
classified as sensor relay components. By contrast, CDPKs bind calcium and function as 
kinases and therefore are sensor responder proteins. CBLs in fact interact with CBL-
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interacting protein kinases (CIPKs) and therefore function as bimolecular sensor responders 
(Batistic and Kudla, 2012). The structures of these proteins are summarised in Figure 1.7. 
 
 
Figure 1.7. Structures of plant calcium binding proteins. Figure based on (Batistic and 
Kudla, 2012).  
CaM – Calmodulin, CDPK – Calcium-dependent protein kinase, CCaMK - Calcium- and 
calmodulin-dependent protein kinase, CRK – CDPK-related kinase, CBL – Calcineurin B-like 
protein, CIPK – CBL-interacting protein kinase. 
 
1.5.1 Calmodulin (CaM)  
 
CaM is the most well characterised EF-hand protein from plants. Whilst animal genomes 
encode a small number of CaM isoforms, typically plant genomes encode many more CaM 
genes for example A. thaliana has seven highly related forms. Furthermore, there are also 
many more CMLs; in A. thaliana there are 50 (DeFalco et al., 2010). This shows both the 
importance of CaM as a calcium sensor in plants and also indicates that it is involved in 
many different processes. 
 
CaM is a s all     150 amino acids,   17 kDa) acidic protein that consists of two globular 
domains, connected by a flexible helical linker region. Each globular domain contains a pair 
of EF-hands. By contrast, CML proteins are more variable and contain variable numbers of 
EF-hands. When calcium binds to CaM at each EF-hand, a hydrophobic patch is exposed via 
a conformational change that allows CaM to interact with downstream targets. The 
EF hand
CCaMK
CaM
CDPK
CBL
CIPK
CRK
Kinase domain CaM binding domainAutoinhibitory region
Degenerate EF hand
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conformational flexibility of the linker region confers target binding specificity. The CaM 
binding domains of target proteins do not have a consensus sequence, however they show 
a consensus secondary structure of an amphipathic α helix (Perochon et al., 2011), 
(DeFalco et al., 2010). Furthermore, CaM binding domains can also feature a net positive 
charge and two hydrophobic anchor residues. Interestingly, in some cases CaM can also 
bind to target proteins in a calcium-independent manner (Tidow and Nissen, 2013). These 
features allow specific and high affinity binding in a variety of signalling pathways. 
 
CaM can bind to a wide variety of target proteins including kinases, phosphatases, 
transcription factors, channels, pumps and many others. Furthermore, AtCaM7 has been 
shown to bind directly to DNA at the Z- and G-box motifs. This induces the expression of 
light-regulated genes (Kushwaha et al., 2008). In addition, CaM is implicated in a wide 
range of processes and is regulated by a wide variety of stimuli. For example CaM functions 
in growth and development, and stress responses including drought, salt, temperature 
shock, wounding and immune responses. Specificity of CaM and CMLs in these responses is 
achieved partially due to comparmentation of the different isoforms (e.g. cytosol, nucleus 
and peroxisome) and due to specific expression patterns during development (Perochon et 
al., 2011), (DeFalco et al., 2010). 
 
1.5.2 Calcium-dependent protein kinases (CDPKs) 
 
CDPKs consist of an N-terminal domain followed by a kinase domain, junction domain, 
calmodulin-like domain bearing four EF-hands and a C-terminal domain (Figure 1.7). They 
are theorised to have originated from gene fusion of a Ser/Thr kinase with an EF-hand 
domain derived from CaM (Zhang and Choi, 2001). CDPKs are also encoded by large 
families of genes in plants; in A. thaliana there are 34 CDPK genes. They are variable in size 
and this is conferred by variation in the N-terminal domain. CDPKs are maintained in the 
inactive state by the interaction of the junction domain, which forms a pseudo-substrate 
and blocks the active site whilst simultaneously interacting with the CaM-like domain. 
When calcium binds to the EF-hands, a large conformational change occurs, along with 
autophosphorylation, and the protein is active for target phosphorylation. Plants can also 
possess two related kinases: CDPK-related kinases (CRKs) and calcium- and calmodulin-
dependent kinase (CCaMK). CRKs have a similar domain structure to CDPKs except the EF-
hands in the CaM-like domain are degenerate and some isoforms can directly bind 
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Ca2+/CaM instead. CCaMKs are dually regulated by calcium and Ca2+/CaM, and their 
structure and activation is described in detail in section 1.7 (Batistic and Kudla, 2012), 
(Harper and Harmon, 2005), (DeFalco et al., 2010). 
 
Calcium-dependent protein kinases all transduce calcium signatures through 
phosphorylation of target proteins. Ser/Thr kinases catalyse the transfer of a phosphoryl 
group fro  the γ-phosphate of ATP to the hydroxyl group of a target residue, yielding a 
phosphorylated target protein and ADP. This is an example of covalent modification and 
can occur on the kinase itself (known as autophosphorylation) and on other target 
proteins. Phosphorylation can occur at serine, threonine or tyrosine residues however all 
plant calcium-dependent kinases phosphorylate just serine and threonine. Regulation by 
phosphorylation can impact negatively or positively on the activity of the protein, can 
create recognition sites for other proteins, and can facilitate transitions between ordered 
and disordered protein states (Endicott et al., 2012). Further regulation can be provided by 
de-phosphorylation for example by the action of phosphatases. Protein phosphorylation in 
response to calcium changes occurs in many different processes in plants, for example with 
CCaMK during symbiosis signalling (discussed in section 1.6).  
 
CPDKs function in diverse areas of cell signalling including: root and pollen tube growth, 
salt and drought stress, regulation of calcium and potassium homeostasis, and pathogen 
defence. Indeed, since there are so many different calcium-regulated kinases in plants it is 
theorised they will be involved in some way in the majority of developmental processes 
(Harper and Harmon, 2005), (Batistic and Kudla, 2012). Therefore specificity of signalling is 
important, and one of the ways in which this is achieved is by comparmentation. For 
example, CDPKs can be specifically found in the cytoplasm, nucleus, mitochondria and 
peroxisome (Harper and Harmon, 2005). Furthermore, many isoforms are membrane-
associated or can be either membrane associated or soluble e.g. AtCPK3 (Dammann et al., 
2003). In addition, some CDPKs can change subcellular localisation in response to stress 
stimuli; for example, Mesembryanthemum crystallinum CPK1 shifts from the plasma 
membrane to the nucleus in response to salt stress (Chehab et al., 2004). 
 
 
 
 
36 
Chapter 1: Introduction 
1.5.3 Calcineurin B-like proteins (CBLs) 
 
CBLs fall within the wider CaM superfamily, but are slightly larger than CaM at 23-26 kDa. 
In general they possess four EF-hands like CaM, but it is not clear if they are all functional. 
The A. thaliana genome encodes ten CBL genes. As described above, CBLs function by 
interacting with CIPK proteins, of which there are a further 26 encoded by A. thaliana. 
CIPKs are structurally related to sucrose-non-fermenting and AMP-activated kinases from 
yeast and animals respectively, although they are characterised by a unique C-terminal 
domain required for interaction with CBLs. Since there are many possible CBL-CIPK 
interaction combinations they have the potential to participate in a wide variety of 
pathways (Batistic and Kudla, 2012) (DeFalco et al., 2010). Similarly to the previously 
described plant calcium binding proteins, the CBLs and CIPKs function in a wide variety of 
processes and in response to many stimuli. These include salt, cold, wounding, pH, low 
oxygen and other stresses. Furthermore, there is also cross-talk between the CBL-CIPK 
network and other pathways including SOS, reactive oxygen species, potassium sensing, 
ABA and nitrate sensing pathways (Yu et al., 2014). 
 
1.6 CCaMK 
 
Calcium- and calmodulin-dependent protein kinase (CCaMK) is a serine/threonine protein 
kinase that is unique to plants but not ubiquitous amongst them. It was first identified in 
Lilium longiflorum where it has an open reading frame of 520 amino acids encoded by a 
single gene and is approximately 56 kDa in size when expressed in Escherichia coli (Patil et 
al., 1995). It was determined to contain three domains: catalytic domain, CaM-binding 
domain and a visinin-like Ca2+ binding domain. CCaMK is regulated in two ways: via 3 
functional EF-hands present on the visinin-like domain or, via CaM binding CCaMK when 4 
Ca2+ ions are bound to CaM. The fact that this protein can bind calcium directly through the 
visinin-like domain and indirectly, via calmodulin, sets it apart from the CDPKs. CCaMK is 
also controlled by autophosphorylation, which is stimulated by Ca2+ ions binding to the EF-
hands of the visinin-like domain, but inhibited by Ca/CaM binding to the CaM binding 
domain. The kinase domain can phosphorylate downstream targets when 
autophosphorylated and Ca2+/CaM is bound to CCaMK (Takezawa et al., 1996). 
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The function of CCaMK in plants remained elusive for several years despite biochemical 
characterisation of the protein. The first proposed function for the protein in L. longiflorum 
and Nicotiana tobacum was to detect transient changes in free Ca2+ and control 
developmental changes in the anther (Poovaiah et al., 1999). This was due to the detection 
of a stage- and tissue-specific expression pattern of CCaMK mRNA and protein during 
anther development. However, the key role of CCaMK was not elucidated until 2004, and 
surprisingly this role was in root and not flower tissue. A mutant of M. truncatula which 
failed to form root nodules (Nod-) known as dmi3 had been previously identified by Catoira 
and colleagues (Catoira et al., 2000). Mitra and colleagues (Mitra et al., 2004) and Levy and 
colleagues (Levy et al., 2004) determined that the DMI3 gene in fact corresponds to a 
CCaMK protein due to the high level of sequence similarity. Furthermore, they postulated 
that since the dmi3 mutant retains the nuclear calcium spiking signal it is therefore 
genetically downstream and so it is consequently the best candidate to interpret and 
transduce this signal in both nodulation and mycorrhization signalling (Levy et al., 2004). 
This was further confirmed by comparison with the sym9 P. sativum gene which has a 
similar phenotype and has a mutation in the orthologous gene. Furthermore, the DMI3 
gene has high sequence similarity to proteins in species which can form arbuscular 
mycorrhization, for example Oryza sativa. However, there is no CCaMK gene in the genome 
of A. thaliana,  which cannot form arbuscules. 
 
1.6.1 Early biochemical characterisation and the domain structure of CCaMK  
 
Early biochemical characterisation of CCaMK was carried out on L. longiflorum CCaMK. The 
domain structure of the CCaMK protein is shown in Figure 1.8. This schematic focuses on 
MtCCaMK because the results presented later in this thesis pertain to that protein, 
however the only difference pertains to the residue of autophosphorylation: T271 in M. 
truncatula and T267 in L. longiflorum. 
 
Figure 1.8. Domain structure of the CCaMK gene of M. truncatula, with key features 
marked. 
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The kinase domain is located at the N-terminus of the protein, and possesses all 11 
conserved sub-domains usually detected in Ser/Thr kinases (Patil et al., 1995). Substrate-
phosphorylation was determined to be Ca2+/CaM-dependent in vitro and 
autophosphorylation was shown to occur at threonine residues in response to calcium-
binding to the EF-hands of the visinin-like domain (Takezawa et al., 1996). Specifically, T267 
in the kinase domain (equivalent to T271 in MtCCaMK) was determined to be the main site 
of autophosphorylation by MALDI-TOF mass spectrometry. Mutation of this residue to 
phospho-ablative alanine abolished calcium-stimulated autophosphorylation and 
Ca2+/CaM-dependent kinase activity. Furthermore, homology modelling with Ca2+/CaM-
dependent protein kinase I (CaMKI) was carried out and it was determined that the T267 
residue was most likely surface exposed and located distantly from the active site of the 
kinase. This therefore suggests an inter-molecular mechanism of autophosphorylation 
occurs (Sathyanarayanan et al., 2001). An inactivation mechanism of the protein was also 
suggested, because it was demonstrated that Ca2+-stimulated autophosphorylation led to 
the loss of kinase activity in vitro due to the formation of a sedimentable enzyme 
(Sathyanarayanan and Poovaiah, 2002). However, the relevance of this finding has not 
been validated in planta. 
 
The CaM binding domain contains a single binding site for CaM and shows high sequence 
identity (79%) to the α subunit of the animal CaMKII protein, with both forming basic 
amphiphilic α helices (Takezawa et al., 1996). The CaM binding domain also overlaps with 
an auto-inhibitory (AI) domain. This was identified because a truncation of the protein 
containing only the kinase domain is constitutively active in vitro, and a calmodulin-binding 
domain peptide was shown to inhibit kinase activity (Ramachandiran et al., 1997). Whilst 
calcium-binding stimulates autophosphorylation 3.4 times basal level, Ca2+/CaM binding 
inhibits autophosphorylation to basal levels (Takezawa et al., 1996). Furthermore, 
Ca2+/CaM affinity is also affected by Ca2+-stimulated autophosphorylation; it was shown 
that after autophosphorylation, Ca2+/CaM binding was eight-fold tighter, releasing 
autoinhibition (Sathyanarayanan et al., 2000). Therefore the kinase activity of CCaMK is 
regulated by both calcium and calmodulin in a complex manner. This is further complicated 
by the potential for differential regulation of CCaMK by CaM isoforms, however this is not 
universal as it was only detected in N. tabaccum CCaMK but not L. longiflorum CCaMK (Liu 
et al., 1998). 
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The visinin-like domain (VLD) is located at the C-terminus of the protein and directly binds 
calcium ions at three functional EF-hands. Using point mutants for each EF-hand which 
prevented Ca2+ binding, it was shown that EF-hands 2 and 3 are essential for a mobility shift 
suggesting that a conformational change occurs on Ca2+ binding to the VLD (Takezawa et 
al., 1996). The three EF-hands are essential for full kinase activity. This was further 
dissected using deletion mutants of the EF-hands; as each EF-hand was sequentially 
deleted, kinase activity decreased. When all three EF-hands were removed, kinase activity 
was just 4% (Ramachandiran et al., 1997). Therefore, the EF-hands also play a key 
regulatory role in the function of CCaMK. The presence of a visinin like domain in a plant 
protein is, in fact, unique to CCaMK. It is so-named due to the structural and sequence 
homology to the animal visinin protein, which is a photoreceptor-specific calcium-binding 
protein that functions in the outer nuclear layers of the retina (Yamagata et al., 1990). 
 
These findings likely also apply to the other CCaMK proteins, including M. truncatula 
CCaMK. For example, Gleason and colleagues (Gleason et al., 2006) confirmed that DMI3 of 
M. truncatula is equivalent to CCaMK from L. longiflorum. Firstly they share 72% sequence 
identity, and secondly despite the fact that L. longiflorum forms only the association with 
mycorrhizal fungi and does not form nodules, LlCCaMK can complement the dmi3-1 mutant 
of M. truncatula. Therefore, it seems that the protein performs the same functions in both 
species, and in both associations. 
 
1.6.2 Gain-of-function mutants 
 
Important discoveries about the role of CCaMK in the sym pathway were made using gain-
of-function mutants. Tirichine and colleagues (Tirichine et al., 2006) characterised the snf1 
(spontaneous nodule formation) mutant of L. japonicus which corresponds to a point 
mutation of T265I. T265 corresponds to the previously characterised autophosphorylation 
residue of T267 in L. longiflorum and T271 in M. truncatula CCaMK.  When T265 was 
mutated to isoleucine, spontaneous nodules were formed in the absence of calcium 
spiking, Nod factor or rhizobial infection. Furthermore, normal bacterially infected nodules 
were formed in the snf1 mutant when inoculated with the bacterial symbiont M. loti. These 
data therefore shows that WT CCaMK is negatively regulated and the loss of the ability to 
be autophosphorylated releases this negative suppression. 
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Gleason and colleagues (Gleason et al., 2006) characterised mutants of M. truncatula 
CCaMK which lacked the auto-inhibitory domain. When expressed under the native 
promoter, spontaneous nodulation and concurrent nodulation-gene expression was 
observed, in a manner analogous to the snf1 mutant phenotype. Similarly, no bacterial 
stimulus was needed and nodules developed with no rhizobial infection. However, in 
contrast to the snf1 phenotype, no infected nodules were developed on inoculation with 
the rhizobial partner, S. meliloti, indicating that the regulatory domains of CCaMK are 
essential for the protein’s full function. They also demonstrated that point mutations of the 
autophosphorylation site T271 to alanine (phospho-ablative) and aspartate (phospho-
mimetic) led to the activation of nodulation gene expression in the absence of Nod factors. 
In contrast to the truncation mutant, both of the point mutations were able to complement 
the dmi3-1 mutant and produced infected nodules. They are therefore fully functional 
proteins. This result was unexpected as usually phospho-ablative and phospho-mimetic 
versions of a protein would yield different biological effects. Furthermore, it implies that 
the mechanisms by which the gain-of-function phenotype occurs is different for the 
truncation and point mutants. 
 
The significance of this work is profound. It shows that CCaMK is upstream of nodule 
organogenesis and furthermore activation of CCaMK alone is sufficient to induce 
nodulation. Further work by Hayashi and colleagues (Hayashi et al., 2010) demonstrated, in 
addition, that upstream Sym pathway elements are required entirely to activate CCaMK in 
the pathway. This is because the gain-of-function T265D mutation complements loss of 
function mutations in upstream elements (symrk, castor, pollux, nup85) for both nodule 
organogenesis and rhizobial and mycorrhizal infection. This emphasizes the central role 
that CCaMK plays in the Sym pathway, and therefore the potential for engineering 
nitrogen-fixing crops by the autoactivation of one protein in the pathway. 
 
1.6.3 Biochemical characterisation of calcium and calmodulin binding 
 
The calcium and CaM binding properties of MtCCaMK were further characterised by 
Swainsbury and colleagues (Swainsbury et al., 2012). The experiments were carried out 
with shorter constructs of CCaMK, containing either the VLD or the AI and VLD, which were 
monomers in solution. The conformational change that occurs when calcium ions bind to 
the EF-hands was determined to correspond to a change in only the tertiary structure of 
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the protein. This corresponded to an exposure of a hydrophobic cleft on the protein, in a 
manner analogous to CaM. Since no change in quaternary structure was detected in the 
presence of calcium, the function of the exposure of this hydrophobic patch and 
conformational change is most likely to facilitate the binding to target proteins and not to 
other CCaMK subunits. However, it is currently unknown as to whether this hydrophobic 
patch is also exposed in the full-length protein.  
 
It was further determined that the three functional EF-hands have different affinities for 
calcium; EF-hand 3 is a high affinity site (Kd ≤ 20 nM) and EF-hands 1 and 2 have a lower 
affinity for calcium (Kd = 200 nM). CaM-binding to CCaMK was determined to occur in a 1:1 
ratio, with an affinity of 55 nM in the presence of calcium. The calcium-binding affinities for 
the EF-hands of CaM were deter ined to be 1 and 15 μM (although these are expected to 
decrease in the presence of a target peptide i.e. CCaMK).  
 
This therefore facilitates the prediction of how CCaMK functions during calcium-spiking. 
Basal calcium levels in the nucleus are estimated at 125 – 150 nM, and at this 
concentration the high affinity EF-hand 3 is occupied, but not EF-hands 1 and 2. During a 
calcium spike (625 – 850 nM), calcium can then bind to the lower affinity EF-hands, and to 
CaM which can then bind to CCaMK. Since association rates of calcium and CaM were 
determined to be near diffusion limited and dissociation rates relatively high, it can also be 
concluded that the formation of the CCaMK-CaM complex (and binding and release of 
calcium from the VLD and CaM) mirrors the calcium spiking signal. 
 
1.6.4 CCaMK structure  
 
No crystal structure for CCaMK from any plant species has yet been elucidated and 
therefore this remains an extremely important question regarding CCaMK. Previous 
attempts to produce crystals of CCaMK or truncations of the protein in this lab have also 
been unsuccessful. The best structural data available for CCaMK currently is based on 
homology modelling. However, homology modelling of CCaMK has limitations due to low 
sequence identity with potential template proteins, and therefore any conclusions drawn 
must be considered in this light. It will become extremely important therefore in future 
work to obtain a high resolution crystal structure of CCaMK in order to validate conclusions.  
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Homology modelling of CCaMK has been carried out with rat brain CaMKI 
(Sathyanarayanan et al., 2001) and more recently with Caenorhabditis elegans CaMKII 
(Shimoda et al., 2012). Despite the relatively low sequence identity of CCaMK with these 
target proteins, some useful structural information was gleaned by this method. 
Conclusions from the CaMKI model were discussed above (Section 1.6.1). From the CaMKII 
model, Shimoda and colleagues predicted a hydrogen bonding network involving the key 
autophosphorylation residue in L. japonicus, T265. This network is predicted to form 
between the un-phosphorylated form of T265 and residues S237, K264, E313 and R317. 
This network was predicted to be disrupted by autophosphorylation at T265 and in gain-of-
function mutants T265D, T265A and T265I. In order to validate this model, they mutated 
one of the predicted residues, R317, to His and spontaneous nodulation was observed as 
predicted. Therefore they postulated that this hydrogen bond network acts as a “molecular 
brake” which would aintain CCaMK in an inactive state. Models for the function of 
CCaMK were therefore proposed based on this data, which are detailed in (Singh and 
Parniske, 2012) and (Poovaiah et al., 2013). These models will not be discussed in this 
review however because subsequent homology modelling of CCaMK was carried out by 
(Miller et al., 2013) using CDPK structure scaffolds in the presence and absence of calcium. 
This model is more consistent with recent in vitro and in vivo data pertaining to the 
autophosphorylation of CCaMK, and therefore is discussed in detail below. 
 
1.6.5 Model of function 
 
Shimoda and colleagues (Shimoda et al., 2012) predicted the existence of a hydrogen bond 
network in LjCCaMK as described above. This network would then be disrupted by 
autophosphorylation at T265 (equivalent to M. truncatula T271) which would allow the 
protein to be active for downstream phosphorylation. However, this model is inconsistent 
with data obtained by Miller and colleagues (Miller et al., 2013) which suggests that 
autophosphorylation at T271 in fact negatively regulates the protein. Several pieces of 
evidence are consistent with this representing the inactive state. First, the mutation or 
deletion of any of the EF-hands leads to a gain-of-function phenotype and therefore the EF-
hands must negatively regulate the protein. Since calcium-binding to the EF-hands 
promotes T271 phosphorylation, it follows that this may be a negative regulator. These 
experiments were carried out using the native promoter and not an over-expression 
promoter (e.g. 35S) (Shimoda et al., 2012) which could account for the differences 
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observed. Alternatively, the differences observed could be explained by the strength of the 
inoculum used (Ben Miller, personal communication). Second, the homology model of M. 
truncatula CCaMK (Miller et al., 2013) predicts the hydrogen bond network involving the 
T271 residue similar to that predicted for LjCCaMK, but this model is instead stabilised by 
the presence of phosphorylation at T271. This involves hydrogen bonds between R323 and 
pT271 (2 bonds) and S322 and pT271 (1 bond). This difference between the two models 
occurs because the model in (Shimoda et al., 2012) did not take phosphorylation into 
account. Finally, truncations of the protein which are autoactive showed low levels of 
phosphorylation at T271, therefore suggesting that pT271 is associated with the inactive 
state of CCaMK. Therefore, the stable inactive state of the protein involves pT271 and a 
hydrogen bond network formed between pT271 and the CaM-binding domain. 
 
The model proposed by Miller and colleagues (Miller et al., 2013) takes these data into 
account, along with the kinetics of calcium and CaM binding to CCaMK as described above 
(Section 1.6.3). This model is shown in Figure 1.9. At basal calcium levels, at least one EF-
hand is predicted to bind calcium and this is sufficient for phosphorylation at T271 over 
time. The mechanism by which this autophosphorylation occurs is currently unknown. In 
contrast to the model proposed by Shimoda and colleagues, this state is the basal, inactive 
state of CCaMK. This predicted inactive state of CCaMK at basal calcium (125-150 nM) is 
stabilised by the hydrogen bond network described above including pT271 and any 
mutation to this residue would perturb this state and lead to a gain-of-function phenotype. 
This is because, in this particular case, a previously assumed phospho-mimetic residue (e.g. 
Asp) would not appropriately mimic the phosphorylated state. Therefore it would not form 
the same predicted hydrogen bonds, and consequently any mutation of this residue is 
predicted to disrupt the hydrogen bond network. 
 
During a calcium-spike (625 – 850 nM), calcium binds to the four EF-hands of CaM and CaM 
can subsequently bind to CCaMK. Due to the proximity of the CaM binding site to the 
hydrogen bonding residues, this disrupts the hydrogen bonding network. This also 
overrides the negative regulation of phosphorylation at T271. In this configuration, CCaMK 
is active for target phosphorylation. In fact, calcium binding to the EF-hands primes the 
protein for activation because the resultant autophosphorylation enhances the affinity of 
CCaMK for calmodulin. This dual regulation of CCaMK by calcium and CaM binding allows 
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CCaMK to distinguish between basal calcium levels and calcium spiking, and therefore 
CCaMK is uniquely placed to interpret the calcium spiking signal in a robust manner.  
 
A mechanism for the inactivation of CCaMK has also been proposed. Two residues in the 
CaM-binding domain have been identified which negatively regulate CCaMK function. 
Routray and colleagues (Routray et al., 2013) and Liao and colleagues (Liao et al., 2012) 
identified S344 and S343, respectively, as autophosphorylated residues. Phosphorylation of 
either of these residues has a negative impact on CCaMK function by inhibition of CaM 
binding, and therefore these residues could represent the “off switch” for the protein. 
However, the mechanism by which this occurs is currently unclear. 
 
Figure 1.9. Schematic of MtCCaMK activation. Figure adapted from (Miller et al., 2013). 
 
1.6.6 CCaMK in different cell types and different plant species 
 
CCaMK has been shown to have particular functions in different cell types in M. truncatula. 
DMI3 is expressed in both the epidermis and cortex during nodulation, with up-regulation 
in dividing cortical cells prior to infection thread growth. Tissue-specific promoters were 
used to unpick the specific roles for CCaMK in these different cell types. It was 
demonstrated that epidermal expression of DMI3 (in the dmi3 mutant) was sufficient for 
infection thread formation, but this expression alone did not allow cortical cell division. 
Interestingly, combined expression of DMI3 in the epidermis and cortex was sufficient for 
both cortical cell divisions and subsequent nodule organogenesis in addition to infection 
thread formation. However, nodule infection was not restored, perhaps due to 
inappropriate levels of the protein provided by the specific promoters. Despite this, these 
data show that CCaMK plays important roles in both early and late symbiosis signalling 
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(Rival et al., 2012). In addition, the cell-specific roles of CCaMK during mycorrhization have 
been explored. The phenotypes observed when tissue-specific expression of DMI3 was 
controlled in mycorrhization were analogous to those observed during nodulation; cortical 
expression alone did not rescue the mutant phenotype, however penetration of the fungus 
was observed with epidermal expression (Rival et al., 2013). Therefore, CCaMK also has 
cell-autonomous roles in mycorrhization. 
 
CCaMK has also been characterised in a number of species. CCaMK has been characterised 
in O. sativa, a species which can form mycorrhizae but not nodules. Godfroy and colleagues 
(Godfroy et al., 2006) theorised that because nodulation likely evolved from the more 
ancient mycorrhization symbiosis, that CCaMK may be able to discriminate and interpret 
both rhizobial and mycorrhizal signals. Interestingly, they demonstrated that the dmi3 
mutant of M. truncatula can be recovered for nodule organogenesis by the CCaMK gene 
from O. sativa. This indicates that CCaMK is able to function in both these pathways despite 
the transfer from a non-legume to a legume, and suggests functional conservation in the 
evolution of the pathway. However, this conservation is not absolute because rhizobial 
infection was not complemented. On the other hand, the conservation of CCaMK was 
further confirmed by mutant analysis in L. japonicus. OsCCaMK was able to fully 
complement the equivalent mutant in L. japonicus for both mycorrhization and nodulation, 
including for infection (Banba et al., 2008). This again indicates strong conservation 
between the pathways, and perhaps indicates a greater similarity between the O. sativa 
symbiotic pathway and that of L. japonicus as opposed to M. truncatula. 
 
CCaMK is also found in the tropical, semi-aquatic legume species Sesbania rostrata, and its 
role in symbiotic signalling in this species has been characterised (Capoen et al., 2009). S. 
rostrata shows a novel mechanism for bacterial invasion; intracellularly at cracks in the root 
epidermis. This is also characterised by an altered calcium spiking signal in which calcium 
spikes have a higher frequency and are more symmetrical. Interestingly, whilst CCaMK is 
conserved in S. rostrata it is not required for the pathway involving crack entry of bacteria. 
This was demonstrated because knockdown of CCaMK prevented nodule development but 
not intercellular infection. Therefore, whilst CCaMK is conserved in this species, it seems 
likely that it functions only in the conventional infection pathway and not the alternate 
infection pathway. 
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Interestingly, CCaMK has also been implicated in roles outside of symbiosis. As discussed 
above, the first role of CCaMK that was discovered was in anther development (section 
1.7). However, subsequently further roles of CCaMK have been indicated in O. sativa and 
Zea mays in abscisic acid- and brassinosteroid-induced antioxidant defence ((Shi et al., 
2014), (Yan et al., 2015), respectively), amongst others. This points to a potentially wider 
role of CCaMK in plants. 
 
1.6.7 Specificity in nodulation and mycorrhization 
 
The way in which specificity is encoded in symbiosis signalling is an important but as yet 
unanswered question. As described previously, recent work has shown it likely that the 
calcium spiking signatures during nodulation and mycorrhization are similar and therefore 
may not encode specificity. However, one possible difference between the pathways is in 
CCaMK regulation. Work by Shimoda and colleagues (Shimoda et al., 2012) using a mutant 
of L. japonicus CCaMK which abolishes CaM binding (CCaMKFN-ED) observed spontaneous 
nodulation, but these were un-infected nodules. However, surprisingly, the same mutant 
could be infected by mycorrhizal fungi. They concluded that the requirement for CaM 
binding to CCaMK differs between nodulation and mycorrhization, where it is dispensable 
for mycorrhization. However, several pieces of evidence call this conclusion into question. 
First, the CaM binding domain is conserved in all CCaMK proteins of non-legumes which 
have been identified, and therefore it follows that it most likely plays an important role in 
mycorrhization. Second, the CCaMKFN-ED mutation autoactivates the protein and leads to a 
lack of CaM binding and yet conclusions about the relevance of CaM binding have been 
drawn. This appears to be counter-intuitive because the mutation has rendered CaM 
binding irrelevant for protein function (Miller et al., 2013). 
 
Further to this work, the same group (Takeda et al., 2012) used a kinase-only form of L. 
japonicus CCaMK, which is a gain-of-function mutant. They showed that this utant didn’t 
complement bacterial entry (consistent with previous reports by Gleason and colleagues 
(Gleason et al., 2006)) however the formation of pre-penetration apparatus in root tissue 
was retained. This was indicated because cytoplasmic reprogramming and nuclear 
enlargement were both detected. This suggests that arbuscular mycorrhizal fungi 
colonisation could be complemented by this mutant, although this was not directly 
demonstrated. If this is the case, it suggests a potential divergence in the regulation of the 
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pathways by CCaMK, where the kinase domain is sufficient in mycorrhizal signalling 
whereas the regulatory domains are required for nodulation. 
 
Two alternative theories are that specificity in symbiosis signalling is encoded downstream 
of CCaMK or by an alternative pathway. 
 
 1.6.8 Interaction partners of CCaMK – CYCLOPS and CIP73 
 
IPD3 (interacting protein of DMI3) was first identified by Messinese and colleagues 
(Messinese et al., 2007) using a yeast-two hybrid system with CCaMK from M. truncatula as 
bait. They determined IPD3 to be a 58 kDa protein and showed that it co-localises with 
CCaMK to the nucleus and that they physically interact. Furthermore, the IPD3 gene is 
highly conserved amongst angiosperms. However A. thaliana lacks a homologue in a 
manner analogous to DMI3. Yano and colleagues (Yano et al., 2008) characterised the 
cyclops mutant of L. japonicus which shows a symbiotic phenotype of aborted infection 
with both rhizobia and mycorrhizal fungi. They determined that the CYCLOPS gene 
corresponded to the IPD3 gene of M. truncatula and confirmed that the physical 
interaction of CCaMK and CYCLOPS in the nucleus occurs constitutively. Furthermore, they 
demonstrated that CYCLOPS is a phosphorylation target of CCaMK. They also showed that 
the CYCLOPS gene from O. sativa complements the L. japonicus mutant and therefore its 
role in nodulation and mycorrhization is highly conserved. Additionally, CYCLOPS mutants 
cannot be complemented either for rhizobial or mycorrhizal infection by CCaMK gain-of-
function mutant, T265D, or WT CCaMK suggesting that CYCLOPS works in concert with 
CCaMK in the sym pathway (Hayashi et al., 2010). 
 
Further characterisation of IPD3 mutants in P. sativum and M. truncatula (Ovchinnikova et 
al., 2011), (Horvath et al., 2011) confirmed that mutation of CYCLOPS leads to “leaky” 
phenotypes, i.e. nodulation/mycorrhization are initiated but then aborted. This is in 
contrast to the other Sym pathway mutants and therefore suggests that mutants of 
CYCLOPS are less penetrant than those of the others components (Capoen and Oldroyd, 
2008). These data taken together show that CYCLOPS plays an important, but unknown, 
role in symbiosis signalling and further indicates that there may be genetic redundancy at 
this level in the pathway. 
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Recently, the function of CYCLOPS was elucidated by Singh and colleagues (Singh et al., 
2014). Interestingly, CYCLOPS functions directly as a transcription factor in a DNA sequence 
specific manner. Five phosphorylation target sites of CCaMK were identified on the 
CYCLOPS protein, two of which (S50 and S154) are needed for symbiosis signalling. When 
these two residues are mutated to Asp (phospho-mimetic), known as CYCLOPS-DD, this 
activates the protein to bind to the NIN promoter, specifically at the newly identified CYC-
BOX sequence. This DNA-binding most likely occurs by a conformational change that occurs 
when the protein is phosphorylated at S50 and S154. The C-terminus of CYCLOPS was 
determined to contain both the activation domain and the DNA binding domain, and the N-
terminus was determined to negatively regulate the protein activity. Crucially however, 
CYCLOPS-DD was shown to lead to a gain-of-function phenotype because in a ccamk 
mutant background, CYCLOPS-DD triggered spontaneous nodules. This therefore shows 
that phosphorylated CYCLOPS is able to bypass the requirement for CCaMK for nodule 
organogenesis and indicates that it is a key regulator of nodulation. 
 
CIP73 (CCaMK-interacting protein of approximately 73 kDa) is also an interaction partner of 
CCaMK in symbiosis signalling (Kang et al., 2011). This protein was similarly identified by 
yeast-two-hybrid screen, however in this case with just the kinase domain of L. japonicus 
CCaMK. CIP73 is a Scythe_N_ubiquitin-like protein and is also phosphorylated by CCaMK in 
the presence of Ca2+/CaM. Furthermore, knockdown of CIP73 decreased nodule formation. 
However, the function of the protein is currently unknown. Recently, an interaction 
between CIP73 and a homologue of an animal HSC/HSP70-interacting protein (HIP) was 
identified in L. japonicus, and knockdown of the HIP gene led to an increase in nodule 
number. Therefore HIP represents a potential negative regulator of nodulation (Kang et al., 
2015). 
 
It is likely that there are more, as yet unidentified, interaction partners of CCaMK because 
there is complexity in the system, i.e. multiple roles of CCaMK, which cannot be explained 
yet. For example, mutants of cyclops still retain Nod factor-induced root curling and cell 
division, and therefore CCaMK likely acts through additional target proteins during 
nodulation (Limpens and Bisseling, 2014). Furthermore, as discussed above, CYCLOPS binds 
to the NIN promoter after phosphorylation by CCaMK, however NIN is only induced during 
nodulation (Marsh et al., 2007). Therefore, additional factors, which are currently not 
understood, must be involved upstream of NIN to confer downstream specificity. 
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1.7 CaMKII 
 
Ca2+/CaM-dependent protein kinase II (CaMKII) is a well-characterised and broadly-
distributed metazoan Ser/Thr protein kinase. It has been used as a model for CCaMK due to 
the significant sequence and structural similarities between the two proteins. However, 
there are also significant differences in the mechanism of function between the two 
proteins. Key features of the mechanism of function and the regulation of CaMKII are 
therefore discussed in this section. 
 
CaMKII has been identified in a wide range of species, from lower organisms e.g. C. elegans 
to mammals e.g.  Homo sapiens. It performs a wide variety of roles in different tissues 
including, but not limited to, the regulation of carbohydrate, lipid and amino acid 
metabolism, calcium homeostasis, cytoskeleton regulation and transcription and 
translation (Hudmon and Schulman, 2002b). It is of particular importance in brain tissue 
and it is one of the most highly expressed proteins within neurons. Specifically, there is 
strong evidence that CaMKII is crucial for long term potentiation (LTP). LTP is the process by 
which long-lasting increases in the strength of synapses are triggered and this is thought to 
be a mechanism by which memory and learning occur within the brain. An increase in 
calcium is thought to activate CaMKII which in turn initiates the signalling cascade which 
leads to LTP (Lisman et al., 2012). CaMKII also plays crucial roles in cardiac tissue and it has 
been shown to have a role in hypertrophy and heart failure (Zhang et al., 2007). 
 
 1.7.1 Structure  
 
CaMKII proteins consist of three main domains: an N-terminal catalytic domain, an 
autoregulatory domain which overlaps with a CaM binding domain and a C-terminal 
association domain (Figure 1.10). In mammals, different isoforms of CaMKII are found for 
exa ple in hu ans there are four denoted α, β, γ and δ. These isoforms are all closely 
related and show 80-95% sequence similarity. These isoforms are differentially localised, 
with α and β situated in brain tissue and γ and δ localised in other regions of the body. 
Furthermore, these isoforms can be alternatively spliced which produces approximately 40 
variants in total (Hudmon and Schulman, 2002a), (Hudmon and Schulman, 2002b), 
(Stratton et al., 2013). One particular example of alternative splicing of CaMKII is discussed 
in section 1.8.3.  
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Figure 1.10 Domain structure of CaMKII. Figure adapted from (Hudmon and Schulman, 
2002b).  
 
The structure of CaMKII has been studied using a variety of methods. Early characterisation 
was carried out with transmission electron microscopy, which revealed that CaMKII forms 
an oligomer, which is usually dodecameric. The association domain is essential for this 
oligomerisation; whilst the association domains cluster together, the kinase domains and 
autoregulatory domains are projected to allow CaM-binding and kinase activity. The 12 
subunits form into two rings consisting of hexamers of subunits, which sit on top of each 
other (Kolodziej et al., 2000). Both hetero- and homo-oligomers of the CaMKII isoforms 
have been observed. More recently, crystal structures of the kinase and autoinhibitory 
domains separately have been resolved ((Rosenberg et al., 2005), (Hoelz et al., 2003) 
respectively  and re arkably a crystal structure of the en re    700 kDa holoenzyme from H. 
sapiens has been resolved (Chao et al., 2011). These structures, alongside small-angle X-ray 
scattering data, confirmed previous data suggesting the structure consisting of two 
hexameric rings with projected kinase domains. They also give further insight into the 
mechanism of function of CaMKII. It is currently unknown as to whether CCaMK forms a 
similar oligomeric structure. 
 
 1.7.2 Activation 
 
CaMKII is maintained in an inactive state by interaction between the catalytic domain and 
the autoregulatory domain. This basal state is 100-1000 fold less than its activated state 
and occurs at basal calcium concentrations. The protein is maintained in this inactive state 
by binding of the α-helical autoregulatory domain which forms a pseudo-substrate and 
blocks both the substrate binding and ATP-binding sites. When this autoregulatory domain 
is removed, the kinase is constitutively active. 
 
CaMKII is activated by Ca2+/CaM binding because, in contrast to CCaMK, calcium ions 
cannot bind directly to the protein. Ca2+/CaM binding to CaMKII releases the autoinhibition 
CaMKII
Kinase domain
Association domain
Autoregulatory/ CaM binding region Linker region
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by interrupting the interaction of the pseudo-substrate and the kinase domain. This 
activates the kinase. CaM binds to CaMKII in a 1:1 ratio, and both lobes of the protein wrap 
around the CaMKII subunit in a head to tail orientation. The conformational change that 
occurs when calcium binds to the EF-hands of CaM further increases its affinity for CaMKII. 
Further regulation involves the interaction of ATP and CaM binding; Ca2+/CaM binding 
enhances the affinity for ATP and ATP binding stabilises Ca2+/CaM binding, therefore 
creating a positive feedback loop (Hudmon and Schulman, 2002a), (Hudmon and Schulman, 
2002b). 
 
 1.7.3 Autophosphorylation  
 
Similarly to CCaMK, autophosphorylation is also key to the regulation of CaMKII. 
Phosphorylation at T286 in the autoregulatory domain is well characterised and has 
dramatic effects on the regulation of CaMKII. Phosphorylation at this residue is also 
Ca2+/CaM-induced and interestingly renders the protein Ca2+/CaM-independent, yielding 
the autonomous form of CaMKII. Phosphorylation at T286 is both necessary and sufficient 
for this. Concurrently, autophosphorylation at T286 increases the affinity of CaMKII for 
Ca2+/CaM 1000-fold, known as CaM-trapping. This provides the protein with a “ e ory” of 
past spikes. Interestingly, the structure of the CaMKII oligomer is crucial to 
autophosphorylation at T286. It has been demonstrated that this autophosphorylation 
occurs in an inter-subunit but intra-oligomeric manner. This was characterised by co-
expression of kinase dead and kinase active subunits within an oligomer (Mukherji and 
Soderling, 1994). Furthermore, this autophosphorylation can also only occur at adjacent 
subunits within the oligomer when CaM binds to both partners. This is because CaM 
binding is necessary to both activate the kinase activity of one subunit and to expose the 
autophosphorylation site on a neighbouring subunit (Hudmon and Schulman, 2002a), 
(Hudmon and Schulman, 2002b). 
 
Autophosphorylation can also occur at residues in the CaM binding domain, including T305 
and T306. Interestingly, phosphorylation at either of these residues is sufficient to block 
CaM binding and therefore also block Ca2+/CaM-induced activation of CaMKII (Colbran and 
Soderling, 1990), (Hanson and Schulman, 1992). Therefore inactivation of CaMKII could 
occur in a manner analogous to that suggested for CCaMK, by phosphorylation of residues 
in the CaM binding domain. 
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 1.7.4 CaMKII and calcium spiking 
 
CaMKII, similarly to CCaMK, interprets a calcium spiking signal. Strikingly, the regulation of 
CaMKII (including CaM-trapping and autophosphorylation) means that the activation of 
CaMKII is dependent on calcium spiking frequency. This allows specificity of activation in 
response to the correct stimuli and enables the correct downstream responses to be 
produced. This is due to the ability of the protein to form an autonomous state when 
phosphorylated at T286. At low frequencies of spiking, CaM will bind but also dissociate 
and phosphorylation will be removed by the action of phosphatases. However, at a higher 
frequency of spiking, there is more likelihood of the binding of CaM to adjacent subunits 
and therefore autophosphorylation at T286 generating the autonomous state. This 
propagates the signal by positive feedback enhancing the CaM binding and leading to 
maximal activation. Therefore, CaMKII activity can be regulated by calcium spike frequency 
and in particular is controlled by the individual holoenzy e’s rate of autophosphorylation 
at T286 (De Koninck and Schulman, 1998). Specificity of the signal can also be conferred by 
differential sensitivities of the isoforms to spiking and differential localisation of these 
isoforms. 
 
1.8 Alternative splicing 
 
Alternative splicing is thought to occur in over 60% of plant intron-containing genes, with 
that number likely to rise as more examples are discovered. In particular, it is thought that 
this number will rise as its roles in plant growth and development, physiology, metabolism 
and responses to environmental stresses and pathogens are explored (Syed et al., 2012). 
Alternative splicing in plants, and especially potential roles in symbiosis signalling and 
establishment, has not been extensively studied. Due to the widespread occurrence of 
alternative splicing in plants and in many functional gene groups, it seems possible that it 
may play a role in symbiosis signalling. 
 
 1.8.1 Mechanism and common types of alternative splicing in plants 
 
Splicing of pre-mRNAs to mature mRNAs involves the removal of introns and joining of 
exons. This is achieved by a large complex consisting of small nuclear ribonucleoprotein 
particles (snRNPs) and over 200 proteins, together known as the spliceosome. This has 
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been well studied in animal systems; however the composition of plant spliceosomes has 
not yet been elucidated. Introns each possess a 5´ and 3´ splice site, a branch point and 
polypyrimidine tract near the 3´ site which interact with core splicing factors. Introns are 
further characterised by their high AU content, in comparison to exons which are GC rich. 
Alternative splicing of pre-mRNAs is determined by splicing factors, the most common of 
which include Ser/Arg-rich (SR) proteins and heterogeneous nuclear ribo-nucleoprotein 
particle (hnRNP) proteins. These are trans-acting regulators, and they bind splice regulatory 
cis-elements in the pre-mRNA sequences which include exonic and intronic splice 
enhancers and silencers. These sequences have not been well-characterised in plants, 
however they function by recruiting and stabilising the spliceosome or recruiting inhibitory 
proteins in an analogous manner to animal systems. Alternative splicing has two main, 
important consequences. First, it can regulate transcript levels by nonsense-mediated 
decay by the incorporation of premature termination codons. Second, if the mRNA forms 
are reflected at the protein level, truncated proteins which lack regulatory domains can act 
as dominant negative protein regulators. This occurs, for example, by dimerization 
interactions which can affect protein function and these can impact on signalling pathways 
(Reddy et al., 2013), (Staiger and Brown, 2013). 
 
There are four main types of alternative splicing which are observed, and they are 
summarised in Figure 1.11. Exon skipping (also known as a cassette exon) involves the 
inclusion or exclusion of an exon in the final transcript. This is the most common form of 
splicing in H. sapiens. An alternative 5´ splice site can be used, which changes the 3´ 
boundary of the exon upstream. Similarly, an alternative 3´ splice site can be used which 
conversely changes the 5´ boundary of the downstream exon. Finally, intron retention can 
occur. This is the most common form of splicing observed in plant species, for example it 
occurs in approximately 45 and 39% of A. thaliana and M. truncatula splice events, 
respectively (Baek et al., 2008). This difference between the predominant types of splicing 
in animals and plants can perhaps be explained by intron size difference; animal introns are 
on average 5 kbp, whereas plant introns are on average 160 bp. Different types of splicing 
can be observed for any given gene and splice variant (Reddy et al., 2013), (Syed et al., 
2012). 
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Figure 1.11. Types of alternative splicing observed in plants. Figure adapted from (Syed et 
al., 2012).  
IR – Intron retention, ES – exon skipping, Alt 5´ ss = alternative 5´ splice site and Alt 3´ ss = 
alternative 3´ splice site. 
 
 1.8.2 Alternative splicing in M. truncatula and symbiosis 
 
RNA sequencing (RNA-seq) has been carried out for M. truncatula at various stages during 
the symbiosis with S. meliloti. From this, 6,587 genes were identified with two or more 
isoforms which suggests extensive alternative splicing in M. truncatula. These were often 
co-expressed in the same organ but were differentially regulated during nodulation 
(Boscari et al., 2013). Furthermore, extensive RNA-seq has been carried out by Roux and 
colleagues (Roux et al., 2014) using laser-capture microdissection which allows further 
sensitivity of the technique. DMI3 and other symbiosis genes were shown to be expressed 
in mature nodules, therefore suggesting that Nod-factor signalling is still necessary at this 
late symbiotic stage.  
 
Despite the fact that extensive characterisation of the role of alternative splicing in root 
symbioses has not been carried out, it has been observed in M. truncatula. MtHAP2-1 is a 
CCAAT-binding transcription factor and plays a key role in nodule development, possibly in 
the meristem. Expression of the conventionally-spliced protein peaks in nodules at 4 days 
post inoculation (dpi) however an alternatively-spliced form, which contains the first 
intron, was highly expressed at 21 dpi. This was shown to result in the expression of an 
upstream open reading frame (uORF) which is able to bind to the 5´ leader sequence of the 
MtHAP2-1 transcript. Furthermore, this induces MtHAP2-1 transcript degradation by an as 
yet unidentified mechanism therefore regulating its expression. The action of uORF and the 
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other regulator of MtHAP2-1, miR169, both act to restrict the expression of MtHAP2-1 to 
the nodule meristem and therefore regulate nodule development (Bayer et al., 2002). This 
is the first known example of a uORF acting as a trans regulator of gene expression, but 
they have previously been demonstrated to act in a cis manner in other, particularly 
animal, systems. It is likely that further examples of alternative splice forms playing a role in 
root symbioses will be identified. 
 
 1.8.3 Alternative splicing of CaMKII 
 
Alternative splicing has also been observed to have powerful effects on the function of 
CaMKII, the protein which shows significant sequence similarity to CCaMK. For example, 
the β subunit has several alternative splice forms including βM, β and βe´. These forms 
contain identical N-terminal kinase domains; however differ in the linker region between 
the kinase and the C-terminal association domains. Interestingly, despite the fact that the 
specific Ca2+/CaM activity of the three isoforms are very similar, they show significantly 
different responses to calciu  oscillations. The βe´ form has a higher activation constant for 
CaM than both βM and β, which is thought to be due to the shorter length of the linker 
region. By contrast, the βM and β have very si ilar activation constants for CaM despite 
differences in linker length. However, instead the βM isoform has a significantly higher 
initial rate of autophosphorylation at T287 (equivalent to T286 of the α isofor   than the β 
isofor , and this is thought to be due to the fact that βM form has a longer linker facilitating 
the spatial mobility of the kinase domain. These differences mean that the isoforms differ 
in their response to the frequency of calcium oscillations. Furthermore, the different 
isoforms show different expression patterns in developing and mature neural tissue, 
thereby allowing cell-specific differential responses to calcium oscillation signatures (Bayer 
et al., 2002). 
 
It is not currently know whether CCaMK is also regulated by alternative splicing. However, 
if this is the case the mechanism by which this occurs would likely be different.  
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1.9 Aims of this project  
 
The mechanism by which CCaMK functions in the sym pathway of nodulation and 
mycorrhization has been characterised to some extent, as described above, however key 
questions remain. The aim of this project, therefore, was to further characterise M. 
truncatula CCaMK. M. truncatula was selected for study because it has previously been 
characterised at the John Innes Centre (Swainsbury et al., 2012), (Miller et al., 2013) and 
therefore there are established protocols for its use. Furthermore, M. truncatula is a widely 
used model legume plant for the study of symbiosis signalling, selected for several reasons 
including its small sequenced diploid genome, short generation time, ease of 
transformation and its interaction with the well-characterised symbiotic partner, S. meliloti 
(Cook, 1999). 
 
First, an in vitro biochemical approach was taken in order to investigate the ways in which 
CCaMK is activated and de-activated. Two key ways in which CCaMK is regulated are 
autophosphorylation and calcium-binding. Autophosphorylation, specifically at T271, is a 
key regulator of CCaMK function not least because mutation of this residue to a non-
phosphorylatable residue (Tirichine et al., 2006) creates a gain-of-function mutation 
leading to spontaneous nodulation. However, the mechanism by which this occurs is not 
well established. By contrast, the mechanism of autophosphorylation of CaMKII, a similar 
animal protein, is well-established and key to the regulation of the protein: CaMKII 
autophosphorylates with an intra-oligomer inter-subunit mechanism in response to 
Ca2+/CaM binding. In order to address this in CCaMK, a full-length form of the protein with 
an MBP-tag for stability was expressed and the oligomerisation status was determined. 
Subsequently a western blot approach was used with a state specific antibody for 
phosphorylation at T271 along with a combination of wild type and kinase-dead versions of 
the protein. The possibilities of inter/intra-monomeric and inter/intra-oligomeric 
phosphorylation were then explored. Furthermore, this has important consequences for 
the kinetics and protein concentration-dependence of the reaction. 
 
As previously discussed, no structural data is currently available for CCaMK despite many 
attempts. Therefore, in order to further investigate the role that calcium-ion binding to the 
EF-hands plays in CCaMK function, two techniques were used to characterise the structural 
change which occurs. These were ANS-fluorescence and small angle X-ray scattering. 
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Furthermore, crystallisation trials were attempted with the aim of obtaining further, crucial 
structural information about CCaMK.  
 
Second, the role of CCaMK in planta prior to, and during, symbiosis signalling was explored 
further. Initial experiments were used to determine whether purification of CCaMK was 
possible from the native host, when under the control of the native promoter, and, if so, 
with what yield. Subsequent work was used to determine if an over-expression line for 
CCaMK could be generated or if a GFP-CCaMK-SBP fusion protein could be purified from M. 
truncatula. Protein purified by this method could then be used to determine if the 
oligomerisation status established in vitro was also true in planta. Furthermore, protein 
purified by this method could potentially be more stable than that produced when 
expressed in E. coli and could therefore be used for structural work. 
 
Finally, the role of CCaMK during the progression of symbiosis signalling was analysed. 
Preliminary data from a collaborator suggested that alternative splicing of DMI3 occurs 
during the establishment of nodulation, and if this is reflected at the protein level in planta 
the consequences are potentially profound. For example, truncations of the protein can 
lead to its autoactivation and spontaneous nodulation (Gleason et al., 2006). Furthermore, 
alternative splice-forms could potentially facilitate differential regulation of the protein in 
response to calcium spiking. Therefore a time-course analysis during nodulation and 
mycorrhization was carried out to determine if alternative splicing occurred at any time, 
and this was analysed at both the RNA and protein levels. 
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2.1 Growth media 
 
Compositions of bacterial, plant and fungal media are detailed in table 2.1. 
 
Medium Constituents /L 
Lysogeny broth-Lennox (L) Tryptone 10 g, yeast extract 5 g, 
NaCl 5 g, D-glucose 1 g 
For solid medium: agar 10 g  
Lysogeny broth (Luria-Bertani) (LB) Tryptone 10 g, yeast extract 5 g, NaCl 10 g 
For solid medium: agar 10 g 
Auto-induction medium (AIM) Yeast extract 10 g, tryptone 5 g, 
(NH4)2SO4 3.3 g, KH2PO4 6.8 g 
Na2HPO4 7.1 g, glucose 0.5 g, α-lactose 2 g, 
MgSO4 0.15 g, auto-induction medium micro 
element mix 0.35 g 
Super orbital broth with catabolite 
repression (SOC) 
Tryptone 20 g, yeast extract 5 g, NaCl 0.58 g, 
KCl 0.19 g, MgCl2 2.03 g, 
MgSO4.7H2O 2.46 g, glucose 3.6 g 
Buffered nodulation medium (BNM) CaSO4.2H20 344 mg, MES buffer 390 mg,  
MgSO4.7H2O 122 mg, KH2PO4 68 mg,  
ZnSO4.7H20 4.6 mg, H3BO3 3.1 g, MnSO4.4H20 
2.9 mg, NaMoO4.2H20 0.25 mg,  
CuSO4.5H2O 0.025 mg, CoCl2.6H20 0.025 mg, 
Na2EDTA 18.65 mg,  FeSO4.7H20 13.9 mg, pH 6 
Modified FP (MOD FP) CaCl2 .2H2O 0.1 g, MgSO4.7H2O 0.1 g, KH2PO4 
0.075 g, Na2HPO4.12H2O 0.1125 g,  
FeC6H5O7 6.25 mg, H3BO3 2.86 mg, MnSO4.4H2O 
2.03 mg, ZnSO4.7H2O 0.22 mg, CuSO4.5H2O 0.4 
mg, H2MoO4 0.4 mg, pH 6 
For solid medium: agar 5 g 
Distilled water agar (DWA) Agar 30 g 
Rhizobium complete medium (TY) Tryptone 5 g, yeast extract 3 g,  CaCl2 .6H2O 
1.325 g 
Table 2.1. Components of media used in this study.  
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2.2 Bacterial strains 
 
Bacterial strains used for cloning, protein expression, plant transformation and nodulation 
are listed in table 2.2.  
 
Strain 
Antibiotic 
resistance 
Genotype Source 
E. coli BL21 (DE3) - F- ompT hsdSB (rB
-mB
-) 
gal dcm (DE3) 
Life Technologies 
E. coli BL21 (DE3) pLysS CamR F- ompT hsdSB (rB
-mB
-) 
gal dcm (DE3) pLysS 
(CamR) 
Life Technologies 
E. coli BL21* (DE3) - F- ompT hsdSB (rB
-mB
-) 
gal dcm rne131 (DE3) 
Life Technologies 
E. coli Top 10 - F- mcrA Δ mrr-hsdRMS-
mcrBC  φ80lacZΔM15 
ΔlacΧ74 recA1 araD139 
Δ ara-leu) 7697 galU 
galK rpsL (StrR) endA1 
nupG λ- 
Life Technologies 
E. coli DH5α - F- φ80lacZ∆M15 
∆(lacZYA-argF) U169 
recA1 endA1 hsdR17 
(rk-, mk+) phoA supE44 
λ- thi-1 gyrA96 relA1 
Life Technologies 
Agrobacterium 
rhizogenes 1193 
RifR, CarbR - John Innes Centre 
Agobacterium 
tumefaciens AGL-1 
RifR, CarbR - John Innes Centre 
S. meliloti 1021 StrepR - John Innes Centre 
Table 2.2. Bacterial strains used in this study. 
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2.3 Antibiotics used   
 
Antibiotics used for the growth selection of E. coli, A. rhizogenes, A. tumefaciens and S. 
meliloti are listed in table 2.3. 
 
Antibiotic Solvent Final concentration (μg/ml) 
Carbenicillin dH2O 100 
Spectinomycin dH2O 50 
Rifampicin Methanol 25 
Chloramphenicol Ethanol 34 
Streptomycin dH2O 100 
Kanamycin dH2O 20 
Table 2.3. Antibiotics used in this study. 
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2.4 In vitro methods 
2.4.1 Constructs used for protein production 
 
Construct name Plasmid 
backbone 
Tag CCaMK amino acids present Antibiotic resistance Reference 
CCaMK pET21a(+) None 1-523 CarbR (Swainsbury, 2011) 
MBP-CCaMK pMAL-c2X MBP 1-523 CarbR (Miller et al., 2013) 
MBP-CCaMK K47E pMAL-c2X MBP 1-523 (K47E mutation) CarbR This study 
AI-VLD pET101 None 318-523 CarbR (Swainsbury et al., 2012) 
His-VLD pET101 His 347-523 CarbR (Swainsbury et al., 2012) 
MBP-CCaMK K47E 
and CCaMK 
pCDFDuet-1 MBP (kinase 
dead only) 
1-523 for both genes (K47E mutation in 
tagged form) 
SpecR This study 
His-SUMO-CCaMK 
peptide (Version 
1 and 2) 
pOPINS3C His-SUMO 261-344 CarbR This study 
SUMO D192N pOPINS3C His-SUMO 1-523 (D192N mutation) CarbR Sylvia Singh 
Table 2.4. Constructs of CCaMK used in this study for protein expression.  
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Figure 2.1. Schematic of CCaMK constructs used in this study. 
The domains and main features of CCaMK are marked on the uppermost schematic. The constructs of CCaMK used for protein expression in E. coli are 
shown below, with any tags and mutations marked if present.  For those constructs which did not contain the full sequence of CCaMK, the amino acids 
present are marked. The residues that correspond to the AI domain are denoted above the appropriate region, the residues that correspond to the CaM 
binding domain are notated on the box that represents this domain. 
 
Kinase domain
Auto-inhibitory/ 
CaM binding 
domain Visinin-like domain
EF 0 EF 1 EF 2 EF 3
Thr271
MBP
His
His-SUMO
Tagless WT CCaMK
MBP CCaMK
MBP-CCaMK K47E
His-SUMO CCaMK D192N
His-VLD
AI-VLD
HisSUMO-CCaMK peptides
MBP
K47E
His-SUMO
D192N
Thr271
1 523
347-523
318-523
261-344
1-306 329-342
323-349
350-523
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2.4.2 Agarose gel electrophoresis for DNA  
 
DNA gel electrophoresis was performed in one of two ways. A 1% (w/v) Tris/acetic 
acid/EDTA agarose gel was made with ethidium bromide added to the molten agarose at a 
concentration of 0.25 μg/ l. Sa ples were ixed with 1 x MassRuler DNA Loading Dye 
(Life Technologies) and loaded into wells, alongside one well containing MassRuler DNA 
Ladder (Life Technologies). A potential of 90 V was applied for 45 min and the DNA was 
visualised by exposure to UV light at a wavelength of 365 nm. 
 
Alternatively, a 1% (w/v) Tris/borate/EDTA agarose gel was made and stained after 
electrophoresis with 0.5 μg/ l ethidiu  bro ide for 15 min. The first method was typically 
used for E. coli recombinant work, and the second method was used for RT-PCR 
experiments. The differences between the two methods did not affect the results. 
 
2.4.3 Plasmid preparation  
 
Plasmid DNA was purified using the QiaPrep Spin Miniprep Kit (Qiagen) according to the 
 anufacturer’s instructions. In order to obtain aterial for use with this kit, single colonies 
of E. coli containing the plasmid of interest were grown overnight in LB medium with the 
correct antibiotic selection. Cells were harvested by centrifugation at 3500 x g for 10 min 
and the cell pellet was used for plasmid preparation. Purified DNA was stored at -20 °C and 
concentrations were determined using a NanoDrop (Thermo Scientific). 
 
2.4.4 Sequencing 
 
Sequencing was performed in one of two ways. Sequencing was carried out with construct-
specific pri ers with the following reaction ix: 1 μl plas id DNA, 1.5 μl sequencing 
buffer, 3.5 μl of 1 μM pri er, 1 μl 30% di ethyl sulfoxide, 2 μl dH2O and 1 μl Big Dye v3.1 
(Life Technologies). PCR cycling conditions were as follows: 96 °C for 2 min, 25 cycles of 96 
°C for 10 seconds, 45 °C for 30 seconds and 60 °C for 4 min, and 1 minute at 15 °C. Samples 
were typically submitted to Eurofins for analysis. 
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Alternatively, if standard sequencing primers were used, purified plasmid DNA was directly 
sub itted to Eurofins in a final volu e of 15 μl with a concentration of 50-100 ng/μl. All 
sequencing data was visualised for analysis using Chromas2 (Technelysium) software. 
 
2.4.5 Transformation of chemically competent cells 
 
One vial of commercial chemically competent cells (Life technologies) was thawed on ice 
per reaction and subsequently incubated with 1 μl  5-10 ng) plasmid DNA for 30 min on ice. 
Cells were heat-shocked for 30 seconds at 42 °C, briefly incubated on ice and 250 μl pre-
warmed SOC media was added. Cells were then incubated at 37 °C with agitation for one 
hour. An appropriate aliquot of the mixture was spread on LB/L agar with the appropriate 
antibiotic selection, and incubated overnight at 37 °C. 
 
2.4.6 Cloning of CCaMK expression constructs  
 
The M. truncatula CCaMK gene was codon-optimised for expression in E. coli (Swainsbury 
et al., 2012) and this sequence was sub-cloned for use in the constructs in this study. 
 
2.4.6.1 K47E mutation in MBP-CCaMK 
 
The K47E mutation was generated in the MBP-CCaMK (pMAL-c2X) plasmid using the 
QuikChange Lightning site-directed mutagenesis kit (Agilent Technologies) according to 
 anufacturer’s instructions. The pri ers used are listed in section 2.6 and were generated 
with the QuikChange Primer Design program (Agilent Technologies).  
 
2.4.6.2 MBP-CCaMK K47E and CCaMK WT in pCDFDuet-1 co-expression 
vector 
 
Wild-type (WT) CCaMK and MBP-CCaMK K47E genes were amplified using PfuUltra High-
Fidelity DNA Polymerase (Agilent Technologies) with primers detailed in section 2.6 and 
cloned into pCDFDuet-1 multiple cloning sites (MCS) one and two, respectively. Firstly, the 
WT CCaMK amplification product was digested with Nco1 and Not1 (Roche) according to 
 anufacturer’s instructions, and purified using the QiaQuick PCR Purification Kit (Qiagen). 
The pCDFDet-1 vector was digested by the same method, subjected to gel electrophoresis 
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and purified using the QiaQuick gel extraction kit (Qiagen). Ligation of the two purified 
products was carried out with T4 DNA ligase (New England Biolabs) according to 
 anufacturer’s instructions. E. coli Top 10 chemically competent cells were transformed 
with 2.5 μl of the ligation reaction, and plas id DNA was isolated as previously described. 
The presence of the correct insert size was verified by a restriction digest with Nco1 and 
Not1 and subsequent gel electrophoresis. A vector containing the correct insert was 
identified by sequencing as previously described (primers listed in section 2.6). 
 
The MBP-CCaMK K47E amplification product was digested with Xho1 and Nde1 (Roche) 
sequentially according to the anufacturer’s instructions, and purified with the QiaQuick 
PCR Purification Kit (Qiagen). The pCDFDuet-1 vector containing the WT CCaMK insert in 
MCS1 was digested by the same method, subjected to gel electrophoresis and purified 
using the QiaQuick gel extraction kit (Qiagen). Ligation, transformation and plasmid 
purification were carried out as described above. A double digest was carried out with 
Xho1 and Nde1 to verify the presence of the correct insert size, and the vector was 
sequenced to confirm the presence of the correct insert as described above. 
 
2.4.6.3 His-SUMO peptides in pOPINS3C 
 
Two His-SUMO peptide constructs were made for use in crystallisation trials; version 1 
without a cleavable His-SUMO tag, and version 2 with a 3C cleavage site. Both constructs 
were made by the following method with different forward primers (detailed in section 
2.6). The sequence was amplified using PfuUltra High-Fidelity DNA Polymerase (Agilent 
Technologies) and purified using the QiaQuick gel extraction kit (Qiagen). The In-Fusion 
reaction was carried out by incubation of 1 μl linearised pOPINS3C vector, 3.5 μl  100 ng  
purified insert, 3.5 μl dH2O and 2 μl In-Fusion enzy e ix for 30 in at 42 °C. DH5α E. coli 
co petent cells were transfor ed with 5 μl of the reaction mixture as previously 
described. Plasmid DNA was purified as before, and sequenced as described.  
 
2.4.7 Expression and purification of CCaMK constructs 
 
2.4.7.1 Tagless CCaMK 
 
67 
 
Chapter 2: Materials and Methods 
Full-length CCaMK was expressed in E. coli BL21 (DE3) pLysS cells grown in LB at 37 °C until 
the OD600 reached 0.3-0.6. Expression was induced with 0.5 mM IPTG for three hours at 28 
°C. Cells were harvested by centrifugation at 7950 x g and stored at -20 °C. Cells were 
thawed on ice and resuspended in 50 mM Tris pH 7.5, 100 mM NaCl, 2 mM CaCl2, 1 mM 
DTT,    1 μg/ml DNase 1, lysozyme and a cO plete™ protease inhibitor cocktail tablet 
(Roche). The cells were disrupted with a TS Series Benchtop 1.1 kW cell disruptor (Constant 
Systems Ltd.) at 25 psi and centrifuged at 38 760 x g for 20 min at 4 °C.  The supernatant 
was filtered with a 0.45 μ  Minisart high flow syringe filter  Sartorius , and applied to a 
CaM-Sepharose 4B column (GE Healthcare) pre-chilled to 4 °C and pre-equilibrated with 50 
mM Tris pH 7.5, 100 mM NaCl, 2 mM CaCl2 and 1 mM DTT. The column was washed with 
five column volumes of the same buffer, and bound CCaMK was eluted with 50 mM Tris pH 
7.5, 100 mM NaCl, 2 mM EDTA and 1 mM DTT. 
 
2.4.7.2 MBP-CCaMK and MBP-CCaMK K47E 
 
MBP-CCaMK (and MBP-CCaMK K47E) was expressed in E. coli BL21 (DE3) cells grown in L 
with 0.1% glucose (v/v) at 37 °C until the OD600 reached 0.3-0.6. Expression was induced 
with 0.5 M IPTG for two hours at 28 °C. Cells were harvested as before and resuspended 
in 20 M Tris pH 7.4, 200 M NaCl, 1 M DTT,    1 μg/ml DNase 1, lysozyme and a 
cO plete™ protease inhibitor cocktail tablet  Roche). Cells were disrupted and centrifuged 
and the supernatant filtered as described in section 2.4.7.1. This was applied to an 
MBPTrap HP 1 ml column (GE Healthcare) pre-chilled to 4 °C and pre-equilibrated with 20 
mM Tris pH 7.4, 200 mM NaCl, 1 mM DTT. The column was washed with ten column 
volumes of the same buffer and MBP-CCaMK was eluted with 20 mM Tris pH 7.4, 200 mM 
NaCl, 1 mM DTT and 10 mM maltose. 
 
When a greater purity was required (for dynamic light scattering, atomic force microscopy 
and 8-anilino-1-naphthalenesulfonic acid-fluorescence), size exclusion chromatography 
(SEC) was also performed with a HiLoad 16/60 Superdex 75 prep grade column (GE 
Healthcare) with buffer containing 50 mM Tris pH 7.5, 5 mM MgCl2, 2 mM EDTA, 200 mM 
NaCl, 10 % glycerol (v/v) and 1 mM DTT. For these three methods, the MBPTrap buffers 
were as described above, except they were used at pH 7.5. 
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2.4.7.3 AI-VLD 
 
The auto-inhibitory and visinin-like domain (AI-VLD) was expressed in E. coli BL21* (DE3) 
cells grown in autoinduction medium (AIM) at 37 °C for two hours, followed by 20 °C for 20 
hours. Cells were harvested as above and resuspended in 50 mM Tris pH 7.5, 1 M NaCl, 2 
mM CaCl2, 1 M DTT,    1 μg/ml DNase 1, lysozyme and a cO plete™ protease inhibitor 
cocktail tablet (Roche). Cells were disrupted and centrifuged and the supernatant was 
filtered as described in section 2.4.7.1. This was applied to a CaM-Sepharose column pre-
equilibrated with 50 mM Tris pH 7.5, 1 M NaCl, 2 mM CaCl2 and 1 mM DTT. The column was 
washed with five column volumes of the same buffer and AI-VLD protein was eluted with 
buffer containing 50 mM Tris pH 7.5, 2 mM EDTA and 1 mM DTT. Additional purification by 
SEC was carried out with a HiLoad 16/60 Superdex 75 prep grade column (GE Healthcare) 
with buffer containing 50 mM Tris pH 7.5, 100 mM NaCl and 1 mM DTT. 
 
2.4.7.4 His-VLD 
 
His tagged visinin-like domain (VLD) protein was expressed as for AI-VLD (section 2.4.7.3 , 
with the following excep ons. Bacterial cell pellet was resuspended in bu er containing 50 
 M Tris pH 7.5, 300 M NaCl, 10 M i idazole,    1 μg/ml DNase 1, lysozyme and a 
cO plete™ protease inhibitor cocktail tablet  Roche . Supernatant was applied to a HisTrap 
HP 1 ml column (GE Healthcare) which was pre-equilibrated with 50 mM Tris pH 7.5, 300 
mM NaCl and 10 mM imidazole. The column was washed with 10 column volumes of the 
same buffer, and His-VLD protein was eluted with 50 mM Tris pH 7.5, 300 mM NaCl and 
500 mM imidazole. SEC was performed as for AI-VLD. 
 
2.4.7.5 MBP-CCaMK-K47E and wt CCaMK co-expression 
 
MBP-CCaMK-K47E and wild-type CCaMK were co-expressed in E. coli BL21 (DE3) pLysS cells 
grown in LB until the OD600 reached 0.3-0.6. Expression was induced with 1 mM IPTG for 2.5 
hours at 28 °C. Cells were harvested as above. The composition of the buffers and the 
purification method was the same as for MBP-CCaMK (section 2.4.7.2) with the exception 
that buffers were used at pH 7.5. 
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2.4.7.6 His-SUMO-CCaMK peptides 
 
Both His-SUMO-CCaMK peptides were expressed in E. coli BL21* (DE3) cells in AIM and 
were grown and induced for 7.5 hours at 37 °C. Cells were harvested as above and the 
bacterial cell pellet was resuspended in 20 mM Tris pH 8, 100 mM NaCl, 10 M 
i idazole,     1 μg/ml DNase 1, lysozyme and a cO plete™ protease inhibitor cocktail tablet 
(Roche). Cells were disrupted and centrifuged and the supernatant was filtered as 
described in section 2.4.7.1. This was applied to a HisTrap HP 1 ml column (GE Healthcare) 
which was pre-equilibrated with 20 mM Tris pH 8, 100 mM NaCl and 10 mM imidazole. The 
column was washed with 10 column volumes of the same buffer, and bound protein was 
eluted with 20 mM Tris pH 8, 100 mM NaCl and 500 mM imidazole. No SEC step was 
necessary. 
 
2.4.7.7 His-SUMO-CCaMK D192N 
 
His-SUMO-CCaMK D192N was expressed in E. coli BL21 (DE3) pLysS cells grown in LB at 37 
°C until the OD600 reached 0.3-0.6. Expression was induced with 0.5 mM IPTG for four hours 
at 28 °C. Cells were harvested, disrupted and centrifuged and the supernatant was filtered 
as described in section 2.4.7.1. The composition of the buffers used and the purification 
method was the same as for His-VLD protein (section 2.4.7.4), except that all purification 
was carried out at 4 °C and no SEC step was necessary. 
 
 2.4.8 SDS-PAGE of proteins  
 
Pre-cast SDS-PAGE gels (Expedeon Ltd.) at 10, 12 and 16% SDS were used to separate 
proteins according to size. The percentage of the gel was selected depending on the 
expected size of protein in question. Samples were prepared by the addition of loading dye 
(200 mM Tris-HCl, pH 6.8, 8% SDS, 4% (v/v) glycerol, 400 mM DTT and 6 mM bromophenol 
blue) and were heated to 95 °C for five in. In general, 16 μl of each sa ple was loaded 
per well and a 2-color SDS marker (Expedeon) protein ladder was added in one well. Gels 
were run in RunBlue Tris-Glycine SDS Run buffer (Expedeon) for 1 hour at 185 V. Gels were 
stained for 15 min in Instant Blue protein stain (Expedeon) when not required for 
subsequent western blotting. 
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To confirm protein identities when necessary, gel bands were excised with a sterile scalpel, 
prepared according to standard procedures (Shevchenko et al., 2006) and subjected to a 
trypsin digest for mass spectrometric characterisation using either a nanoLC-MSMS on an 
Orbitrap Fusion™ Tribrid™ Mass Spectro eter coupled to an UltiMate® 3000 RSLCnano LC 
system (Thermo Scientific, Hemel Hempstead, UK) or MALDI-TOF on a Bruker Ultraflex 
TOF/TOF. Mass spectrometric analysis was performed by Gerhard Saalbach (JIC). 
 
 2.4.9 Protein concentration determination 
 
Protein concentration was determined with either DirectDetect (MerckMillipore) according 
to anufacturer’s instructions, or a La bda 25 UV/Vis spectrophoto eter (Perkin Elmer). 
For the Lambda 25 determination, a zero reading was taken with a buffer only sample and 
the spectrophotometer was used in scanning mode. The absorbance value for protein 
concentration determination was taken at 280 nm, and the concentration was calculated 
using the Beer-Lambert law. Where necessary, the extinction coefficient was calculated 
using ProtParam. 
 
2.4.10 Dynamic light scattering (DLS)  
 
Fresh MBP-CCaMK protein was used immediately after purification prior to freezing. The 
protein sample was filtered with a Minisart high flow 0.2 μ  syringe filter (Sartorius). A 
quartz cuvette was thoroughly cleaned using sterile water and isopropanol, and dried with 
compressed air. The DynaPro Titan (Wyatt Technology Corporation) was used with 
Dynamics V6 software. Laser power was increased to 100% and the quartz cuvette was 
confir ed clean with a Count Rate of less than 40,000 for a 13 μl sterile filtered water 
sa ple. The cuvette was cleaned and dried again and a 13 μl protein sa ple was added. 
Ten measurements were taken of 10 s each with 2 replicates at 20 °C. 
 
2.4.11 8-Anilino-1-naphthalenesulfonic acid (ANS) fluorescence 
 
MBP-CCaMK protein (made with Liang Zhou) was prepared with SEC as described in section 
2.4.7.2. The protein sample was dialysed overnight at 4 °C with stirring in 10 mM Tris pH 
7.5, 50 mM NaCl and 1 mM TCEP. A 10 ml 150 mM solution of ANS was made with 50 
mg/ml NaOH and 50 mg/ml dimethylformamide and the concentration of MBP-CCaMK was 
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deter ined to be 10 μM. Four sa ples were used: 5 μM MBP-CCaMK + 2 mM CaCl2, 5 μM 
MBP-CCaMK + 2 mM EDTA, ANS buffer + 2 mM CaCl2 and ANS buffer + 2 mM EDTA.  
 
ANS was added to give a final concentration of 150 μM in each sa ple. Fluorescence 
analysis was carried out with an LS55 luminescence spectrophotometer (Perkin Elmer) with 
the following parameters: excitation wavelength 480 nm, wavelength range 400 – 680 nm, 
slit size 10 n , scan speed 500 n / in and cuvette size 100 μl. The cuvette was cleaned in 
between each sample thoroughly with water and ethanol, and then dried with compressed 
air. Data were plotted using Microsoft Excel. 
 
2.4.12 Atomic force microscopy (AFM) 
 
MBP-CCaMK protein was prepared as described in section 2.4.7.2 and stored in the gel 
filtration buffer at 4 °C without freezing. Two different conditions for AFM were tested: no 
glycerol on a mica surface coated with poly-L-lysine or with 10% (v/v) glycerol in air on 
untreated mica. The conditions without glycerol were obtained via buffer exchange using a 
PD-10 column. Protein sample preparation was carried out with Liang Zhou and AFM was 
performed by Patrick Gunning and Andrew Kirby (IFR). Only the data corresponding to the 
condition with glycerol is presented because it was of higher quality. The average diameter 
of MBP-CCaMK was determined from a representative section of an enlarged version of the 
AFM image. All particles in the selected area were measured in mm and the axes were used 
to convert these easure ents in μ . An average of these easure ents was calculated. 
 
2.4.13 Kinase and phosphatase assays and αpT271 western blotting 
 
Kinase assays were perfor ed for 30 in at 30 °C in a total reaction volu e of 20 μl. 
Reaction ixtures for the negative control  “none”  contained 50 M HEPES, pH 7.5 and 1 
mM DTT, and the calcium-induced reaction mixture in addition contained: 200 µM ATP, 10 
mM MgCl2 and 0.2 mM CaCl2.. All proteins were purified at 4 °C, de-salted (if necessary, to 
20 M Tris pH 7.5, 200 M NaCl, 1 M DTT  and diluted to approxi ately 400 ng/μl. 
Protein was added in a volu e of 3 μl, with 1.5 μl of each protein if two proteins were 
mixed in one assay. By contrast, when co-expressed MBP-CCaMK-K47E and WT CCaMK 
protein was used in the assay, 10 μl of freshly purified protein with no freeze-thaw step 
was used. 
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When required, a phosphatase assay was carried out with Lambda protein phosphatase 
 NEB  according to the anufacturer’s instructions with a 30 in incubation at 30 °C. 
Reactions were terminated by the addition of 4 x SDS-PAGE sample buffer and incubation 
at 95 °C for 5 min.  
 
Prepared protein samples from the kinase assay were separated using a 1.5 mm 10% SDS-
PAGE gel and transferred to polyvinylidene difluoride membrane (Bio-Rad). A 
phosphorylation state-specific antibody for Thr271 CCaMK was used which was produced 
against the following sequence: CSFYEKpTWKGISQ (Eurogentec), and is referred to as 
αpT271. This antibody was produced by Akira Miyahara (Miller et al., 2013). 
Immunodetection of proteins was performed using αpT271 (1:150) and a secondary 
antibody, horseradish peroxidase–conjugated anti-rabbit antibody (1:10 000). A 
chemiluminescent signal was generated by Pierce ECL Substrate (Life Technologies) and 
detected by autoradiography with Fuji Medical x-ray film (FUJIFILM). 
 
Protein staining was carried out for western blots with 0.1% (w/v) PonceauS in 5% (v/v) 
acetic acid in water. The membrane was incubated with agitation in approximately 20 ml 
PonceauS stain, de-stained by washing with water prior to visualisation with a G:BOX 
(Syngene). 
 
2.4.14 Small angle X-ray scattering (SAXS) 
 
Small angle X-ray scattering was carried out for the AI-VLD and VLD in the presence and 
absence of calcium. However aggregation of both the proteins occurred to an un-
satisfactory level. Therefore the data presented in this thesis is based on a previous data 
set obtained by David Swainsbury for the His-VLD only. However, new data was consistent 
with the previous data set. Data were collected at the X33 beam line on the DORIS III 
synchrotron at EMBL, DESY in Hamburg, Germany and data analysis was carried out by 
Dmitri Svergun.  
 
His-VLD protein was dialysed into buffer containing 10 mM Tris pH 7.5, 50 mM NaCl, 1 mM 
TCEP with either 2 mM CaCl2 or 0.1 mM EDTA. Readings were taken at various protein 
concentrations within a range of 0.5 - 7.4 mg/ml and 1.9 - 7.4 mg/ml with CaCl2 and EDTA 
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respectively. Scattering curves were measured for the buffer, then the protein solution, 
then a second buffer blank. To monitor for the radiation damage, eight 15 s exposures of 
protein solutions were compared and no significant changes were observed. The data were 
normalized to the intensity of the transmitted beam and radially averaged; the scattering 
of the bu er was subtracted and the di erence curves were scaled for protein 
concentration. Data processing was carried out with the program package PRIMUS. A 
homology model of the His-VLD was generated with SWISSMODEL against a human 
neuronal calcium sensor (Heidarsson et al., 2012) (29% sequence identity) and further 
refined against the SAXS data using BUNCH. 
 
2.4.15 Crystallography methods  
 
 2.4.15.1 VLD protein preparation with DAPase  
 
His-VLD protein was purified as described in section 2.4.7.4 but without SEC. Protein was 
dialysed overnight at 7 °C with stirring in 10 mM Tris pH 7.5, 50 mM NaCl and 1 mM DTT. 
His-tag-removal was carried out with TAGZyme DAPase Enzyme (Qiagen) according to the 
 anufacturer’s instructions. In order to ensure co plete digestion, protein was incubated 
with DAPase for 4.5 hours at 37 °C and then for 16 hours at 4 °C. The DAPase enzyme and 
co-purified contaminants were removed from the digested VLD protein by subtractive 
immobilized-metal affinity chromatography. Digestion and purity of the sample were 
confirmed by SDS-PAGE. Protein was concentrated to 15 mg/ml with Amicon Ultra-4 
Centrifugal Filter Unit with Ultracel-10 membrane (Merck Millipore), frozen in aliquots with 
liquid nitrogen and stored at -80 °C until used.  
 
Crystallisation trials were set up in 96 well MRC plates (Molecular Dimensions) with 50 μl of 
each screen condition added to each well by the Freedom evo liquid handling robot 
 Tecan . Each crystallisation drop consisted of 0.3 μl protein and 0.3 μl of the screen liquid, 
and was mixed in the sitting drop format by the OryxNano robot (Douglas Instruments 
Ltd.). The following screens were set up: PEG, ammonium sulphate (Qiagen), PACT, JCSG, 
Structure, Morpheus and Midas (Molecular Dimensions). Plates were covered and stored at 
20 °C. Conditions that yielded potential protein crystals were followed up with optimisation 
screens in the 24-well hanging drop format in VDX optimisation plates (Molecular 
Dimensions). Wells were filled with 1 ml of the screen condition, and drops consisted of 1 
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μl of each condition ixed with 1 μl protein fro  the original stock  and, if appropriate, 
with an additional 0.2 μl crystal seed-stock). Further screens were set up for VLD protein in 
the presence of either CaCl2 or EDTA. Protein preparation was as described above, except 
digested VLD protein was dialysed in 10 mM Tris pH 7.5, 50 mM NaCl, 1 mM DTT with 
either 1 μM CaCl2 or 1 mM EDTA. Protein was concentrated to 11 and 12 mg/ml 
respectively and the same seven crystallisation screens were set up. 
 
2.4.15.2 Surface entropy reduction of the VLD 
 
Potential surface-exposed, high entropy amino acids in the VLD were selected for mutation 
to small, low entropy residues for potential crystallisation enhancement by the SERp server 
(Goldschmidt et al., 2007). Three clusters were identified by the server, and the cluster 
with the highest SERp score was selected for mutation; specifically cluster 1 KEEEIE 
mutation to AAAEIE. Site-directed mutagenesis was carried out with the QuikChange 
Lightning site-directed mutagenesis kit (Agilent Technologies) according to the 
 anufacturer’s instructions with pri ers designed using the QuikChange Pri er Design 
software (Section 2.6). Sequencing was carried out as described above to confirm the 
presence of the correct mutations.  
 
SER VLD was expressed, purified and digested as described above for the VLD. Protein was 
concentrated to 19 mg/ml and the following 96-well screens set up as previously described: 
KISS (Custom screen comprising PEG and ammonium sulphate, Clare Stevenson), JCSG, 
Morpheus and Structure (Molecular Dimensions). Appropriate 24-well optimisation screens 
were set up as previously described. 
 
2.4.15.3 SUMO peptide crystallography  
 
HisSUMO-CCaMK peptide version 1 (with no 3C cleavage site) was purified as described in 
section 2.4.7.6, and dialysed overnight into 20 mM Tris pH 8 and 100 mM NaCl. Protein was 
concentrated to 15 mg/ml and the following 96-well crystallisation screens were set up: 
KISS (Custom screen comprising PEG and ammonium sulphate, Clare Stevenson), PEG 
(Qiagen), Structure, PACT and JCSG (Molecular Dimensions). The procedure was as 
previously described except screens were transferred to 96-well plates with a Liquidator™ 
96 Manual Pipetting System (Mettler Toledo). Proteins were digested with 3C protease 
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 Banfield lab  at a final concentration of 10 μg/μl for 16 hours at 4 °C. Where necessary, 5 
mM DTT was added or digestion was carried out at room temperature     20 °C).  
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2.5 In planta methods 
 
 2.5.1 M. truncatula plant lines used 
 
Plant line Description Reference 
A17 Wild type line derived from the cultivar Jemalong (Barker et al., 
1990) 
Jester Wild type ecotype ,   90% similar to Jemalong 
(Fertiprado, Portugal) 
(Hill, 2000) 
R108 Wild type ecotype  (Hoffmann et al., 
1997) 
dmi3-1 (TRV25) Mutant of CCaMK consisting of a 14 bp deletion at 
position 594. This leads to a premature stop 
codon and truncated protein  CCaMK 1‐208 . 
Derived from an A17 background. 
(Levy et al., 2004) 
GFP-CCaMK-SBP 
694/1 
Coding sequence of DMI3 under the control of the 
native promoter in a dmi3-1 background, with an 
N-terminal GFP tag and a C-terminal SBP tag. 
Developed by 
Akira Miyahara 
Table 2.5. M. truncatula lines used in this study. 
 
2.5.2 Hydroponic growth method  
 
M. truncatula Jester seeds were surface-sterilised with 10% sodium hypochlorite solution 
for 2 -3 min then washed six times with dH2O, and imbibed at    20 °C for at least five hours. 
When other M. truncatula lines were grown hydroponically, an initial 1-2 minute 
scarification step with sand paper was added prior to sterilisation. The tank and mesh used 
for growth was sterilised with 10% sodium hypochlorite solution, rinsed with water six 
times, cleaned with 70% ethanol and rinsed with dH2O. It was then filled with 16 litres of 
sterile BNM medium and two aeration bricks were spaced evenly throughout the medium 
and attached to an external air pump with tubing. Hydroponic tanks were located in a 
controlled environment room (22 °C, 75% relative humidity,    250-300 μ ol -2 s-1, 16-hour 
photoperiod). After imbibition, seeds were spread evenly across the mesh with a sterile 
spatula and moistened with dH2O. The use of the airbricks also ensured the mesh was 
sufficiently moistened for germination; if necessary two transparent lids were used in 
addition to keep germinating seedlings moist for the first three days of seedling growth. 
Seedlings were grown for approximately three weeks, until substantial root growth 
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occurred with minimal over-crowding of the mesh. If necessary the level of the medium 
was replenished with dH2O. Root material was harvested with a sterile scalpel, blotted 
briefly and frozen immediately in liquid nitrogen. Root material was stored at -80 °C until 
use.  
 
A nodulation test was carried out as follows:    100 growing A17 seedlings entrapped in the 
mesh were inoculated by immersion in 500 ml BNM medium containing rhizobia at OD600  = 
0.001 for approximately three days. They were then returned to the main un-inoculated 
tank. 
 
2.5.3 αMtCCaMK antibody generation 
 
AI-VLD protein was prepared as described in section 2.4.7.3 and stored at -80 °C. This 
protein was concentrated appropriately with a pre-rinsed Amicon Ultra-15 Centrifugal 
Filter Unit with Ultracel-10 membrane (Merck Millipore). Protein was used for 
immunization in the SEC buffer consisting of 50 mM Tris pH 7.5, 100 mM NaCl and 1 mM 
DTT. Eight aliquots of 500 μl at 260 μg/ l were sent to Eurogentec on dry ice for 
immunization. The anti-protein speedy 28-day polyclonal programme was carried out, with 
two rabbit hosts. Antibody serum was stored at -80 °C on arrival, with working aliquots 
stored at -20 °C. 
 
2.5.4 Western blotting with αMtCCaMK and αT271 
 
Pre-cast 10% (w/v) SDS-PAGE gels (Expedeon Ltd.) were used to separate protein samples 
which were then transferred to nitrocellulose membrane (GE Healthcare). 
I  unodetection of proteins was perfor ed using αMtCCaMK  1:10 000  and a secondary 
antibody, horseradish peroxidase–conjugated anti-rabbit antibody (1:10 000). A 
chemiluminescent signal was generated by Pierce ECL Substrate (Life Technologies) or 
SuperSignal West Femto Substrate and SuperSignal West Pico Substrate used together in a 
1:10 ratio  Life Technologies . This was visualised using the I ageQuant™ LAS 500  GE 
Healthcare). 
 
The αT271 antibody corresponded to the non-specific fraction from the purification of the 
phospho-antibody, produced against CSFYEKpTWKGISQ (Eurogentec). This antibody 
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recognised both the phosphorylated and non-phosphorylated forms of T271. Western 
blotting with αT271 was carried out using the method above with the following exception: 
αT271 was used at a ratio of 1:150. 
 
2.5.5 Generation and testing of an over-expression line 
 
 2.5.5.1 Golden Gate cloning of EC10265 binary vector 
 
Cloning of the EC10265 vector was carried out using the Golden Gate system (Engler et al., 
2009) with components synthesised by GeneArt (Life Technologies). The level one vector 
was digested and ligated with the following reaction ix: 1 μl linearised backbone vector 
 100 ng/μl , 1 μl pLjUB  100 ng/μl , 1 μl MtCCaMK  100 ng/μl , 1 μl t35S  100 ng/μl , 0.15 μl 
100 x BSA, 1 μl Bsa1, 1.5 μl 10 x T4 buffer, 1 μl T4 DNA ligase (New England Biolabs) and 
7.35 μl dH2O. Cycling conditions were as follows: 25 cycles of 3 min at 37 °C, 4 min at 16 °C, 
followed by 5 min at 50 °C and 5 min at 80 °C. E. coli DH5α cells were transfor ed with 1 μl 
of the ligation reaction as described in section 2.4.5. Colony PCR was performed with 
GoTaQ Green and the following reaction ix: 1 μl each FOR- DMI3 and REV-DMI3 primers 
 20 μM , 3 μl dH2O, 5 μl GoTaQ Green and one colony per reaction. PCR cycling conditions 
were as follows: 95 °C for 10 min, 30 cycles of 95 °C for 10 seconds, 53 °C for 20 seconds 
and 72 °C for 3 min, with a final extension step of 5 min at 72 °C. The corresponding E. coli 
colonies were grown overnight in LB with appropriate antibiotic selection. Agarose gel 
electrophoresis, plasmid preparation and sequencing were carried out as described in 
sections 2.4.2, 2.4.3 and 2.4.4. 
 
The level two vector was constructed using the same method, with the following exception. 
The digestion and ligation mix was as follows: 1 μl linearised backbone vector pAGM 4723 
 100 ng/μl , 1 μl BASTA  100 ng/μl , 1 μl level 1 vector  100 ng/μl , 1 μl dsRED  100 ng/μl , 1 
μl ELE3 end linker, 0.15 μl 100 x BSA, 1 μl Bpi1, 1.5 μl 10 x T4 buffer, 1 μl T4 DNA ligase 
(New England Biolabs) and 6.35 μl dH2O. Sequencing primers used for this construct are 
detailed in section 2.6.5. 
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  2.5.5.2 Hairy root transformation 
 
A 20 μl aliquot of A. rhizogenes strain AR1193 was transfor ed with 1.5 μl  150 ng  purified 
plasmid DNA by the following procedure. DNA and cells were incubated on ice for 5 min, 
transferred to an electroporation cuvette (Cell Projects, UK) and subjected to an 
electroshock of 1.25 V, 25 μ F and 200 Ω  Gene-Pulser, Bio-rad). Cells were re-suspended in 
500 μl SOC ediu , grown for 1 hour at 28 °C with agitation and plated onto TY medium 
containing the appropriate antibiotic selection. Plates were incubated for two days at 28 
°C. 
 
Single colonies were grown for two or three days in TY medium containing the appropriate 
antibiotic at 28 °C with agitation. Two ml culture was centrifuged at 12 470 x g for 30 
seconds, and the cell pellet was resuspended in 400 μl TY ediu . Ger inating seedlings 
of dmi3-1 were prepared by removal of 3 mm of the radical with a sterile scalpel. Cut 
seedlings were dipped briefly into the A. rhizogenes culture, and replanted on MOD FP 
plates. These were sealed with 3M Micropore tape (Slaughter Ltd, R & L) and grown for 
three weeks in a controlled environment room (22 °C,    300 μ ol -2 s-1, 16-hour 
photoperiod). 
 
  2.5.5.3 dsRED fluorescence and nodulation assay tests 
 
Roots were scored for successful transformation by fluorescence microscopy (Leica MZFLIII) 
with a green filter for visualisation of the dsRED marker. Plants containing hairy roots with 
strong fluorescence were used for a nodulation complementation assay with S. meliloti 
strain 1021. S. meliloti was cultured in liquid TY media with the appropriate antibiotic 
selection two days prior to use, and then diluted to OD600 = 0.02-0.05 in 400 ml BNM 
medium. Seedlings were dipped in rhizobia prior to planting in Phytratray II growth pods 
(Sigma-Aldrich) containing a 1:1 mix of sand:terragreen (Oil-dry company, UK). Plants were 
grown in a controlled environment room  22 °C,    300 μ ol -2 s-1, 16-hour photoperiod) 
and nodulation was scored three weeks after inoculation. Images of nodulation with dsRED 
fluorescence were taken with an Infinity 1 camera (Luminera). 
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  2.5.5.4 Stable line production in R108 
 
A. tumefaciens strain AGL-1 was transfor ed with 1.5 μl  100 ng/μl  purified plasmid DNA 
in section 2.5.5.2. Transformation of M. truncatula R108 was carried out according to 
standard methods by Matthew Smoker (TSL). 
 
  2.5.5.5 Testing of potential transformants 
 
Plantlets which developed from embryos grown on antibiotic selective media were re-
planted in soil by horticultural services at the John Innes. Genomic DNA extractions were 
carried out on leaf tissue using the DNeasy Plant Mini Kit (Qiagen) by Richard Gorem.  
Concentrations of the DNA extractions were determined with a NanoDrop (Thermo 
Scientific). PCR was performed with GoTaQ Green and the following reaction ix: 2 μl 
gDNA, 6 μl dH2O, 1 μl of each DMI3-F new and DMI3-R-nostop primer  20 μM  and 10 μl 
GoTaq Green 2x Master Mix. PCR cycling conditions were as follows: 95 °C for 10 min, 35 
cycles of 95 °C for 10 seconds, 53 °C for 20 seconds and 72 °C for 2 min, with a final 
extension step of 5 min at 72 °C. Agarose gel electrophoresis was performed as described 
in section 2.4.2. 
 
 2.5.6 GFP-CCaMK-SBP stable line testing  
 
A potentially transgenic line in a dmi3-1 background was tested for successful 
transformation with pCCaMK:GFP-CCaMK-SBP. Seeds were harvested from 16 T1 
generation plants and subjected to a nodulation complementation test. Seeds were 
sterilised as described in section 2.5.2, with an additional scarification step with sandpaper 
for 1-2 min prior to sterilisation. They were then plated onto DWA, stratified in the dark at 
4 °C for two days and then germinated overnight at room temperature. Twelve seedlings 
for each line were planted in sand:terragreen (Oil-dry company, UK) in 60-well trays and 
were covered with transparent lids for three days. After seven days, seedlings were 
inoculated with rhizobia at OD600 = 0.04 by direct application of 2 ml culture to the base of 
the seedling. They were then scored three weeks post inoculation for the presence of 
nodules. 
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One line from the T2 generation was selected for experiments on the basis of successful 
nodulation and a strong western blot protein band at the correct size for the fusion 
protein, probed with the αMtCCaMK antibody. This line was subjected to a copy number 
analysis by iDNA Genetics using a TaqMan-based analysis which confirmed the line was 
heterozygous for the insert. Seeds were bulked for the line by horticultural services at the 
John Innes. 
 
2.5.7 Purification methods used for MtCCaMK 
 
 2.5.7.1 Buffer trials – RIPA/Li buffers and YS/Li 
 
To compare the extraction of RIPA and Li buffers (method 1), frozen Jester root tissue was 
ground to a fine powder in a pre-chilled pestle and mortar with liquid nitrogen and divided 
equally between two buffers. Either RIPA buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1 mM 
EDTA, 1% (v/v) Triton X-100, 0.5% (v/v) sodium deoxycholate, 0.05% (v/v) SDS, 5 mM DTT, 1 
mM EGTA, cO plete™ protease inhibitor cocktail tablet  Roche   or Li bu er  150 M Tris 
pH 7.8, 50 M potassiu  acetate, 20 %  v/v  glycerol, 4 M DTT,    1 μg/ml DNase 1, 
cO plete™ protease inhibitor cocktail tablet  Roche   (Li et al., 1996) was added at 
approximately 2 ml/g tissue. Samples were subjected to cell disruption at 20 psi, incubated 
on ice for 5 min and centrifuged at 38 760 g for 20 min at 4 °C. Samples were prepared for 
SDS-PAGE as previously described, and separated using a pre-cast 16% (w/v) SDS-PAGE gels 
(Expedeon Ltd.). Western blotting probed with αMtCCaMK was perfor ed as described in 
section 2.5.4. 
 
To compare the extraction of YS and Li buffers (method 2), frozen Jester root tissue was 
ground to a fine powder in a pre-chilled pestle and mortar with liquid nitrogen and divided 
equally between two buffers. Either YS buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1 mM 
EDTA, 5 mM DTT, 1% (v/v) IGEPAL CA-630, 20% (v/v) glycerol, cO plete™ protease 
inhibitor cocktail tablet (Roche)) or Li buffer was added at 2 ml/g tissue. Samples were 
incubated with agitation at 7 °C for 1 hour, prepared for SDS-PAGE as before and subjected 
to western blot probed with αMtCCaMK as described in section 2.5.4. 
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 2.5.7.2 MonoQ purification 
 
Jester extract was prepared as in method 1 (section 2.5.7.1) with a Li buffer extraction and 
dialysed overnight at 4 °C with stirring in 20 mM Tris pH 7.8, 10% (v/v) glycerol and 1 mM 
DTT. The sample was filtered with a Minisart high flow syringe filter, 0.45 μ   Sartorius , 
and applied to a Mono Q 5/50 GL column (GE Healthcare) pre-equilibrated with 20 mM Tris 
pH 7.8, 10% (v/v) glycerol and 1 mM DTT. The column was washed with five column 
volumes of the same buffer, and bound proteins were eluted with 20 mM Tris pH 7.8, 1 M 
NaCl, 10% (v/v) glycerol and 1 mM DTT. 
 
 2.5.7.3 DEAE purification  
 
Jester extract was ground to a fine powder in a pre-chilled pestle and mortar with liquid 
nitrogen and resuspended in Li buffer at 4 °C. In this case, the sample was ground further 
with a 1 L ball mill (Capco Test Equipment) run at 7 °C for 18 hours. The sample was then 
subjected to cell disruption at 20 psi and centrifuged at 38 760 g for 20 min at 4 °C. The 
sample was dialysed twice at 7 °C with stirring in 20 mM Tris pH 7.8 and 1 mM DTT. The 
sample was filtered with a 0.45 μm Minisart high flow syringe filter (Sartorius), and applied 
to a HiTrap DEAE Sepharose FF column (GE Healthcare) pre-chilled at 4 °C pre-equilibrated 
with 20 mM Tris pH 7.8 and 1 mM DTT. The column was washed with five column volumes 
of the same buffer, and bound proteins were eluted with 20 mM Tris pH 7.8, 1 M NaCl and 
1 mM DTT. For each new purification a new DEAE column was used that was cleaned 
according to anufacturer’s instructions prior to use. 
 
 2.5.7.4 CaM-Sepharose purification  
Jester extract was ground as described in section 2.5.7.3 (without ball milling) and 
resuspended in 1 ml/g Li buffer at 4 °C. The sample was subjected to cell disruption and 
centrifugation as previously described. The supernatant was dialysed overnight at 7 °C with 
stirring in 50 Tris pH 7.5, 100 mM NaCl, 2 mM CaCl2 and 1 mM DTT. The sample was filtered 
as before and applied to a CaM-Sepharose 4B column (GE Healthcare) pre-equilibrated 
with 50 Tris pH 7.5, 100 mM NaCl, 2 mM CaCl2 and 1 mM DTT. The column was washed 
with five column volumes of the same buffer, and bound proteins were eluted with 50 Tris 
pH 7.5, 100 mM NaCl, 2 mM EDTA and 1 mM DTT. 
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 2.5.7.5 DEAE followed by CaM-Sepharose purifications 
 
Jester extract was prepared and DEAE purification carried out as described in sec on 
2.5.7.3 with the following excep ons. Ground  ssue was resuspended in bu er containing 
20 M Tris pH 7.8, 5%  v/v  glycerol, 1 M DTT,    1 μg/ml DNase 1 and cO plete™ 
protease inhibitor cocktail tablet (Roche) and the supernatant was not subjected to a 
dialysis step prior to application to the HiTrap DEAE Sepharose FF column (GE Healthcare).  
 
Appropriate protein fractions from the DEAE purification were dialysed overnight at 7 °C 
with stirring in 50 Tris pH 7.5, 100 mM NaCl, 2 mM CaCl2 and 1 mM DTT. CaM-Sepharose 
purification was carried out as described in section 2.5.7.4 with the following exception: 
purification was carried out at 4 °C.  
 
 2.5.7.6 GFP-CCaMK-SBP purification trials (DEAE, Streptavidin, CaM-
Sepharose and SEC) 
 
DEAE purification was carried out for GFP-CCaMK-SBP protein as described in section 
2.5.7.3 with the following exceptions. Ground tissue was resuspended in buffer at 4 ml/g 
and resuspended tissue was extracted for 1 hour at 7 °C with stirring, instead of a ball mill 
extraction.  
 
GFP-CCaMK-SBP root tissue was prepared for streptavidin-column purification using the 
same method as for DEAE purification in this section. The supernatant was dialysed 
overnight at 7 °C with stirring in 20 mM Tris pH 7.5, 100 mM NaCl and 1 mM DTT. The 
sample was filtered as before and applied to a HiTrap Streptavidin HP column (GE 
Healthcare) pre-chilled to 4 °C and pre-equilibrated with buffer containing 20 mM Tris pH 
7.5, 100 mM NaCl and 1 mM DTT. The column was washed with ten column volumes of the 
same buffer, and bound proteins were eluted with 20 mM Tris pH 7.5, 100 mM NaCl, 10 
mM d-Desthiobiotin and 1 mM DTT. 
 
CaM-Sepharose purification of GFP-CCaMK-SBP was performed as described in section 
2.5.7.4 with the following exceptions. Li buffer was added to ground tissue at 4 ml/g, 
resuspended tissue was extracted for 1 hour at 7 °C with spinning prior to cell disruption 
and purification was carried out at 4 °C.  
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SEC chromatography was carried out on appropriate fractions from the CaM-Sepharose 
purification. Purification was carried out at room temperature (approximately 20 °C) with a 
HiPrep 16/60 Sephacryl S-300 HR column (GE Healthcare) with buffer containing 50 mM 
Tris pH 7.5, 200 mM NaCl and 1 mM DTT. 
 
2.5.8 Growth method for nodulation and mycorrhization time-course  
 
Seeds for Jester, A17 and GFP-CCaMK-SBP 694/1 seeds were used for time-course 
experiments. A17 and GFP-CCaMK-SBP 694/1 were scarified with sandpaper for 1-2 min, 
and seeds for all three lines were subsequently surface sterilised with 10% sodium 
hypochlorite solution for 2 -3 min. Seeds were then washed six times with dH2O, and 
imbibed for at least three hours. They were then plated onto DWA, stratified in the dark at 
4 °C for three days and then germinated overnight at room temperature. Germinated 
seedlings were transplanted to MOD FP pH 6 agar plates (6/plate) on a layer of sterile filter 
paper and sealed with 3M micropore tape. Seedlings were grown on plates for 10 days at  
 22 °C,    300 μ ol -2 s-1, 16-hour photoperiod). 
 
For nodulation and mycorrhization time-courses, seedlings from the MOD FP plates were 
transferred to an autoclaved 1:1 mix of sand:terragreen (Oil-dry company, UK) in 40-well 
trays. Day 0 root samples for each line were harvested in liquid nitrogen prior to potting 
out in terragreen/sand. Seedlings for both nodulation and mycorrhization time-courses 
were grown in a controlled environment growth room  22 °C, 75% rela ve hu idity,    250-
300 μ ol -2 s-1, 16-hour photoperiod). Transparent lids were used to cover seedlings for 
three days after their transfer to terragreen:sand, and they were subsequently watered 
with RO water.  
 
Nodulation of seedlings was carried out with S. meliloti strain 1021. S. meliloti was cultured 
in liquid TY media with appropriate antibiotic selection two days prior to use, and then 
diluted to OD 600 = 0.03-0.05 in 400 ml BNM medium. Seedlings were dipped in rhizobia 
prior to pricking out, and root samples were harvested four, 10 and 21 days post 
inoculation. Seedlings were rinsed, blotted and roots removed with a sterile scalpel prior to 
immediate freezing in liquid nitrogen. Typically roots from five plants were pooled and 
frozen together. 
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Mycorrhization of seedlings was carried out with SolRize Pro G. intraradices inoculum 
(Agrauxine) used at 1:12 (v/v spore:terragreen/sand). Seedlings were planted directly into 
the terragreen/sand containing the inoculum. The progression of mycorrhization was 
monitored by staining of representative root samples. Roots were pre-cleared by 
incubation in 10% (w/v) KOH at 95 °C for 10 min, rinsed three times with water and stained 
with 5% ink (with 5% acetic acid) (v/v) for 6 min at 95 °C. Roots were de-stained with water, 
and visualised with a Leica M80 Stereo microscope (Leica) and images taken with a Retiga-
2000R CCD camera (QImaging). Colonisation was scored with the gridline intersect method 
(Giovannetti and Mosse, 1980). Root samples were therefore harvested seven, 13 and 21 
days post inoculation. 
 
2.5.9 Immunoprecipitation 
 
Frozen root tissue was ground in liquid nitrogen and incubated with 2 ml/g extraction 
buffer (Li) for one hour at 7 °C with agitation. Samples were taken at this stage for crude 
extract western blot analysis with αMtCCaMK. In so e cases, cell disruption of sa ples at 
20 psi was carried out (not for time-course experiments). Samples were then centrifuged at 
38 760 x g for 20 min at 4 °C and filtered through two layers of Miracloth (Calbiochem). The 
supernatant was centrifuged again at 38 760 g for 10 min at 4 °C and filtered through two 
layers of Miracloth. The supernatant was used for immunoprecipitation.  
 
αMtCCaMK antibodies were covalently i  obilized to Pierce™ NHS-Activated Magnetic 
Beads  Life Technologies  according to the anufacturer’s instructions. Prepared sa ples 
(or a purified protein fraction) were incubated with the appropriate volume of conjugated 
beads (40 – 80 μl  proportional to the sa ple volu e. The storage buffer was re oved 
from the beads and samples were incubated for five hours with rotation in a falcon tube 
(Corning) using a Techne Hybridiser HB-2D at 7 °C, after an input sample was taken. 
Antibody coupled beads were collected using a magnet, and the supernatant was stored as 
the flow-through sample. Beads were washed three times with Li buffer, and protein was 
eluted with 100 μl 0.1 M glycine pH 2 for five in with agitation. Eluted protein samples 
were neutralised with 20 μl 1 M pH 10 glycine, and 20 μl of each sa ple was prepared for 
SDS-PAGE and western blotting as described in section 2.5.3. 
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2.5.10 RNA preparation and cDNA synthesis   
 
Plant root tissue was stored at -80 °C and ground in an autoclaved and pre-chilled pestle 
and mortar with liquid nitrogen. Ground tissue was placed into RNA-free tubes pre-chilled 
on dry ice, and RNA was extracted with the RNeasy plant mini kit (Qiagen). RNA 
concentration was determined using a Nanodrop-1000 (Thermo Scientific), and the 
A260/280 ratio was checked for quality (1.8-2.2). Three micrograms of RNA for each sample 
was treated with DNase-1 (Sigma) in a 30 μl reaction volu e according to the 
 anufacturer’s instructions. The quality of the DNase-1 treated RNA was checked by 
agarose gel electrophoresis. A 1% agarose gel was loaded with 1 μg DNase-1 treated RNA, 
run for 20 min at 120 V and post-stained with 0.5 μg/ l ethidiu  bro ide for 15 min. RNA 
was tested for contaminating DNA by PCR with DMI3 pri ers with reagents as follows: 1 μl 
RNA, 1 μl each DMI3-F new and DMI3-R-nostop  20 μM , 7 μl dH2O and 10 μl GoTaq Green 
2x Master Mix (Promega). Cycling was as follows: 95 °C for 10 min, 30 cycles of 95 °C for 10 
seconds, 53 °C for 20 seconds and 72 °C for 4 min, with a final extension step of 5 min at 72 
°C. 
 
cDNA synthesis was carried out with the iScript cDNA synthesis kit (Bio-rad  for 1 μg RNA 
for each sample according to anufacturer’s instructions. RNA sa ples were stored at -80 
°C and cDNA samples were stored at -20 °C.  
 
2.5.11 RT-PCR  
 
RT-PCR was perfor ed with GoTaQ Green and the following reaction ix: 2 μl cDNA, 6 μl 
dH2O, 1 μl of each DMI3-F new and DMI3-R-nostop primer  20 μM  and 10 μl GoTaq Green 
2x Master Mix. PCR cycling conditions for 2 minute extension time experiments were as 
follows: 95 °C for 10 min, 30 cycles of 95 °C for 10 seconds, 53 °C for 20 seconds and 72 °C 
for 2 min, with a final extension step of 5 min at 72 °C. PCR cycling conditions for 1 minute 
extension times were as follows: 95 °C for 10 min, 35 cycles of 95 °C for 10 seconds, 58 °C 
for 20 seconds and 72 °C for 1 minute, with a final extension step of 5 min at 72 °C. PCR 
cycling conditions for 30 second extension time experiments were as follows: 95 °C for 10 
min, 35 cycles of 95 °C for 10 seconds, 58 °C for 20 seconds and 72 °C for 30 seconds, with a 
final extension step of 5 min at 72 °C. 
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2.5.12 PCR product cloning and sequencing 
 
PCR product cloning was carried out with the PCR product cloning kit (Qiagen) according to 
 anufacturer’s instructions. PCR products were used directly in the ligation reaction, with 
no prior purification. E. coli Top 10 chemically competent cells were transformed with the 
ligation reaction as described in section 2.4.5. Colonies were screened using blue-white 
selection and subsets of white colonies were selected for colony PCR. Colony PCR was 
performed with GoTaQ Green and the following reaction mix: 1 μl each DMI3-F new and 
DMI3-R-nostop  20 μM , 3 μl dH2O, 5 μl GoTaQ Green and one colony per reaction. PCR 
cycling conditions were as follows: 95 °C for 10 min, 30 cycles of 95 °C for 10 seconds, 53 °C 
for 20 seconds and 72 °C for 2 min, with a final extension step of 5 min at 72 °C. 
Corresponding E. coli colonies were grown overnight in LB medium with appropriate 
antibiotic selection. Agarose gel electrophoresis was carried out as described in section 
2.4.2 to identify the appropriate vectors for sequencing. Plasmid DNA was purified as 
described in sections 2.4.3 and sequenced using the standard T7 and SP6 promoter primer 
as described in 2.4.4.  
 
 
2.6 Oligonucleotide primer sequences (5´-3´) 
 
Where necessary, standard sequencing primers (T7 promoter, T7 terminator and SP6) were 
used for sequencing reactions and are not listed here. 
 
2.6.1 Quikchange primers for K47E mutation 
 
Primer name Primer sequence 
A139G_CCaMK_F TCACAAAGCCAGGTTGCCATTGAAACCCTGCGCC 
A139G_CCaMK_R GGCGCAGGGTTTCAATGGCAACCTGGCTTTGTGA 
Table 2.6. Primers used for generation of the Quikchange K47E mutation. 
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 2.6.2 pMal sequencing primers to check for K47E mutation 
 
Primer name Primer sequence 
MalE-F GGTCGTCAGACTGTCGATGAAGCC 
M13_pUC-R CGCCAGGGTTTTCCCAGTCACGAC 
Table 2.7. Primers used for sequencing of the pMal vector. 
 
 2.6.3 pCDF duet vector cloning and sequencing 
 
Primer name Primer sequence 
CCaMK-MCS1-F CGTTCAGAGCCATGGGCTATGGTACA 
CCaMK-MCS1-R AATTATTGCGGCCGCTTACGGGCGGAT 
MBP-CCamK-F GGCGCACGCATATGAAAATCGAAG 
MBP-CCamK-R GATTGATACTCGAGTTACGGGCGGATT 
DuetUP2 TTGTACACGGCCGCATAATC 
pACYCDuet-1UP GGATCTCGACGCTCTCCCT 
DuetDOWN-1  GATTATGCGGCCGTGTACAA 
Seq_in_MBP-CCamK-F  CCAACATCGACACCAGCA 
Seq_in_MBP-CCamK-R  GACCAACAACAGGGTCGGT 
pCDF-upMCS1-F GTTTTCGCAGAAACGTGGCT 
pCDF-upMCS1-R CAGCAGAGTATCACTCACGG 
Table 2.8. Primers used for duet vector generation and sequencing. 
 
 2.6.4 His-SUMO-CCaMK peptide cloning primers 
 
Primer name Primer sequence 
POPINS3C_CCaMKpep_F 
GCGAACAGATCGGTGGTATGAACGGTAACTTTAGCTTTT
ACG 
S3C_new_CCaMK-F 
AAGTTCTGTTTCAGGGCCCGATGAACGGTAACTTTAGCT
TTTACG 
POPINS3C_CCaMKpep_R 
ATGGTCTAGAAAGCTTTAGCTAGACCAAACCGACGCAAT
GGC 
Table 2.9. Primers used for generation of two HisSUMO-CCaMK peptide vectors. 
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2.6.5 Quikchange primers for surface entropy reduction of the VLD 
 
Primer name Primer sequence 
a49g_a50c_a53c_a56c 
CCTGGTCGGCTCATATGATCTGGCAGCAGCAGAAATCGA
AAACCTGCGCATG 
a49g_a50c_a53c_a56c_antisense 
CATGCGCAGGTTTTCGATTTCTGCTGCTGCCAGATCATAT
GAGCCGACCAGG 
Table 2.10. Primers used for surface entropy reduction of the VLD. 
 
2.6.5 Golden Gate cloning and sequencing primers for EC10265 
 
Primer name Primer sequence 
proLjUB_end_F CAGTTCCCAACCCTAACAATTCTTG 
MtCCaMK_sta_F CACAATAGGGTTCCCTACAATGAGAC 
DsRED_end_F GGGACGCCACCATCTGTTCCTTTAAGC 
Pro-DsRED-end_F GCCAATTTTCAGCTCCACCGTAT 
DsRED_sta_F CAGATGCAGATCTTAATGGGGTCATC 
BASTAseq_F GACGCGGGACAAGCCGTTTTACGTTTG 
GoldenGate-3 CCCGCCAATATATCCTGTC 
GoldenGate-4 GCGGACGTTTTTAATGTACTG 
MtCCaMK_sta_F CACAATAGGGTTCCCTACAATGAGAC 
REV-DMI3 TTATGGACGAATAGAAGAGAGAAC 
REV-DMI3.1 CTTCATATTCATCTGAGAG 
FOR-DMI3 ATGGGATATGGAACAAGAAAAC 
Table 2.11. Primers used for Golden Gate cloning of CCaMK over-expression construct. 
 
2.6.7 DMI3 PCR and RT-PCR primers 
 
Primer name Primer sequence 
Mt-DMI3-F ATGGGATATGGAACAAGAAAACTC 
Mt-DMI3-R-nostop TGGACGAATAGAAGAGAGAACTAC 
Table 2.12. DMI3 primers used for PCR and RT-PCR experiments. 
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3.1 Introduction  
 
Autophosphorylation, particularly at T271, is a key regulator of CCaMK function. This 
residue is particularly important because mutation to a non-phosphorylatable residue 
(Tirichine et al., 2006) creates a gain-of-function mutation leading to spontaneous 
nodulation. This is thought to be due to the disruption of a predicted hydrogen-bond 
network, involving pT271, which autoactivates the protein for downstream signalling 
(Miller et al., 2013). Therefore, autophosphorylation at T271 is key to the regulation of 
CCaMK. However, the mechanism by which this occurs is not well understood. 
 
In contrast, the mechanism by which autophosphorylation at T286 in CaMKII occurs is well 
characterised. Autophosphorylation at this particular residue occurs in an inter-subunit, 
intra-oligomeric mechanism (Mukherji and Soderling, 1994). Since CCaMK shows significant 
sequence and structural similarities to CaMKII, this begs the question of whether 
autophosphorylation of CCaMK occurs with an analogous mechanism. This was first 
addressed with an investigation into the oligomeric status of the protein using a non-
aggregating, full length construct of CCaMK. This construct consisted of an E. coli codon-
optimised CCaMK with an N-terminal MBP tag for stability. 
 
The mechanism of autophosphorylation at T271 has been studied previously, however the 
results were contradictory. Sathyanarayanan and colleagues (Sathyanarayanan et al., 2001) 
studied the protein concentration-dependence of the rate of autophosphorylation at T271. 
They observed a saturation curve and concluded an inter-monomeric/oligomeric 
mechanism; however this trend does not show the required second order kinetics for this 
conclusion. The mechanism of autophosphorylation at T271 was also studied by Tirichine 
and colleagues (Tirichine et al., 2006). By contrast, they observed an exponential increase 
in phosphate incorporation in a protein-concentration dependent manner, which is 
consistent with second order kinetics and an inter-monomeric/oligomeric mechanism of 
autophosphorylation. Therefore despite the observation of different trends of 
phosphorylation dependence on protein concentration in two studies, the same conclusion 
was reached on the mechanism of autophosphorylation. In order to clarify this discrepancy, 
a thorough investigation was undertaken to test all possible mechanisms of 
autophosphorylation at T271: intra-monomeric, inter-monomeric, inter-oligomeric and 
intra-oligomeric. 
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3.2 MBP-CCaMK purification 
 
In order to characterise biochemical properties of CCaMK, it was necessary to purify the M. 
truncatula CCaMK protein using an E. coli expression system. Previous work by David 
Swainsbury established that when full-length CCaMK was purified with or without His or 
GST tags, it formed large aggregates. Therefore, previous biochemical characterisation of 
CCaMK was carried out using truncations of the protein which lacked the kinase domain 
that were present in solution as monomers (Swainsbury et al., 2012). However, in order to 
characterise the oligomeric state of CCaMK, it was necessary to establish an expression 
system for the full-length protein. Therefore, a maltose binding protein (MBP) fusion was 
utilised, in order to aid protein stability and prevent aggregation. This was developed using 
the codon-optimised sequence for expression in E. coil by Akira Miyahara (Miller et al., 
2013). Previous work by Liang Zhou established that this fusion protein was a stable 
oligomer with low levels of aggregation and therefore was suitable for biochemical 
experiments (section 3.2.1). 
 
In order to isolate protein of sufficient purity, a two-step purification was used. MBP-
affinity chromatography (Figure 3.1A) was utilised followed by size exclusion 
chromatography (SEC) (Figure 3.1B) to remove contaminants. The size and purity of the 
protein was confirmed using SDS-PAGE (Figure 3.1C). The later SEC peak was also analysed 
by SDS-PAGE, and was shown to not contain MBP-CCaMK protein (data not shown). Some 
minor contaminants remained in the MBP-CCaMK sample after SEC however the protein 
was of sufficient purity for subsequent experiments.
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Figure 3.1.  Purification of recombinant MBP-CCaMK using MBP affinity chromatography and SEC. 
(A) Chromatogram for the purification of MBP-CCaMK using an MBPTrap HP column. Fractions corresponding to the marked peak were collected, pooled 
and subjected to size exclusion chromatography, shown in (B). 
(B) Size exclusion chromatogram for MBP-CCaMK using a HiLoad 16/60 Superdex 75 prep grade column. The marked peak was confirmed to contain the 
correct protein by SDS-PAGE shown in (C).  
(C) SDS-PAGE for MBP-trap and SEC purification of MBP-CCaMK. The observed size of MBP-CCaMK was approximately 98 kDa, as predicted. The second 
elution peak did not contain MBP-CCaMK, and this was also confirmed by SDS-PAGE (data not shown). 
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3.2.1 Size estimates of the MBP-CCaMK oligomer with SEC, DLS and AFM 
 
In order to characterise the size of the MBP-CCaMK oligomer analytical SEC, dynamic light 
scattering (DLS) and atomic force microscopy (AFM) were used. First, analytical SEC was 
carried out by Liang Zhou of MBP-CCaMK with a HiPrep 16/60 Sephacryl S-300 HR column 
(Figure 3.2A). MBP-CCaMK eluted in a single peak at 39.3 ml which indicated the presence 
of a large oligomer. A calibration curve for the column was established with monodisperse 
proteins of known molecular weights, and from this a size estimate of the MBP-CCaMK 
oligomer was calculated of 1607 ± 1.3 (Sx) kDa. The predicted size of a monomer of MBP-
CCaMK is 100 kDa so therefore the oligomer size observed during SEC corresponded to 
approximately 16 subunits.  
 
DLS was also carried out on freshly purified MBP-CCaMK and three readings are shown 
(Figure 3.2B). Each graph corresponded to an average of 10 individual measurements 
carried out on the same protein sample. The most abundant species detected in the first 
reading (left panel) was 1341 kDa which corresponded to an oligomer size of approximately 
13-14 subunits. A much larger species was present (Radius = 34.3 nm, Size = 13201 kDa, 
Mass % = 7.3) and was presumably an aggregate of MBP-CCaMK. For both measurement 
two and three (middle and right panel, respectively), the most abundant species detected 
was formed of 20-21 subunits (molecular weights detected were 2072 and 2014 kDa, 
respectively). The diameter of the oligomer was also measured and the three readings gave 
a mean diameter of 29 nm ± 3 (SD). Substantial variation was detected between several 
measurements taken on the same protein in quick succession. This variability between and 
within measurements is somewhat expected because DLS is affected by the polydispersity 
of the sa ples. Sa ples were filtered with an 0.2 μ  filter in order to reduce the presence 
of large species which may have affected this. However, at least in the first measurement a 
larger aggregate was detected, and this polydispersity may have affected the variability of 
these data. This is why many readings were taken, and then the average was recorded.  In 
addition, assumptions were made when carrying out DLS since DLS assumes that 
macromolecules are spherical, which is most-likely not the case for MBP-CCaMK. Therefore 
the mean size of the MBP-CCaMK oligomer of 18 ± 4 (SD) subunits from DLS was an 
estimate only. 
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AFM was carried out on MBP-CCaMK by Patrick Gunning and Andrew Kirby (Figure 3.2C). 
Distinct particles which corresponded to oligomers of MBP-CCaMK were detected using 
this method. Their size was variable, where the larger particles most likely corresponded to 
aggregates of the protein. However, from the smaller particles it was possible to determine 
that oligomers of MBP-CCaMK were globular in shape with a mean diameter of 33 nm ± 12 
(SD). From discussions with Andrew Kirby and Patrick Gunning it was determined that this 
resolution would be the limit of this technique, so therefore a rough estimate of the size 
and shape was the maximum level of certainty that can be established from this technique. 
However, this size was consistent with the DLS data obtained. 
 
Taken together, these techniques provided an estimate of the size of the MBP-CCaMK 
oligomer. Recombinant MBP-CCaMK forms an oligomer of 16-18 subunits with a diameter 
of    31 nm (Table 3.1). 
 
 
Figure 3.2. Recombinant MBP-CCaMK is an oligomer. 
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(A) Analytical gel filtration chromatogram for freshly prepared MBP-CCaMK protein carried 
out by Liang Zhou with a HiPrep 16/60 Sephacryl S-300 HR column. MBP-CCaMK eluted at 
39.29 ml and is marked on the chromatogram. Calibration of the column was performed 
using the following standards: blue dextran (2000 kDa), apoferritin (669 kDa), apoferritin 
(443 kDa , β-amylase (200 kDa), albumin (66 kDa) and carbonic anhydrase (29 kDa). 
(B) DLS for freshly-prepared MBP-CCaMK showing percentage mass against radius. 
Insignificant peaks were removed in order to prevent data skew. Each graph corresponded 
to an average of ten 10 s measurements, taken sequentially on the same protein sample. 
Insets show the radius, mass and percentage mass of the main species detected. 
(C) AFM image for freshly-prepared MBP-CCaMK in air on untreated mica with glycerol. 
Protein sample preparation was carried out with Liang Zhou and AFM was performed by 
Patrick Gunning and Andrew Kirby (IFR). To determine the average diameter of MBP-
CCaMK, the particles in a representative section were measured in mm on an enlarged 
version of the AFM image. These were converted to μ  using the axes and an average was 
taken of these values. 
 
 
Technique  Size (kDa) 
Number of 
subunits 
Diameter (nm) 
Gel filtration  1607 ± 1.3 (Sx) 16 - 
Dynamic light scattering  1809 ± 406 (SD) 18 ± 4 (SD) 29 ± 3 (SD) 
Atomic force microscopy  - - 33 ± 12 (SD) 
Table 3.1. MBP-CCaMK is an oligomer of 16-18 subunits with a diameter of    31 nm.  
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3.3 Mechanism of autophosphorylation at Thr271 
 
Phosphorylation at T271 stimulated by calcium binding to the EF-hands is crucial to the 
function of CCaMK as previously described. However the mechanism by which this 
autophosphorylation occurs is unclear. This has important kinetic implications (Section 
3.3.1) for how the protein decodes calcium spiking in the sym pathway. There are four 
possible mechanisms by which autophosphorylation can occur: intra-monomeric, inter-
monomeric, intra-oligomeric and inter-oligomeric as shown in Figure 3.3.  
 
In order to determine whether intra-monomeric autophosphorylation was possible, a 
homology model of the kinase domain with the autoinhibitory domain was generated with 
Phyre2 (Figure 3.4). The predicted spatial positioning of the T271 residue and the active site 
suggested that intra-monomeric phosphorylation is unlikely because they were located on 
two different sides of the protein. The kinase domain is well-conserved and therefore this is 
likely to be reliable despite the use of a homology model. Furthermore, there are no 
indications on the model that a significant conformational change to facilitate intra-
monomeric autophosphorylation is possible. Additionally, the autoinhibitory helix 
appeared to be located over the active site. However, even if this helix is removed (which 
would be necessary for phosphorylation to occur) intra-monomeric autophosphorylation is 
unlikely. This conclusion is consistent with homology modelling carried out by 
Sathyanarayanan and colleagues (Sathyanarayanan et al., 2001).  
 
Evidence described above in section 3.2.1 showed that CCaMK is likely present as an 
oligomer. This therefore suggested that an inter-monomeric mechanism of 
autophosphorylation was unlikely due to the presence of 16-18 subunits of CCaMK in a 
complex. Therefore it seems likely that autophosphorylation occurs either within or 
between oligomers. Furthermore, preliminary data obtained by Liang Zhou suggested that 
the oligomeric state of CCaMK may be crucial to its ability to autophosphorylate. A mutant 
of CCaMK which lacked the first five amino acids was unable to form a stable oligomer. 
Interestingly, this mutant was also unable to autophosphorylate itself, suggesting that the 
presence of neighbouring subunits was essential to autophosphorylation. In addition, data 
from Akira Miyahara suggested that inter-oligomeric autophosphorylation does not occur 
(Figure 3.5). These data comprise an autoradiogram showing total protein phosphorylation 
and the corresponding protein stained gel for GST-CCaMK (wild type, WT), GST-CCaMK 
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K47E (a point mutation which rendered the kinase inactive) and WT CCaMK. When the 
proteins were present singly, autophosphorylation was detected in WT GST-CCaMK and not 
GST-CCaMK K47E after a kinase assay, as expected. When GST-CCaMK K47E and WT CCaMK 
were mixed and then subjected to a kinase assay, autophosphorylation was detected only 
in the WT protein. Therefore no inter-oligomeric autophosphorylation was detected. 
However, this experiment was carried out using GST-CCaMK, without calcium-induction 
and autophosphorylation at all potential phosphorylation sites was detected. This construct 
is also not ideal for study because it does not require calcium for autophosphorylation so it 
has limited relevance to CCaMK in planta. Therefore it remained to be determined if the 
outcome of the experiment would be the same with calcium-induced autophosphorylation 
at T271, using MBP-CCaMK.  
 
Therefore these preliminary data indicated that most likely phosphorylation does not occur 
inter-oligomerically and that oligomerisation most likely plays a role in 
autophosphorylation. However they did not demonstrate definitively that 
autophosphorylation in CCaMK occurs intra-oligomerically. Therefore an experiment was 
designed to distinguish between the three most likely mechanisms of autophosphorylation 
at T271: inter-monomeric, inter-oligomeric or intra-oligomeric mechanism. 
 
 
 
 
Figure 3.3. Schematic of possible mechanisms of autophosphorylation at Thr271. 
 
 
Intra-oligomer Inter-oligomer
Intra-monomer Inter-monomer
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Figure 3.4. Intra-monomeric phosphorylation is unlikely due to the locations of Thr271 and 
the active site. 
This model of the kinase domain with the auto-inhibition domain was produced with 
Phyre2 and the locations of the active site and Thr271 residues are marked in green and 
red respectively. The active site and Thr271 residue are predicted to be located on different 
faces of the well-conserved kinase domain and the AI domain is predicted to be located 
over the active site (marked with an arrow). Therefore, intra-monomeric phosphorylation is 
unlikely. 
 
 
 
Figure  3.5. Autophosphorylation does not occur between separately expressed and 
subsequently mixed WT CCaMK and GST-CCaMK K47E. Data are courtesy of Akira 
Miyahara.  
 Separately expressed constructs of GST-CCaMK, GST-CCaMK K47E and WT CCaMK mixed 
with GST-CCaMK K47E were subjected to a kinase assay followed by autoradiography to 
detect total autophosphorylation. Autophosphorylation was observed for GST-CCaMK and 
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not for GST-CCaMK K47E, as expected. Autophosphorylation was observed only with WT 
CCaMK and not GST-CCaMK K47E when both proteins were mixed in the kinase assay. All 
kinase assays were performed in the presence of Mg2+ and Mn2+, and without calcium 
because this construct did not require it. This therefore implies that this CCaMK construct is 
not fully functional. 
 
3.3.1 Kinetic implications of the mechanism of autophosphorylation 
 
The mechanism of autophosphorylation at T271 has important implications on the kinetics 
of the phosphorylation reaction which justify its study. Figure 3.6 shows examples of the 
extent of normalised phosphorylation over time. The mechanism by which phosphorylation 
occurs has implications for the protein concentration-dependence of the reaction as 
shown. If the reaction occurs intra-oligomerically (or intra-monomerically), alteration of the 
concentration of the protein does not affect the rate at which the reaction proceeds. This 
reaction proceeds with first order kinetics and eventually levels off. Conversely, an inter-
oligomeric (or inter-monomeric) reaction would be concentration-dependent, with an 
increase in reaction rate when the concentration of the protein increases. This is due to the 
increasing likelihood of two molecules colliding and reacting with second order kinetics.  
 
 
 
Figure 3.6 Kinetics of the inter- and intra-oligomeric mechanisms. Figure courtesy of 
Stephen Bornemann. Three sample curves are shown for each mechanism type and in the 
case of intra-oligomeric phosphorylation these three curves overlap. 
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 3.3.2 Experimental design 
 
An experiment was devised in order to distinguish between the mechanisms of 
autophosphorylation (Mukherji and Soderling, 1994) (Figure 3.7). Two forms of CCaMK 
were used for the experiment: tagless WT CCaMK and MBP-CCaMK K47E (kinase-dead 
point mutation). These forms were co-expressed in E. coli using a pCDFDuet-1 vector to 
form mixed oligomers consisting of kinase-active and kinase-dead subunits. These mixed 
oligomers were purified using MBP affinity chromatography and the presence of both 
proteins was confirmed by SDS-PAGE and subsequent mass spectrometry. Therefore, the 
proteins must have been present in mixed oligomers. These proteins were also expressed 
and purified as separate oligomers. 
 
In order to determine if inter-oligomeric phosphorylation occurred, the two proteins were 
separately expressed and then mixed before a kinase assay and subjected to western 
blotting probed with αpT271, a state-specific antibody which specifically recognised 
phosphorylation at T271. Due to the presence of an MBP tag on the kinase dead form, it 
could be determined whether the WT form could phosphorylate the kinase dead form 
when present in separate oligomers using SDS-PAGE prior to western blotting. This 
approach assumed that once oligomers were formed, subunits were not exchanged 
between them during the kinase assay. This experiment would also determine whether 
inter-monomeric phosphorylation could happen, since some of the proteins could be 
present as monomers rather than oligomers. 
 
By contrast, to determine if intra-oligomeric phosphorylation occurred, the co-expressed 
mixed oligomers were subjected to a kinase assay and a subsequent western blot with 
αpT271. Due to the presence of the MBP tag on the kinase-dead form, it could be 
determined whether the WT subunits present in the same oligomer could phosphorylate 
the kinase dead subunits in an intra-oligomeric manner using SDS-PAGE prior to western 
blotting. 
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Figure 3.7. Experimental design to distinguish between an intra- or inter-oligomeric 
mechanism of autophosphorylation at Thr271. 
Constructs of CCaMK were co-expressed in a pCDFDuet -1 vector or expressed separately 
and mixed, and then subjected to a kinase assay. In each case a kinase dead (K47E/D192N) 
and kinase active form (WT) of CCaMK was used.  The kinase dead form was tagged in each 
case for separation by SDS-PAGE from the WT form. Co-expressed mixed oligomers were 
confirmed by purification using a tag (MBP) and a mass spectrometric analysis.  
 
Express hetero-oligomers 
with pCDFDuet-1 vector 
Compare to singly expressed proteins
Kinase active protein Kinase dead protein
??
103 
 
Chapter 3: Mechanism of autophosphorylation at T271 
3.3.3 Inter-oligomeric autophosphorylation  
 
In order to determine if autophosphorylation occurred inter-oligomerically, MBP-CCaMK 
K47E and WT CCaMK were separately expressed and purified, and then mixed during a 
kinase assay. MBP-CCaMK K47E was purified as described in section 3.2, except no SEC was 
performed. WT tagless CCaMK was purified as shown in Figure 3.8. CaM-Sepharose affinity 
chromatography was used and, as with MBP-CCaMK K47E, no subsequent SEC purification 
was required. This was because both proteins were of sufficient purity for use in the kinase 
assay despite the presence of some co-purified contaminants. 
 
MBP-CCaMK K47E and WT CCaMK were both diluted to approxi ately 400 ng/μl and equal 
volumes of each protein were mixed in a kinase assay with the addition of ATP, Ca2+ and 
Mg2+ and then subjected to western blotting probed with αpT271  Figure 3.9 . 
Phosphorylation at T271 was observed only in the WT protein and no phosphorylation was 
detected in the kinase dead protein. The presence of the kinase dead protein was 
confirmed by staining of the blot after development with Ponceau S. Therefore, under 
these conditions no inter-oligomeric autophosphorylation was detected. It follows 
therefore that no inter-monomeric phosphorylation was detected in this experiment 
either. A control WT MBP-CCaMK protein was also subjected to a kinase assay, and strong 
autophosphorylation was detected. This did not appear to be exclusively calcium-induced. 
However, this was most likely due to the presence of background phosphorylation that 
sometimes occurred during the expression of the protein in E. coli.  
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Figure 3.8.  Purification of recombinant WT, tagless MtCCaMK.  
(A) Chromatogram for CCaMK purified using the CaM-Sepharose column at 4 °C. Fractions corresponding to the marked peak were collected and verified by 
SDS-PAGE as shown in (B). 
(B) SDS-PAGE of CaM-Sepharose purification of WT CCaMK. The observed size of CCaMK was 58 kDa, as predicted.  
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Figure 3.9. Autophosphorylation at Thr271 does not occur via an inter-oligomeric 
mechanism. 
MBP-CCaMK K47E and WT CCaMK were separately expressed and subsequently mixed 
before a kinase assay, and subjected to western blotting probed with αpT271. 
Autophosphorylation was induced with the addition of ATP, Ca2+ and Mg2+. 
Autophosphorylation was detected only in the WT CCaMK oligomers and not in the kinase-
dead oligomers. MBP-CCaMK was present in the first two lanes as a control. 
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3.3.4 Intra-oligomeric autophosphorylation 
 
In order to determine if intra-oligomeric phosphorylation occurred at T271, MBP-CCaMK 
K47E and WT CCaMK were co-expressed to generate mixed oligomers and subjected to a 
kinase assay. Co-expression was carried out with the pCDFDuet-1 vector and purification 
was carried out with MBP-affinity chromatography (Figure 3.10). Purified protein was 
analysed by SDS-PAGE and the presence of both of the proteins was confirmed by a mass 
spectrometric analysis. SEC was not performed so that a higher concentration of the 
protein was retained for use in the assay, because it was anticipated that it might not be 
possible to concentrate the protein complex due to potential aggregation after extra time 
and manipulations. Due to the purification method used, a higher proportion of MBP-
CCaMK K47E was present in the mixed oligomers compared to the concentration of WT 
protein present in the complexes (Figure 3.10B) and it was not possible to alter this ratio. 
However, due to the higher concentration of the MBP-K47E subunits it followed that the 
WT subunits would most likely be directly adjacent to a kinase-dead subunit instead of 
another WT subunit. Since intra-oligomer inter-subunit phosphorylation would most likely 
occur at adjacent subunits, this protein preparation is ideally suited to detect this 
autophosphorylation. Therefore, if phosphorylation did occur within the oligomers, it 
would most likely be able to occur in this protein conformation. 
 
Freshly co-purified MBP-CCaMK K47E and WT CCaMK oligomers were subjected to a kinase 
assay induced with the addition of ATP, Ca2+ and Mg2+ and subsequent western blotting 
probed with αpT271  Figure 3.11 . In contrast to the inter-oligomeric experiment, low 
levels of phosphorylation were detected in both the WT subunits and the kinase dead 
subunits. Surprisingly, however, no calcium-induction of autophosphorylation was detected 
in either the WT or the kinase dead protein. Therefore the phosphorylation detected 
corresponded either to intra-oligomeric autophosphorylation which occurred during 
expression and not during the assay, or the bands detected corresponded to non-specific 
background signal. Separately expressed WT CCaMK showed calcium-induced 
autophosphorylation and separately expressed MBP-CCaMK K47E showed no 
phosphorylation at T271 under the same conditions. The control proteins therefore 
showed the expected trend under these conditions. Taken together, these data suggest 
that intra-oligomeric autophosphorylation may occur in this protein configuration.  
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In order to determine if the potential intra-oligomeric phosphorylation detected was real or 
just a background signal, lambda protein phosphatase was used to test if the signal was 
specifically removed (Figure 3.12). As with Figure 3.11, low levels of phosphorylation were 
apparently detected in co-expressed oligomers of both WT and kinase dead subunits. 
However, when the lambda phosphatase-treatment was used, the signal was mostly lost 
from the WT subunits but was not from kinase-dead protein. A control MBP-CCaMK WT 
protein subjected to the same treatment showed almost complete removal of the 
phosphorylation signal detected. Therefore, it can be concluded that the signal detected in 
the kinase dead subunits, and the residual signal detected for WT subunits and MBP-
CCaMK protein after the phosphatase treatment, most likely corresponded to a 
background signal and not phosphorylation. The signal detected for the mixed oligomers 
was significantly lower than for the separately expressed proteins, since the exposure time 
of the western blot membrane necessary to produce the image in Figures 3.11 and 3.12 
was significantly longer. It therefore follows that the signal detected corresponded to 
background signal and not to autophosphorylation. Therefore, it could not be determined 
from this experiment whether autophosphorylation at T271 can occur intra-oligomerically.  
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Figure 3.10. Co-purification of mixed oligomers containing WT tagless CCaMK and MBP-CCaMK K47E using MBP affinity chromatography.  
(A)  Chromatogram for MBP-CCaMK K47E and CCaMK WT mixed oligomers purified using an MBPTrap column at 4 °C. Fractions corresponding to the 
marked peak were collected and verified by SDS-PAGE as shown in (B). 
(B) SDS-PAGE of co-expressed MBP-CCaMK K47E and WT CCaMK. The observed sizes of MBP-CCaMK K47E and WT CCaMK were 98 and 58 kDa, respectively, 
as predicted. The presence of both proteins was verified by a mass spectrometric analysis.  
A Co-purified MBP-CCaMK 
K47E + WT CCaMK
Fraction number
A
b
so
rb
an
ce
 a
t 
2
80
 n
m
B
195
142
96
71
48
33
28
22
12
7.6
MBP-CCaMK K47E
WT CCaMK
MBP-trap
Protein 
marker
kDa
CBB
109 
 
Chapter 3: Mechanism of autophosphorylation at T271 
 
 
Figure 3.11. Low levels of intra-oligomeric autophosphorylation with no calcium-induction 
are observed for co-expressed MBP-CCaMK K47E and WT CCaMK.  
Co-expressed MBP-CCaMK K47E and WT CCaMK were subjected to a kinase assay and 
analysed by western blotting probed with αpT271. Autophosphorylation was induced with 
the addition of ATP, Ca2+ and Mg2+. Phosphorylation was detected in both the WT CCaMK 
subunits and in the kinase dead subunits. However, levels of autophosphorylation were low 
and no calcium-induction was observed. Separately-expressed WT CCaMK and MBP-CCaMK 
K47E were present as control proteins and calcium-induced autophosphorylation was 
detected in WT CCaMK but not MBP-CCaMK K47E, as expected.  
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Figure 3.12. Intra-oligomeric phosphorylation of MBP-CCaMK K47E is not removed by a λ 
phosphatase treatment.  
Co-expressed oligomers comprising MBP-CCaMK K47E and WT CCaMK were subjected to a 
kinase assay followed by a λ phosphatase (λPP) treatment which was analysed by western 
blotting probed with αpT271. Low levels of phosphorylation with no calcium-induction 
were detected in both WT and kinase dead subunits following the kinase assay, as observed 
in Figure 3.11. However, the band corresponding to MBP-CCaMK K47E phosphorylation 
was not removed by the phosphatase treatment. The same three treatments were 
repeated in lanes 3-6, which confirmed this trend. However, under the same conditions, 
phosphorylation of the MBP-CCaMK WT control protein was removed by the phosphatase 
treatment.  Background signal was detected in the phosphatase-treated MBP-CCaMK and 
therefore the signal detected for co-expressed MBP-CCaMK K47E most likely also 
corresponded to background signal and not to intra-oligomeric phosphorylation.  
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3.3.5 Inter-oligomeric autophosphorylation experiment with an alternative 
kinase dead mutation (D192N)  
 
It was theorised that the presence of the K47E kinase dead mutation could have affected 
the ability of CCaMK to be autophosphorylated at T271, and therefore affect whether the 
protein could be either an acceptor or donor of phosphate. In order to determine if the 
spatial location of the mutation could have affected T271, the mutation was located on the 
Phyre2 homology model of the kinase domain with the autoinhibitory domain (Figure 3.13). 
This showed that the Lys47 residue was located distantly from T271. In addition to the 
location of the K47E mutation, the position of an alternative kinase dead mutation, D192N, 
was located on the model. This residue was also predicted to be distantly located from the 
T271 residue. This most likely means that the mutations would not affect the ability of T271 
to phosphorylated for example by blocking it. However, distant mutations can also affect 
the protein in unknown ways and therefore it could not be determined with certainty from 
this model what global affects the mutations could have on the protein. 
 
In order to determine whether the use of an alternative kinase dead mutation altered the 
ability of T271 to be phosphorylated, a form of CCaMK possessing the D192N mutation was 
expressed with a His-SUMO tag using the pOPINS3C vector. Purification was carried out 
with a HisTrap column and the presence of the correct protein was verified by SDS-PAGE 
(Figure 3.14). No SEC purification was necessary. His-SUMO-CCaMK D192N and WT CCaMK 
were both diluted to approxi ately 400 ng/μl and equal volu es of each protein were 
mixed in a kinase assay induced with the addition of ATP, Ca2+ and Mg2+ and subsequently 
subjected to western blotting with αpT271  Figure 3.15 . Calciu -induced 
autophosphorylation was detected in WT protein and a background signal only was 
detected in the kinase-dead protein. This was determined to correspond to a background 
signal because there was no calcium-induction of autophosphorylation and the His-SUMO-
CCaMK D192N protein subjected to a kinase assay alone showed the same low signal. 
Separately expressed WT CCaMK showed calcium induced autophosphorylation as 
expected under the same assay conditions. Therefore inter-oligomeric 
autophosphorylation was also not detected when an alternative kinase dead mutation was 
used, and therefore it can be concluded that the specific kinase-inactivation mutant most 
likely did not affect the ability of the protein to be phosphorylated if an inter-oligomeric 
mechanism were to occur. 
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The data presented in this section showed that autophosphorylation at T271 most likely 
does not occur by an inter-oligomeric (or inter-momomeric) mechanism and it follows 
therefore that it must occur via an intra-oligomeric mechanism. This is because inter-
oligomeric phosphorylation did not occur with GST-CCaMK K47E, MBP-CCaMK K47E or His-
SUMO-CCaMK D192N and previous data suggested that CCaMK is not able to 
autophosphorylate when it did not form oligomers. Intra-oligomeric autophosphorylation 
was not able to be shown conclusively with the mixed oligomer experiment. However, this 
is most likely due to interference from the tag and insufficient WT protein in the mixed 
oligomer experiment. A further possibility is that the kinase dead mutation affected the 
ability of the protein to be phosphorylated, and this cannot be ruled out for both 
experiments. However, taken together, these data indicated that the most likely 
mechanism of autophosphorylation at T271 is intra-oligomeric.   
 
 
Figure 3.13. The kinase dead mutations are predicted to be located distantly from the 
Thr271 residue.  
A model of the kinase and auto-inhibitory domain was produced with Phyre2, and the 
locations of Asp192 and Lys47 are marked in pink and orange respectively.  Mutation of 
either Asp192Asn or Lys47Glu confers a classical kinase-dead phenotype. The location of 
the key residue of autophosphorylation, Thr271, is marked in red and is predicted to be 
distantly located from both kinase-dead mutations.  
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Figure 3.14. Purification of recombinant His-SUMO CCaMK D192N protein.   
(A) Chromatogram for His-SUMO CCaMK D192N purified using the HisTrap column at 4 °C. The marked peak was confirmed to contain the correct protein 
by SDS-PAGE, as shown in (B). 
(B) SDS-PAGE of His-SUMO CCaMK D192N protein. The protein was observed at 72 kDa, as predicted. Non-specifically bound proteins which co-eluted with 
CCaMK D192N protein were also observed. 
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Figure 3.15. Inter-oligomeric autophosphorylation is not observed between His-SUMO 
CCaMK D192N and WT CCaMK.  
His-SUMO-CCaMK D192N and WT CCaMK were separately expressed and mixed before a 
kinase assay, and subsequently subjected to western blotting probed with αpThr271. 
Autophosphorylation was induced with the addition of ATP, Ca2+ and Mg2+. Phosphorylation 
was detected in the WT CCaMK protein and a background signal only was detected in the 
kinase-dead His-SUMO-CCaMK D192N protein, indicating no inter-oligomeric 
phosphorylation had occurred. WT tagless CCaMK showed calcium-induced 
autophosphorylation as expected and a background signal only was detected for His-SUMO 
D192N protein.  
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3.4 Discussion 
 
The aim of this Chapter was to elucidate the mechanism of autophosphorylation at T271. 
First, it was necessary to determine the oligomeric status of CCaMK. Previous biochemical 
characterisation of MtCCaMK has been carried out using truncations of the protein lacking 
the kinase domain, which were present as monomers (Swainsbury et al., 2012). In order to 
characterise the full-length protein, an MBP-CCaMK fusion was generated (Miller et al., 
2013). Previous work by Liang Zhou established the stability of this fusion protein by SEC 
before and after freeze-thawing of the protein. This fusion was therefore a stable, non-
aggregating full-length construct of CCaMK and the most suitable candidate for oligomeric 
status experiments. Using SEC, AFM and DLS it was determined that MBP-CCaMK forms an 
oligomer of 16-18 subunits with a diameter of    31 nm. Whilst these data provided an 
estimate only of the oligomer size, it nevertheless indicates that CCaMK forms a large 
oligomer when expressed in E. coli. Furthermore, previous data obtained by Liang Zhou 
indicates that a construct of CCaMK lacking the first five amino acids of the kinase domain 
does not form stable oligomers. This finding, in addition to that of Swainsbury and 
colleagues, indicates a likely role of the kinase domain in oligomer formation. 
 
The ability of CCaMK to form oligomers leads to the question of whether the oligomeric 
state of the protein impacts on the mechanism of autophosphorylation at T271. Data 
presented in this Chapter indicates that this likely occurs in an intra-oligomeric manner. 
Whilst it was not possible to determine this with certainty, several pieces of evidence likely 
rule out the other possible mechanisms. Homology modelling carried out on the kinase and 
AI domains indicates that intra-monomeric autophosphorylation is unlikely due to the 
locations of T271 and the active site in the well-conserved kinase domain. In addition, three 
experiments carried out to determine if inter-monomeric or inter-oligomeric 
autophosphorylation occurs showed no evidence of the occurrence of either of these 
mechanisms. Finally, the lack of intra-oligomeric autophosphorylation detected in this 
particular experiment could be due to a number of experimental factors. These include 
interference of the MBP-tag due to the presence of un-tagged and tagged protein in the 
complex and insufficient WT CCaMK present to detect the autophosphorylation signal. The 
interference of the MBP-tag itself can be ruled out because this protein shows calcium-
induced autophosphorylation when expressed separately (Miller et al., 2013). A further 
possibility is that the kinase-dead mutation prevents the subunit from being 
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phosphorylated. However, two kinase-dead mutations were tested in the separately 
expressed experiment as a control and both showed the same result. However, such 
mutations cannot be ruled out as interfering factors. 
 
The likely intra-oligomeric mechanism of autophosphorylation at T271 has important 
kinetic implications. As described above, the rate of an inter-oligomeric (or inter-
monomeric) mechanism is dependent on protein concentration, whereas an intra-
oligomeric (or intra-monomeric) mechanism is not. These correspond to second and first 
order kinetics, respectively. Therefore, it follows that an intra-oligomeric mechanism is 
more robust and more efficient than an inter-oligomeric mechanism. As this is most likely 
the case, CCaMK follows a similar mechanism of autophosphorylation to that of CaMKII at 
T286. 
 
3.5 Summary 
 
MBP-CCaMK is an oligomer of 16-18 subunits with a diameter of    31 nm when expressed in 
E. coli. This has implications for the mechanism of autophosphorylation at T271. Homology 
 odelling indicates this likely doesn’t occur intra-monomerically, and three experiments 
using different CCaMK constructs do not show inter-monomer or inter-oligomeric 
autophosphorylation. The likely mechanism is therefore intra-oligomeric, which is 
kinetically more efficient and protein concentration-independent. 
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4.1 Introduction 
 
CCaMK is controlled by calcium in two ways: directly by binding to three EF-hands in the 
visinin-like domain (VLD) and indirectly, when four calcium ions bind to CaM which binds to 
the CaM-binding domain. Interestingly, previous data have shown that CCaMK undergoes a 
conformational change when calcium binds to the EF-hands of the VLD. This was first 
characterised in L. longiflorum CCaMK by Takezawa and colleagues (Takezawa et al., 1996) 
by mobility shift assay. They demonstrated, using point mutations at each EF-hand, that EF-
hands 2 and 3 are predominantly responsible for this conformational change.  The 
conformational change has been further characterised by mobility shift assay by Shimoda 
and colleagues (Shimoda et al., 2012). They determined that L. japonicus CCaMK also 
undergoes a conformational change, and under these circumstances EF-hand 3 is 
predominantly responsible. Finally, the conformational change of M. truncatula CCaMK 
was characterised by Swainsbury and colleagues (Swainsbury et al., 2012) using monomeric 
truncations of the protein for stability. They determined that the calcium-induced 
conformational change corresponds to a change in tertiary structure, and reveals a 
hydrophobic cleft on the protein. Therefore, the conformational change that CCaMK 
undergoes in the presence of calcium has been characterised to some extent, however key 
questions remained. Consequently, two strategies were undertaken in this Chapter to 
further characterise this important conformational change. First, a non-aggregating full-
length construct of CCaMK, MBP-CCaMK, was used to determine if the hydrophobic patch 
is also exposed when the kinase domain is present. Second, small-angle X-ray scattering 
(SAXS) was used to characterise the conformational change which occurs in the VLD. 
 
In addition to SAXS analysis of the VLD, crystallography trials for this protein are also 
detailed in this Chapter. One of the key remaining challenges for CCaMK is to obtain an 
atomic-resolution structure for the protein. Currently, the best structural data available for 
CCaMK consists of homology modelling based on CaMKI (Sathyanarayanan et al., 2001), 
CaMKII (Shimoda et al., 2012) and a CDPK scaffold (Miller et al., 2013). However, homology 
modelling of CCaMK has limitations because of low sequence similarity to potential 
templates so conclusions drawn using homology modelling must therefore be considered in 
this light. Extensive previous attempts to crystallise CCaMK have been unsuccessful due to 
the tendency of CCaMK to aggregate, particularly when the kinase domain is present. 
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Therefore, crystal trials of two truncations of CCaMK are detailed in this Chapter: the VLD 
and a peptide containing T271 and the CaM-binding domain. 
 
4.2 CCaMK elongates when calcium binds 
 
4.2.1 MBP-CCaMK exposes a hydrophobic patch when Ca2+ binds to the EF-hands 
In order to characterise the conformational change that occurs when calcium ions bind to 
the EF-hands of CCaMK a hydrophobic dye, 8-anilino-1-naphthalenesulfonic acid (ANS), was 
used. ANS is a hydrophobic dye that increases in fluorescence when it binds to hydrophobic 
regions of proteins. Therefore fluorescence was recorded in the presence of ANS dye with 
either Ca2+ ions or EDTA. EF-hand containing proteins, for example CaM, expose 
hydrophobic residues when calcium binds which interact with target proteins (Hoeflich and 
Ikura, 2002). It is currently unknown as to whether full-length CCaMK exposes a 
hydrophobic patch, and, if it does, whether this facilitates the binding of CCaMK to itself or 
target proteins. 
 
Previous work carried out by David Swainsbury showed that both the autoinhibitory 
domain and VLD (AI-VLD) and the His-VLD underwent a calcium-dependent increase in 
fluorescence in the presence of ANS (Swainsbury et al., 2012). This corresponded to the 
exposure of a hydrophobic patch on each protein and therefore a calcium-dependent 
conformational change occurred in each. Furthermore, baseline fluorescence in the 
presence of ANS and EDTA was higher for the AI-VLD compared to the His-VLD. This 
indicated that hydrophobic residues were exposed when Ca2+ was not present in the AI-VLD 
and these were not present in the VLD.  
 
In order to determine whether a hydrophobic patch was also exposed when calcium ions 
bound to the full-length protein, full-length MBP-CCaMK was tested (Figure 4.1). MBP-
CCaMK protein was purified as described in Figure 3.1. Similarly to the AI-VLD and His-VLD, 
an increase in fluorescence was detected in the presence of calcium for MBP-CCaMK. This 
indicated that full-length CCaMK also underwent a conformational change leading to an 
exposure of hydrophobic residues when calcium ions bound to the EF-hands. In a manner 
analogous to the AI-VLD, background fluorescence was increased compared to baseline 
120 
 
Chapter 4: Structural studies of CCaMK 
when protein was added in the presence of EDTA. This suggested that the same 
hydrophobic residues exposed on the AI-VLD were also exposed in the full length protein. 
 
Due to the nature of this technique, it was not possible to quantify the fluorescence change 
in any meaningful way. However, since the qualitative change in fluorescence was 
observed with full-length CCaMK, it can be deduced that the function of this hydrophobic 
patch was not to interact with other CCaMK subunits. This is because no increase in 
fluorescence would have been detected if the patch was already blocked by interaction 
with CCaMK subunits. Therefore, it follows that the function of this patch exposure could 
be to bind a target signalling protein which could potentially be CYCLOPS or another as yet 
unknown target binding partner of CCaMK.  
 
 
 
Figure 4.1. MBP-CCaMK exposes a hydrophobic patch when Ca2+ ions bind to the EF-hands.   
Fluorescence spectra of 8-anilino-1-naphthalenesulfonic acid (ANS) in the presence of MBP-
CCaMK with either 2 mM CaCl2 (purple dotted line) or 2 mM EDTA (purple solid line). 
Equivalent spectra for ANS fluorescence with no protein and either 2 mM CaCl2 or 2 mM 
EDTA are shown with a dashed grey line and a solid grey line, respectively. The increase in 
fluorescence detected in the presence of calcium indicated the exposure of hydrophobic 
residues. This experiment was carried out in conjunction with Liang Zhou. 
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4.2.2 His-VLD elongates when Ca2+ binds to the EF-hands 
In order to further characterise the conformational change that occurs when calcium binds 
to the EF-hands, small angle X-ray scattering (SAXS) was carried out. This technique 
involves the illumination of a sample in solution with X-rays and the measurement of the 
scattered radiation. This yields information on the size and structure of the 
macromolecules in solution, and can be refined to produce a SAXS envelope. Crucially, 
samples are required to be highly monodisperse in order to yield high quality scattering 
data, so therefore no full length construct of CCaMK was suitable. Hence, the AI-VLD and 
the His-VLD proteins were used. However, the AI-VLD protein showed unsatisfactory levels 
of aggregation during the scattering experiments and therefore the data was not of 
sufficient quality for analysis, so it was not considered further.  
 
His-VLD protein was purified as shown in Figure 4.2. In order to isolate protein of sufficient 
purity, a two-step purification was used. Nickel-affinity chromatography (Figure 4.2A) was 
utilised followed by SEC (Figure 4.2B) to remove contaminants. The size and purity of the 
protein was confirmed using SDS-PAGE (Figure 4.2C). SAXS data were collected at the X33 
beam line on the DORIS III synchrotron at EMBL, DESY in Hamburg, Germany. An original 
set of data was obtained by David Swainsbury, but there were concerns with these data 
due to low statistical significance of the difference observed between the forms in the 
presence and absence of calcium. This is an issue because of the low-resolution of this 
technique. Therefore, I carried out two further attempts to improve upon the quality of the 
data obtained. Strategies to improve the data included the use of DTT to reduce 
aggregation and the use of the same protein and buffer solutions divided between calcium 
and EDTA treatments. However, an improvement on the original data was not possible due 
to a little aggregation which occurred in both new datasets in a manner analogous to AI-
VLD. The data presented in Figure 4.3, therefore, corresponds to a previously acquired data 
set for the His-VLD obtained by David Swainsbury, which was subsequently re-analysed by 
Dmitri Svergun. This data analysis was carried out subsequently to my newly obtained data, 
and therefore is presented in this thesis for the first time. The newly-analysed data are 
consistent with both datasets that I acquired. 
 
Scattering profiles were obtained for the His-VLD at various protein concentrations within a 
range of 0.5 - 7.4 mg/ml and 1.9 - 7.4 mg/ml with CaCl2 and EDTA, respectively (Figure 4.3). 
The ab initio models constructed from the SAXS data were fitted to the calcium-bound 
122 
 
Chapter 4: Structural studies of CCaMK 
structure of a human neuronal calcium sensor (Heidarsson et al., 2012). This neuronal 
calcium sensor contains four EF-hands of which three are able to bind calcium, analogous 
to the VLD of CCaMK (Swainsbury et al., 2012). Furthermore, this template protein 
undergoes a conformational change on calcium-binding, revealing a hydrophobic crevice, 
allowing the protein to bind to targets (Ames and Lim, 2012). Overall, the SAXS envelopes 
for the His-VLD were broadly similar with and without calcium. However, a conformational 
change was observed leading to an overall extension of the structure when calcium was 
present. Surprisingly, although the template structure from which the model was derived 
was calcium-bound, the template showed a better fit to the envelope in the presence of 
EDTA. Due to the limit of resolution, the exact structural change that occurred could not be 
modelled. Furthermore, the statistical difference observed between treatments was 
marginal. Nevertheless, these data indicate the likely structural change occurring in the 
VLD. Moreover, these data correlate with the observation in section 4.2.1 that when 
calcium binds to the EF-hands, a hydrophobic patch is exposed on full-length CCaMK 
indicating a conformational change. Therefore, this change likely corresponds to an 
elongation of the EF-hand domain. 
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Figure 4.2. Purification of recombinant His-VLD for small angle X-ray scattering (SAXS).  
(A) Chromatogram for the purification of His-VLD by nickel affinity chromatography using a HisTrap column. Fractions corresponding to the marked peak 
were collected, pooled and subjected to size exclusion chromatography as shown in (B).  
(B)  A size exclusion chromatogram for the His-VLD using a HiLoad Superdex 75 prep grade 16/60 column. The marked peak was confirmed to contain the 
correct protein by SDS-PAGE shown in (C). 
(C) SDS-PAGE of HisTrap and SEC fractions of His-VLD. His-VLD was observed at 21 kDa, as predicted, and was highly pure. Fractions from the SEC 
purification were pooled and dialysed, concentrated appropriately and sent on dry ice for SAXS analysis.  
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Figure 4.3. ab initio SAXS envelopes of  the His-VLD show an elongation of the protein 
when calcium binds to the EF-hands (Figure courtesy of David Swainsbury and Dmitri 
Svergun). 
(A) SAXS envelope of the His-VLD (blue) fitted to a homology model of the protein 
generated against a calcium-bound human neuronal calcium sensor (Heidarsson et al., 
2012) using SWISSMODEL (magenta), in the presence of 0.1 mM EDTA. Readings were 
taken at various protein concentrations within a range of 1.9 - 7.4 mg/ml (90 - 352 μM . 
(B) 90° rotation of the His-VLD SAXS envelope in the presence of 0.1 mM EDTA. 
(C)  SAXS envelope of the His-VLD (blue) fitted to the SWISSMODEL homology model of the 
protein (magenta) in the presence of 2 mM CaCl2. Readings were taken at various protein 
concentrations within a range of 0.5 - 7.4 mg/ml (24 - 352 μM . 
(D) 90° rotation of the His-VLD SAXS envelope in the presence of 2 mM CaCl2.  
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4.3 Crystallography trials of His-VLD with DAPase digestion 
 
To date, no crystal structure of CCaMK has been elucidated. A crystal structure of CCaMK 
would clarify many questions which still remain as to the mechanism by which CCaMK 
functions. Full-length CCaMK is unsuitable for crystallisation due to its tendency to 
aggregate. Therefore constructs of CCaMK were considered which were potentially more 
stable than the full-length form, in particular those that excluded the problematic kinase 
domain. The AI-VLD which lacked the kinase domain only was not suitable due to low 
yields. Previous work performed by David Swainsbury using the His-VLD demonstrated that 
the stability and solubility of the protein was significantly increased by the removal of the 
His tag using DAPase digestion. Therefore, crystallisation trials were attempted with this 
construct. 
 
His-VLD was purified as shown in Figure 4.2A with no SEC purification. Protein was dialysed 
overnight in buffer containing in 10 mM Tris pH 7.5, 50 mM NaCl, 1 mM DTT. Purified 
protein was digested with DAPase which removed the His tag and yielded the protein 
shown in Figure 4.4A from the red arrow onwards. Successful digestion of the protein was 
confirmed using a 17 % SDS-PAGE gel that was sufficient to show a gel shift corresponding 
to the tag removal (Figure 4.4B). Contaminants which co-purified with the His-VLD, un-
digested His-VLD protein, the cleaved tag and the DAPase enzyme (which possessed a C-
terminal His tag) were removed with reverse immobilised metal affinity chromatography 
(IMAC). The purity of the digested protein was confirmed by SDS-PAGE (Figure 4.4C). The 
protein was concentrated to 15 mg/ml and frozen in liquid nitrogen followed by storage in 
aliquots at -80 °C prior to use. 
 
Crystallisation screens were set up for digested VLD protein as described in Table 4.1 and 
plates were stored at 20 °C. Screens were monitored for approximately one month, and 24-
well optimisation screens were set up for conditions that yielded potential protein crystals, 
namely condition C2 in the JCSG screen (0.2 M ammonium dihydrogen phosphate, 0.1 M 
Tris pH 8.5, 50% (v/v) MPD) and H9 in the structure screen (0.1 M MES pH 6.5, 12% (w/v) 
PEG 20 000). Two crystals which formed in the C2 JCSG optimisation screen were frozen in 
liquid nitrogen and data was collected for one crystal using the Rigaku RU-H3R rotating 
anode X-ray generator at the John Innes Centre by Clare Stevenson. However, the 
diffraction pattern corresponded to that of a salt crystal and not a protein crystal. 
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Therefore no conditions from these screens yielded protein crystals for structure 
determination. 
 
In order to determine if the presence or absence of calcium stabilised the VLD, further 
crystallisation trials were carried out using digested VLD protein in the presence of either 1 
μM CaCl2 or 1 mM EDTA. Protein was concentrated to 11 and 12 mg/ml respectively and 
crystallisation screens were set up as described in table 4.1. Screens were monitored for 
approximately one month and 24-well optimisation screens were set up for two conditions: 
B11 in the PEG screen (0.2 M potassium sulfate, 20% (w/v) PEG 3350) and C4 in the 
structure screen (0.1 M HEPES pH 7.5, 1.5 M lithium sulfate), both in the presence of 
calciu . The B11 PEG condition opti isation was set up with an additional 0.2 μl crystal 
seed-stock from the original screen present in the drop. However, none of the conditions 
which were tested yielded protein crystals in the presence of either calcium or EDTA. 
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Figure 4.4. His-VLD digestion with DAPase for VLD crystallography trials. 
(A) The amino acid sequence of the His-VLD construct. The three functional EF-hands are 
marked with coloured boxes, and the non-functional EF-hand is marked with a grey box. 
The site of DAPase cleavage is marked with a red arrow.  
(B) SDS-PAGE (17%) of His-VLD protein purified by nickel affinity chromatography using a 
HisTrap column and the VLD protein after removal of the His tag by digestion with DAPase.  
(C) SDS-PAGE of DAPase-digested VLD after reverse IMAC purification to remove the 
DAPase enzyme and contaminants, which co-purified with the His-VLD. The VLD protein 
was subsequently concentrated and used for crystallography trials. 
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Protein 
construct 
Protein 
concentration 
(mg/ml) 
Additional conditions Screens set up 
VLD 15 - 
PEG, ammonium sulphate, 
PACT, JCSG, Structure, 
Morpheus, Midas 
VLD 11 1 μM  CaCl2 
PEG, ammonium sulphate, 
PACT, JCSG, Structure, 
Morpheus, Midas 
VLD 12 1 mM EDTA 
PEG, ammonium sulphate, 
PACT, JCSG, Structure, 
Morpheus, Midas 
Table 4.1. Crystallisation trial conditions for the VLD. 
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4.3.1 Crystallisation trials of the VLD with surface entropy reduction 
 
Successful crystallisation of a protein involves the development of intermolecular contacts 
and the subsequent formation of a crystalline lattice. The side chains that are surface 
exposed on a protein can potentially affect the ability to crystallise.  Surface entropy 
reduction (SER) involves the selection of high-entropy surface-localised residues for 
mutation to residues of lower entropy. This involves the mutation of a small cluster of high 
entropy residues, e.g. Lys, Glu or Gln, to Ala and has been shown to increase the ability of 
some proteins to crystallise (Goldschmidt et al., 2007). 
 
Therefore, in order to thermodynamically favour the crystallisation of the VLD, residues 
were selected for mutation for SER using the SERp server (Figure 4.5). Three clusters were 
predicted for mutation, and ranked by SERp score, where the highest score corresponds to 
the best candidate for mutation. A homology model of the VLD was generated using Phyre2 
to map the spatial locations of the three selected clusters. Since cluster 2 overlapped with 
an EF-hand domain, this cluster was not selected. Conserved sequences were not 
recommended for mutation because mutation could negatively affect the structure of the 
protein. Cluster 1 and 3 were both surface exposed in the homology model, however it was 
not recommended to mutate more than one cluster. Therefore cluster 1 was selected for 
mutation due to the higher SERp score. 
 
Mutation of the cluster from KEEEIE to AAAEIE as recommended by the SERp server was 
carried out using the QuikChange Lightning site-directed mutagenesis kit and confirmed by 
sequencing. The protein was expressed, purified and digested as described for the VLD 
(Section 4.3). Protein was concentrated to 19 mg/ml and crystallisation screens were set up 
as described in table 4.2, with plates stored at 20 °C. Screens were monitored for 
approximately one month, and 24-well optimisation screens were set up with conditions 
that yielded potential protein crystals, namely condition A9 from the customised KISS 
screen (0.1 M MES pH 6, 10% (w/v) PEG 3350) and A10 from the KISS screen (0.1 M MES pH 
6, 20% (w/v) PEG 3350). A further optimisation screen was set up using crystal seed stock 
from the A9 optimisation screen, which was added to a 96-well PEG screen and monitored. 
Despite these efforts, potential crystals corresponded to fungal contamination and SER of 
the VLD yielded no protein crystals for structure determination. 
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Figure 4.5. Three high-entropy residue clusters are predicted for surface entropy reduction of the VLD by the SERp server.  
(A) Surface-exposed and high-entropy residues for potential mutation were predicted for the VLD protein with the SERp server. The three predicted clusters 
are marked 1-3, with the corresponding SERp scores shown above. Green bands show predicted residues for mutation in each cluster, with low entropy 
residues marked in grey. Blue peaks correspond to coiled coil predictions and red peaks correspond to the predicted average entropy of residues. 
(B) Homology model of the VLD produced with Phyre 2 showing the locations of EF-hands 1, 2 and 3 in orange, cyan and white respectively and the three 
proposed clusters marked in red, pink and green, respectively. Cluster 2 overlapped with EF-hand 2 and was therefore disregarded, and cluster 3 had a 
markedly lower SERp score than cluster 1 or 2. Therefore cluster 1 was selected for mutation due the highest SERp score and residues 15-17 (KEE) were 
mutated to alanines.  
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Protein 
construct 
Protein 
concentration 
(mg/ml) 
Additional 
conditions 
Screens set up 
VLD with SER 19 - 
KISS, JCSG, Morpheus, 
Structure 
Table 4.2. Crystallisation trial conditions for the VLD with SER.  
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4.4 Crystallography trials of His-SUMO-CCaMK peptides 
 
Attempts to crystallise the VLD of CCaMK yielded no protein crystals for structural studies, 
therefore alternative truncations of CCaMK were considered for crystallisation trials. 
Previous work carried out by Sathyanarayanan and colleagues (Sathyanarayanan et al., 
2001) utilised an 84 amino-acid peptide from L. longiflorum CCaMK for CaM-binding 
experiments. This peptide possessed the T267 residue (equivalent to T271 in MtCCaMK) 
and the CaM-binding site. Interestingly, this peptide showed a five-fold increase in affinity 
for calmodulin when phosphorylated at T267, compared to a seven-fold increase detected 
when full-length CCaMK was used. Therefore the peptide retained some of the 
functionality of the full-length protein and it follows that it retained some of the same 
structural characteristics as when it was present in the full-length protein. Since acceptable 
homology models can be produced of the kinase domain with the autoinhibition domain 
(Figure 3.4) and the VLD (Figure 4.5), the data provided by a crystal structure of the link 
between the kinase and VLD would provide crucial missing information about how CCaMK 
is activated and deactivated.  
 
Therefore, the equivalent MtCCaMK peptide (Figure 4.6A) was sub-cloned for expression 
with a His-SUMO tag in the pOPINS3C vector. Two versions of this construct were produced 
for use in structural experiments: version 1 which possessed a non-cleavable His-SUMO tag 
and version 2 which possessed a 3C cleavage site for removal of the tag. Both His-SUMO-
CCaMK peptides were purified using nickel affinity chromatography with a HisTrap column 
(Figure 4.6B) and the presence of the correct protein was verified by SDS-PAGE (Figure 4.6C 
and D, version 1 and 2, respectively). The presence of both proteins was also confirmed by 
mass spectrometric analysis. His-SUMO-CCaMK peptide version 1 was significantly purer 
after purification. However, since version 2 of the peptide possessed a cleavage site, the 
protein would be subsequently purified further by subtractive IMAC. Therefore both 
peptides were sufficiently pure for structural studies. 
 
His-SUMO-CCaMK peptide (version 1) was prepared for crystallisation trials by buffer 
exchange to 20 mM Tris pH 8 and 100 mM NaCl and subsequent concentration to 15 
mg/ml. Crystallisation screens were set up for this protein as described in Table 4.3. 
Screens were monitored for approximately one month however no potential protein 
crystals were observed.  
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Figure 4.6. Purification of the recombinant His-SUMO CCaMK peptides. 
(A) Sequence of the CCaMK peptide present in the pOPINS3C vectors. The Thr271 residue is 
marked in red, and the CaM-binding site is marked in purple. The same amino acid 
sequence was present in both versions of the His-SUMO-CCaMK peptide vectors. Version 1 
of the vector lacked a 3C protease cleavage site, and version 2 possessed a 3C protease 
cleavage site for removal of the His-SUMO tag from the purified protein.  
(B) Representative chromatogram for purification of the His-SUMO-CCaMK peptides 
purified using the HisTrap column. Fractions corresponding to the marked peak were 
collected and verified by SDS-PAGE as shown in (B) and (C).  
(C) SDS-PAGE of purified His-SUMO CCaMK peptide without a 3C cleavage site (version 1). 
The protein was predicted to be 23.7 kDa (peptide = 9.4 kDa, His-SUMO tag   14.3 kDa  and 
observed at    21 kDa. The presence of the correct protein was verified by mass 
spectrometric analysis. This purification was performed by Karl Syson. 
(D) SDS-PAGE of purified His-SUMO CCaMK peptide with a 3C cleavage site (version 2). The 
protein was predicted to be 23.7 kDa (peptide = 9.4 kDa, His-SUMO tag   14.3 kDa  and 
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observed at    21 kDa. Non-specifically bound proteins which co-eluted with the SUMO 
peptide were also observed. The presence of the correct protein was verified by mass 
spectrometric analysis.  
 
Protein construct 
Protein concentration 
(mg/ml) 
Additional 
conditions 
Screens set up 
His-SUMO-CCaMK 
peptide 
(version 1, no cleavage 
site) 
15 - 
KISS, PEG, Structure, 
PACT and JCSG 
Table 4.3. Crystallisation trial conditions for the His-SUMO-CCaMK peptide lacking a 
cleavage site (version 1).  
 
4.4.1 Digestion trials of His-SUMO-CCaMK peptide with the 3C protease 
His-SUMO-CCaMK peptide (version 2) was subjected to 3C protease cleavage trials in an 
attempt to produce a tagless version of the peptide for further crystallisation trials (Figure 
4.7 . Digestion was carried out at 4 °C for a ini u  of 16 hours with 10 μg/μl 3C 
protease. Surprisingly, no digestion of the His-SUMO-CCaMK peptide was observed with 
these typical digestion conditions (Figure 4.7A) whereas digestion of a control protein was 
observed (Figure 4.7B). The size shift of the protein, which corresponded to removal of the 
tag, was 14.3 kDa, as expected. Despite the presence of the 3C protease at approximately 
the same size as the His-SUMO-CCaMK peptide, it was established by mass spectrometric 
analysis that the His-SUMO-CCaMK peptide was present. Further digestion trials of the His-
SUMO-CCaMK peptide (version 2) were carried out in the presence of 5 mM DTT (in an 
attempt to stimulate the activity of the cysteine protease) and at room temperature 
(approximately 20 °C) however no digestion was observed under these alternative 
conditions (data not shown).  
 
Since the cleaved His-SUMO tag from the control protein was observed at approximately 
the same size as the His-SUMO-CCaMK peptide (Figure 4.7A-B), IMAC was carried out to 
determine if the protein was digested however no gel shift was observed (Figure 4.7C). No 
evidence of digested CCaMK peptide was seen in the flow-through fractions which 
represented proteins which did not bind to the HisTrap column. However, a strong band 
corresponding to the undigested His-SUMO-CCaMK peptide was detected in the fraction 
that corresponded to proteins that were eluted from the column using 500 mM imidazole. 
Therefore, under the conditions tested no evidence of the digestion of the His-SUMO-
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CCaMK peptide was observed, which was most likely due to obstruction of the cleavage site 
by the conformation of the protein.  
 
In addition, purification trials were attempted with the same peptide fused to a His-tag in 
the Topo100 vector. However, protein was not expressed to a sufficient level to attempt 
crystal trials using this expression system. 
 
Therefore, no protein crystals of CCaMK were obtained by these experiments and therefore 
no structural elucidation could be carried out.  
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Figure 4.7. 3C protease digestion trials of the His-SUMO-CCaMK peptide (version 2).  
(A) SDS-PAGE of a 3C protease digestion trial for His-SUMO-CCaMK peptide where no size 
shift corresponding to His-SUMO tag cleavage was observed. The 3C protease was 
observed at 22 kDa. The predicted size of SUMO-peptide is 23.7 kDa (Peptide = 9.4 kDa, 
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His-SUMO tag = 14.3 kDa), and the observed size was smaller at approximately 21 kDa. The 
presence of the His-SUMO-CCaMK peptide was confirmed by mass spectrometric analysis.  
(B) Digestion of a control His-SUMO tagged protein (52 kDa predicted, 47 kDa observed) 
that showed the expected size shift of 14.3 kDa which corresponded to the successful 
removal of the His-SUMO tag. This digestion was carried out under the same conditions as 
used for the His-SUMO-CCaMK peptide digestion trial shown in (A).  
(C)  SDS-PAGE of the subtractive IMAC for the His-SUMO-CCaMK peptide after a 3C 
protease digestion trial. The correct protein was observed only in eluted protein fractions 
and not in the flow-through wash fractions and therefore the protein was not digested.  
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4.5 Discussion  
 
The first aim of experimental work presented in this Chapter was to characterise the 
conformational change that occurs when calcium binds to the EF-hands of the VLD. EF-
hand proteins typically undergo a calcium-induced conformational change in order to bind 
target proteins (Gifford et al., 2007). CaM is a calcium binding protein that contains four EF-
hands present in pairs on two globular domains, separated by a helical linker region. When 
calcium ions bind, CaM also undergoes a conformational change, and interestingly this 
corresponds to the exposure of hydrophobic residues in the linker region which bind to 
targets (Bhattacharya et al., 2004). Data presented in this Chapter demonstrates that this 
exposure of hydrophobic residues in the presence of calcium also occurs in full-length 
CCaMK. This had previously been demonstrated as the case for truncations of the protein 
only, lacking the kinase domain or both the kinase and AI domains (Swainsbury et al., 
2012). Furthermore, data presented in this Chapter showed the conformational change as 
an elongation of the VLD in the presence of calcium ions, using SAXS. 
 
The exposure of a hydrophobic patch in response to calcium binding in CCaMK has now 
been observed in the VLD, AI-VLD (Swainsbury et al., 2012) and full length MBP-CCaMK. 
This demonstrates that the conformational change that occurs in the VLD still occurs in the 
context of the whole protein. Furthermore, this indicates that the likely binding target of 
this hydrophobic patch is not the interaction with other CCaMK monomers. Instead, it is 
likely that the function of this patch is to bind another target of CCaMK, perhaps CYCLOPS 
or another phosphorylation target. The SAXS data obtained demonstrated further that this 
hydrophobic patch exposure corresponds to a likely elongation of the VLD. The SAXS data 
obtained is clearly consistent with the ANS data presented in this Chapter and with the 
conformational change data presented in (Swainsbury et al., 2012). Therefore, these data 
taken together provide strong evidence for the hydrophobic patch corresponding to 
elongation of the VLD. 
 
It is currently unclear as to exactly which EF-hands are responsible for this structural 
change, and most likely it requires the functionality of all three EF-hands. First, it was 
demonstrated that functionality of EF-hand 2 and 3 was necessary for this conformational 
change (Takezawa et al., 1996), and it was further confirmed that functionality of EF-hand 3 
was necessary by Shimoda and colleagues (Shimoda et al., 2012). Interestingly, analysis of 
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calcium affinities by Swainsbury and colleagues (Swainsbury et al., 2012) showed that EF-
hand 3 corresponds to a high affinity site which likely has calcium bound at basal calcium 
levels. Therefore, it seems possible that the conformational change recorded in the 
experiments presented in this Chapter correspond to the binding of calcium to EF-hands 1 
and 2, but that the calcium-binding functionality of EF-hand 3 is also necessary for this 
change. Further work will be required to unpick this complex regulation. 
 
Crystal trials for two constructs of CCaMK were also presented in this Chapter. Two 
truncations of CCaMK were selected for this work because full-length CCaMK has a 
tendency to aggregate with or without a tag over longer time scales (Swainsbury et al., 
2012). The unsuitability of full-length CCaMK for crystallography was confirmed by a 
crystallisation prediction using the XtalPred server (Slabinski et al., 2007). Predictions are 
based on a variety of factors including length, predicted structural disorder and isoelectric 
point. Two predictions carried out by this server deter ined that CCaMK is in the “difficult” 
and “least pro ising” categories for crystallisation. Therefore, extensive crystal trials were 
carried out for truncations of CCaMK. For the VLD, the full available range of precipitant 
conditions was trialled. In addition, the presence of calcium or EDTA and SER was tested in 
an attempt to improve the ability of the VLD domain to crystallise. In addition, two 
different tags were tested for the expression of a central peptide, and the His-SUMO-
tagged peptide was selected for use in crystal trials. A range of precipitant conditions were 
tested and removal of the tag was unsuccessfully trialled. The tag was most likely unable to 
be removed due to the obstruction of the cleavage site when fused to the peptide because 
a control protein was digested under identical conditions. After these extensive crystal 
trials, no crystals of CCaMK were obtained. It therefore remains an important future goal to 
obtain high-resolution structural data for CCaMK in order to validate the model of function 
(Miller et al., 2013). 
 
4.6 Summary 
 
CCaMK undergoes a conformational change when calcium binds to the EF-hands. This 
corresponds to an elongation of the VLD and this conformational change is also present in 
the full-length protein. Furthermore, this corresponds to the exposure of a hydrophobic 
patch which is likely involved in the binding of CCaMK to phosphorylation targets. Crystal 
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trials for truncations of CCaMK are detailed; however these were unsuccessful in the 
production of crystals for structure elucidation. 
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5.1 Introduction 
 
The aim of the experimental work in this chapter was to determine to what extent it is 
possible to purify CCaMK from M. truncatula. This involved the development of a multi-
stage purification strategy. First, a growth strategy for M. truncatula was required in order 
to maximise the yield of root tissue obtained. This was necessary because the protein is 
likely present in cells at a low concentration. Commercial wild-type M. truncatula seeds 
were obtained in order to have enough material for large-scale growth trials, because it 
was anticipated that root material in the order of 500 g would be required for protein on a 
milligram scale, based on studies on other plant proteins (Requena, 2000). M. truncatula 
Jester seeds were selected for this, because the cul var is    90 % similar to Jemalong 
(Kamphuis et al., 2013), from which the commonly used A17 line is derived. Alternative 
sources of protein were also explored and are detailed in this section, namely an over-
expression line for tagless WT protein and an M. truncatula line with CCaMK under the 
native promoter and dual-tagged with GFP and SBP.  
 
Second, it was necessary to develop an antibody in order to monitor the purification 
strategies tested. For this, a construct of CCaMK which lacked the kinase domain was 
purified in E. coli for use as an antigen, and tested for specificity against various constructs 
of CCaMK. Once this system was established, a wide variety of purification strategies were 
tested in order to determine to what extent MtCCaMK can be extracted and characterised. 
The first aim of these trials was to establish if it was possible to obtain a single band on a 
western blot probed with the developed antibody that corresponded to MtCCaMK. This 
was carried out to determine if the size of CCaMK in M. truncatula corresponds to the 
expected protein size, for example as determined in L. longiflorum at approximately 56 kDa 
(Patil et al., 1995). Subsequently, purification trials were carried out in order to determine 
whether it was possible to purify sufficient protein for biochemical characterisation. 
Protein purified from M. truncatula could be used for key experiments to validate 
experiments carried out with constructs of CCaMK expressed in E. coli. For example, as 
detailed in Chapter 3, recombinant MBP-CCaMK forms an oligomer of 16-18 subunits which 
has important consequences for the mechanism of autophosphorylation. Therefore, the 
number of subunits of CCaMK present in this oligomer in planta could be addressed. 
Furthermore, as detailed in Chapter 4, previous attempts to crystallise CCaMK when 
purified in E. coli have been unsuccessful, however it is possible that CCaMK is more stable 
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when purified from the native host. Therefore, this Chapter details the purification trials 
carried out for MtCCaMK. 
 
5.2 Development of a growth strategy for Jester 
 
In order to purify as much MtCCaMK as possible, a growth strategy was required which 
maximised root growth. Growth on agar plates was deemed too labour intensive and low 
yielding, while growth on soil would have required extra cleaning steps to be viable and so 
was not considered further. Two possible growth strategies were therefore identified and 
trialled: aeroponics and hydroponics. Figure 5.1A shows a representative trial for an 
aeroponic growth of A17 in a caisson chamber. Seedlings were individually planted in a 
perforated plate located at the top of chamber (left panel), and roots grew down towards a 
pump located at the bottom of the chamber, which misted the growing roots with BNM 
medium. Root growth was excellent with this method, with roots extending significantly 
further than when grown by other methods. However, when scaled up and planted onto a 
mesh instead of a plate, growth was less optimal – plants either became infected because 
they were excessively moist, or dried out too much. It was also theorised that whilst 
aeroponics allowed extensive root growth, this could be sub-optimal for protein extraction 
since it may be the case that the extension corresponds to higher water content and not 
more protein.  
 
Therefore, hydroponics was trialled as an alternative. A system established in the 
Bornemann group for the purification of a barley enzyme was trialled due to its previous 
success (Figure 5.1D). This was trialled initially with 1000 A17 seeds, and root growth was 
determined to be healthy and substantial without excessive root elongation (Figure 5.1B). 
Seeds were bleached, scarified and imbibed for approximately 5 hours and then spread in a 
single layer on the mesh. Sixteen litres of BNM medium was added to the tank, and 
aeration was provided by two air bricks per tank to minimise stress caused by anaerobicity, 
which can lead to infection. This also allowed the medium to moisten the mesh and seeds 
and provide sufficient moisture for seed germination. In this set up, it was also established 
that despite the fact that roots were present in liquid, nodulation was possible (Figure 
5.1C). A subset of the seedlings growing in the mesh were inoculated by immersion in 500 
ml BNM medium containing rhizobia (OD600  = 0.001) for several days. They were then 
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returned to the main un-inoculated tank, and pink nitrogen-fixing nodules were observed 
after approximately three weeks. 
 
In order to produce enough root material for preparative protein extraction, growth in the 
hydroponics system was scaled up ten-fold and two tank systems were used 
simultaneously (Figure 5.1E). Jester seeds were used instead of A17 due to the low 
availability of A17, and after a trial it was revealed that higher germination rates were 
achieved by eliminating the scarification step. The tanks were also re-located to a 
controlled environment room to further increase yield. Seedlings were grown for 
approximately 3 weeks, which produced large quantities of root material and prevented 
overcrowding of the individual plants in the tank. Although other nitrogen-rich media were 
considered, growth was excellent with BNM nitrogen-limiting medium so this was used for 
all subsequent hydroponics growths. This also allowed the potential for nodulation 
experiments if required. From 20 000 seeds planted in one batch, approximately 800 g of 
root material was harvested, blotted briefly and flash frozen in liquid nitrogen for future 
experiments. 
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Figure 5.1. Strategy for maximising root growth in M. truncatula for protein purification. 
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(A) Trial of M. truncatula A17 growth in an aeroponic caisson chamber.  
(B) Small-scale trial of a hydroponic growth method, planted with approximately 1000 M. 
truncatula A17 seeds. 
(C) A representative A17 root from the trial hydroponic set up (B) showing fully-developed 
nodules. 
(D) Schematic of the hydroponic growth system.  
(E) Large-scale preparative growth of M. truncatula Jester in two hydroponic tanks planted 
with approximately 20 000 seeds in total. 
 
5.3 Generation and testing of αMtCCaMK  
 
In order to establish a purification method for MtCCaMK, it was most practical to generate 
an antibody to assess different purification strategies. After an extensive search for a 
suitable peptide antigen for immunization, it was decided that the sequence similarity of 
target peptides was too high to many other M. truncatula proteins. This was based on the 
sequence similarity of more than 4 consecutive amino acids between the peptide and other 
host proteins. Therefore, a protein antigen strategy was used instead. Previous work in the 
Bornemann lab with CCaMK in vitro constructs has determined that full-length, tagless 
CCaMK was unstable and difficult to purify in quantities suitable for antibody production. 
Specifically the kinase domain was found to cause solubility issues (Swainsbury et al., 
2012). Therefore, two existing constructs were considered: AI-VLD and His-VLD. The AI-VLD 
was selected since using a larger section of the protein would increase coverage of the 
target protein and potentially improve specificity (especially since EF-hands have a 
consensus sequence common to many proteins) and the lack of a tag would reduce 
artefactual cross-reactivity.  
 
In order to isolate protein of sufficient purity, a two-step purification was used. Affinity 
chromatography with a CaM-Sepharose column (Figure 5.2A) was utilised and followed by 
a SEC step to remove any remaining contaminating proteins from the sample (Figure 5.2B). 
The size and purity of the protein was confirmed by SDS-PAGE (Figure 5.2C). Since the yield 
of protein from the CaM-Sepharose column was comparatively low, this process was 
repeated twice, and the resulting protein was pooled and dialysed in the buffer required 
for i  unization. The protein was diluted to the appropriate concentration  260 μg/ l , 
and aliquots were sent for a one-month immunization programme in two rabbit hosts 
(SY05 and SY06). 
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Sera from both rabbits were tested at various concentrations to test for the affinity and 
specificity of the polyclonal antibodies to CCaMK (Figure 5.2D). Initial trials established that 
serum dilutions of 1:500 and 1:1000 were too low (data not shown), therefore dilutions of 
1:2000 and 1:10 000 were used. Both sera were tested with three constructs of CCaMK: 
MBP-CCaMK (full-length), AI-VLD and His-VLD and all forms were recognised by both sera. 
At the 1:2000 dilution, both sera showed some band smearing, which was not present at 
the 1:10 000 dilution therefore the higher dilution was selected. At this dilution, the MBP-
CCaMK lane contained two main bands, the higher of which is MBP-CCaMK and the lower 
of which is presumably a degradation product. His-VLD shows one strong and one very 
weak band, therefore this is also a specific interaction. AI-VLD shows a strong band for the 
correct protein, and also some cross-reactivity. However, it is likely that these were E. coli- 
derived contaminants that were present at very low concentrations in the AI-VLD samples 
administered to the rabbits. Such contaminants would therefore not be present in plant 
tissue. SY06 serum was selected for future use due to it giving slightly less band smearing, 
particularly with the AI-VLD protein. There were no bands detected in the pre-immune sera 
when tested against the same three proteins consistent with the antibodies being raised 
against AI-VLD. Therefore, SY06 serum was deemed to recognise CCaMK strongly and 
specifically and no further purification of the serum was necessary. This serum was used 
throughout the rest of this study and is henceforth referred to as αMtCCaMK. 
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Figure 5.2. αMtCCaMK antibody generation and testing. 
(A) Chromatogram for AI-VLD purified using the CaM-Sepharose column. Fractions 
corresponding to the marked peak were collected, pooled and subjected to size exclusion 
chromatography as shown in (B).  
(B) A size exclusion chromatogram for the AI-VLD using a HiLoad Superdex 75 prep grade 
16/60 column. The marked peak was confirmed to contain the correct protein by SDS-PAGE 
shown in (C).  
(C) SDS-PAGE of CaM-Sepharose and SEC fractions of AI-VLD. The observed size of AI-VLD 
was 24 kDa as predicted. Appropriate fractions from SEC were pooled, diluted to 260 μg/ml 
and sent for antibody production in 500 μl aliquots.  
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(D) Western blots to test appropriate concentrations of sera (using purified AI-VLD antigen) 
derived from rabbits SY05 and SY06. The observed sizes of MBP-CCaMK, AI-VLD and VLD 
recombinant proteins were 98, 24 and 21 kDa, respectively, as predicted. SY06 at 1:10,000 
dilution was selected for future use due to its strong affinity for CCaMK in various forms 
and its lower cross-reactivity.  
 
 
5.4 Development of a purification strategy for Jester MtCCaMK 
 
In order to develop a purification strategy for Jester MtCCaMK, a buffer trial was first 
undertaken. Briefly, root tissue was ground in liquid nitrogen, re-suspended in buffer, 
passed through a cell disruptor at 20 psi, incubated on ice for extraction and centrifuged. 
The resulting supernatant was blotted for comparison of two buffers (RIPA and Li) (Figure 
5.3A). Extraction was superior with the Li buffer, especially regarding a 58 kDa protein 
(marked with an arrow) which corresponds to full-length CCaMK, so therefore this buffer 
was selected for further purification experiments. Also notable from this extraction is a 
strong band recognised by αMtCCaMK at just below 48 kDa  henceforth denoted as the 48 
kDa protein). 
 
The purification strategy subsequently trialled with Jester extract involved ion-exchange 
chromatography to remove many contaminants and CaM-Sepharose affinity 
chromatography to purify CCaMK further. Firstly, two columns were trialled for ion-
exchange: MonoQ and DEAE Sepharose. The fractions corresponding to eluted protein 
were subjected to western blotting and probed with αMtCCaMK  Figure 5.3B and C, 
respectively). In both cases, two main proteins were detected by the antibody at 96 and 48 
kDa. DEAE purification was selected for future experiments because it proved more robust 
and high-throughput than the MonoQ purification. Many attempts were made to increase 
the yield of these proteins, especially the 48 kDa protein, to give enough protein for mass 
spectrometric analysis. These attempts included the use of a ball mill, pulverisette machine 
and blender to extract more protein. This also involved alteration of the pressure and the 
number of extractions with the cell disruptor. Despite this effort, the yield of the 48 kDa 
protein was never high enough to see an equivalent band on an SDS gel and therefore a 
mass spectrometric analysis of this protein was not possible.  
 
Since the 48 kDa protein was recognised strongly by the αMtCCaMK antibody, it was either 
a form of CCaMK that was smaller than expected (e.g. due to alternative splicing or 
proteolysis) or a protein to which the antibody cross-reacts. In order to explore this further, 
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crude Jester extract from 20 g of starting root material was applied directly to a CaM-
Sepharose column. The resulting eluted protein fractions (Figure 5.3D) and flow-through 
wash fractions  Figure 5.3E  were subjected to western blotting probed with αMtCCaMK. 
Six main proteins that were eluted from the column were detected, including a 48 kDa 
protein and potential full-length 58 kDa CCaMK. Again, there was not enough protein 
purified by this method for subsequent experiments. A 48 kDa protein was also detected in 
the wash fractions which could either indicate that it doesn’t bind to CaM-Sepharose or the 
capacity of the column was exceeded. 
 
In an attempt to purify the 48 kDa protein on a preparative scale, a large scale extraction of 
Jester was attempted with 100 g of starting root material (Figure 5.3F). The 48 kDa protein 
was first purified in batches using the DEAE step, and this protein was collected, dialysed, 
and loaded onto a CaM-Sepharose column. Surprisingly, this protein did not bind to this 
column and was therefore not purifiable using this method. Therefore, it appears that this 
protein is either not CCaMK-derived or is a splice-variant of CCaMK that lacks the CaM-
binding domain. Furthermore, since no full-length protein was purified by these methods, a 
new approach was needed to both clarify if the 48 kDa protein corresponds to a variant of 
CCaMK and if it is possible to purify full-length CCaMK from Jester.  
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Figure 5.3. Purification trials for M. truncatula Jester CCaMK show predominantly a smaller 
protein (approx. 48 kDa) according to western blots probed with αMtCCaMK. 
(A) Blot showing a comparison of RIPA and Li extraction buffers for extraction of CCaMK 
from M. truncatula Jester. Briefly, tissue was ground in liquid nitrogen, subjected to cell 
disruption at 20,000 psi and centrifuged. Li buffer was selected for further use due to 
superior extraction, particularly of full-length CCaMK protein (58 kDa).  
(B) Blot showing eluted protein fractions from MonoQ ion exchange chromatography with 
M. truncatula Jester extract. Two main proteins were detected using this method at 
approximately 96 and 48 kDa.  
(C) Blot showing eluted protein fractions from ion exchange chromatography using a DEAE 
column with M. truncatula Jester extract. Two main proteins were detected using this 
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method at approximately 96 and 48 kDa. Lanes 1-4 correspond to crude Jester extract at 
stages during the extraction process. 
(D) Blot showing eluted protein fractions from affinity chromatography using a CaM-
Sepharose column with M. truncatula Jester extract. Lanes 1-2 correspond to crude Jester 
extract prior to CaM-Sepharose purification. 
(E) Blot showing fractions from the CaM-Sepharose column wash step (prior to elution) 
from the same affinity purification as blot (D). Lanes 1-3 correspond to crude Jester extract 
prior to CaM-Sepharose purification. 
(F) Eluted protein from DEAE purification (left panel) was purified by CaM-Sepharose 
affinity purification and the protein fractions were blotted (right panel). The 48 kDa protein 
which was detected after the DEAE purification was not detected in fractions 
corresponding to the protein elution peak after CaM-Sepharose purification and 
subsequent western blot analysis.  
 
 
5.5 Characterisation of a 48 kDa protein and 58 kDa MtCCaMK from Jester 
 
In order to deter ine whether αMtCCaMK also recognised the 48 kDa protein in a native 
environment, immunoprecipitation experiments were carried out. Firstly, crude Jester 
extract was incubated with αMtCCaMK-cross-linked beads for 5 hours, and the resulting 
protein was blotted and probed with αMtCCaMK (Figure 5.4A). Surprisingly, although no 
protein bands were visible in the input extract because the concentration was presumably 
too low, a single band was visible in the eluted output protein. This protein corresponds to 
full-length CCaMK at 58 kDa and no 48 kDa protein was detected in the eluted protein. 
Therefore either the 48 kDa did not bind to αMtCCaMK during the i  unoprecipitation, or 
the concentration of the 48 kDa protein was too low in crude extract to be successfully 
enriched by this method. 
 
In order to determine if the 48 kDa was able to be detected when present at a higher 
concentration in the IP input, the appropriate fraction from the DEAE purification of Jester 
extract (Figure 5.3C  was subjected to i  unoprecipitation with the αMtCCaMK beads 
(Figure 5.4B). In both the input and flow-through fractions, the 48 and 96 kDa proteins 
were detected with αMtCCaMK, as expected. However, the eluted output protein showed 
a single band at the full-length size of 58 kDa, with no sign of the 48 kDa protein. It 
therefore appeared that the 48 kDa protein did not bind to αMtCCaMK in a native 
environment and therefore may not be CCaMK-derived. 
 
Finally, in order to establish if the 48 kDa protein functioned as a kinase and therefore was 
CCaMK-derived, an aliquot of the appropriate DEAE fraction (Figure 5.3C) was also 
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subjected to kinase and phosphatase assays. These samples were then analysed by western 
blot with both αMtCCaMK  Figure 5.4C  and αpT271  Figure 5.4D . One fraction fro  the 
DEAE purification was selected, concentrated and subjected to either a kinase assay, 
phosphatase assay, or a kinase assay followed by a phosphatase treatment. When probed 
with αMtCCaMK, the 48 and 96 kDa proteins were detected, as expected. Surprisingly, 
when probed with αpT271, the predo inant protein detected corresponded to full-length 
58 kDa CCaMK. It was unclear whether this protein behaves as a kinase because when 
subjected to a kinase assay; the strength of the band detected appears weaker when 
compared to untreated protein. This indicated a surprising reduction in phosphorylation 
instead of the expected increase. When co pared to the αMtCCaMK blot of the sa e 
samples, it can be determined that the protein concentrations present in the first two lanes 
were approximately equal, so this result was not a consequence of protein loading. It 
would therefore appear that the kinase assay was unsuccessful. However it has been 
previously established that CCaMK function can be disrupted by freeze-thawing and this 
protein sample had been freeze-thawed before use in the assay.  It therefore seems likely 
that, despite not behaving as expected for a kinase, the 58 kDa protein detected by αpT271 
likely corresponded to a full-length form of CCaMK.  
 
Taken together, these data suggest the 58 kDa full-length CCaMK protein was purifiable 
(e.g. with DEAE chromatography) but the concentration of the protein was too low to 
detect by western blotting without concentration by IP. These data also suggest that the 48 
kDa protein is in fact not CCaMK-derived, because it is not pulled down by IP and is not the 
predo inant for  detected by the αpT271 antibody. So e cross-reactivity with other M. 
truncatula proteins is seen with the αpT271 antibody, however this is likely because the 
antibody was raised against a peptide which may have similarity to other proteins. 
 
It see s likely therefore that the epitope recognised by αMtCCaMK in the 48 kDa protein is 
internal to the protein and is therefore only recognised in denaturing conditions (i.e. SDS 
PAGE and western blotting) but not recognised by the antibody in conditions where the 
protein is in the native state (i.e. during IP). A mass spectrometric analysis was therefore 
attempted of the 48 kDa protein, by the excision of the appropriate section of the SDS-
PAGE of the DEAE fraction (despite there being no visible bands with coomassie staining of 
the gel). This revealed a large number of M. truncatula proteins, not including CCaMK. The 
proteins that also showed some sequence similarity to CCaMK in a BLAST analysis, and 
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could therefore have been recognised by the antibody, were: phosphopyruvate hydratase 
(GenBank: AES75861.2) and pyridine nucleotide-disulfide oxido-reductase (GenBank: 
KEH42067.1). In addition, these proteins were approximately 48 kDa and therefore were 
good candidates. Nevertheless, there were also many other proteins identified by the mass 
spectrometric analysis which the antibody could have cross-reacted with. 
 
It was also therefore clear that these purification methods for full-length MtCCaMK from 
Jester yielded too little protein for biochemical characterisation. 
 
 
Figure 5.4. Immunoprecipitation and kinase assay of Jester extracts reveal full-length 
MtCCaMK protein (58 kDa).  
(A) A western blot with αMtCCaMK of immunoprecipitate generated from M. truncatula 
Jester root extract and magnetic beads cross-linked with αMtCCaMK gave a single protein 
band of approximately 58 kDa, which corresponded to full-length CCaMK protein.  
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(B) A western blot with αMtCCaMK of immunoprecipitate from a 48 kDa-containing 
fraction of M. truncatula Jester protein purified using the DEAE column (Figure 3(C)). Input 
and flow-through fractions from the IP confirmed the presence of the 48 kDa protein band, 
whereas the IP output sample showed a single protein band of approximately 58 kDa 
indicative of full-length CCaMK.  
(C) A fraction of Jester protein purified using a DEAE column (Figure 5.3C) was subjected to 
a kinase assay followed by λ-phosphatase-treatment to assess whether the proteins 
function as kinases. The resulting fractions were assessed with a western blot probed with 
αMtCCaMK to verify relative protein concentrations. Lanes contained protein after either 
no treatment, protein subjected to a kinase assay with 0.2 mM Ca2+ and 10 mM Mg2+, λ-
phosphatase treated protein or finally protein subjected to a kinase assay followed by a λ-
phosphatase treatment. The predominant protein detected was approximately 48 kDa in all 
cases.  
(D) The same samples as in (C) were subjected to western blot with a primary antibody 
αpT271. In contrast to (C) the predominant protein detected was approximately 58 kDa 
which corresponds to full-length CCaMK protein. However, the 58 kDa does not show 
evidence of autophosphorylation or phosphate removal because the protein fraction had 
been freeze-thawed prior to analysis. 
 
5.6 Generation and testing of an over-expression line 
 
Since levels of MtCCaMK in M. truncatula Jester were extremely low, an alternative source 
of protein for biochemical characterisation of CCaMK was sought. Therefore the 
development of an over-expression line was attempted (Figure 5.5). A binary-vector was 
generated using Golden Gate cloning (Patron et al., 2015) for A. tumefaciens-mediated 
stable transformation. This vector contained MtCCaMK cDNA with an L. japonicus ubiquitin 
over-expression promoter, and a dsRed reporter to check for successful transformation 
(Figure 5.5A). This construct was tested for functional complementation by hairy root 
transformation of dmi3-1 seedlings and successful transformation was confirmed by both 
dsRed fluorescence (Figure 5.5B) and a nodulation complementation assay. 
 
The construct was then used for stable transformation of R108 M. truncatula by Matthew 
Smoker. This line was selected because of the ease of transformation and the high number 
of potential transformants which are usually generated. Transformation was carried out 
according to standard procedures, however the incorrect plant selection marker was used 
due to a miscommunication (kanamycin instead of BASTA) (Figure 5.5C). Since kanamycin 
was the bacterial selection marker (and was not contained within the right and left border) 
and BASTA was the plant selection marker, this kanamycin selection should not have been 
functional for plant transformation. Despite this, approximately 30 potential transformants 
were generated after approximately 6 months and were therefore tested for the presence 
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of the correct transgene in case the marker was also functional for plant selection due to a 
leaky left border transformation. 
 
PCR was carried out with DMI3 primers on DNA extracted from potential transformants, 
and an extension time of two minutes was used to amplify any 1.5 kbp transgene if present 
(Figure 5.5D). This would distinguish between the transgene and the genomic DNA because 
the band amplified from gDNA would contain introns giving a 4 kbp amplification product. 
Four samples showed amplification of the appropriately sized band (marked with arrows) 
and so were potentially transgenic. However, this PCR experiment was repeated twice 
more with these samples and the bands were not reproduced. In addition, a TaqMan-based 
copy number analysis for the BASTA gene was performed by iDNA genetics and no BASTA 
gene was detected in any of the samples. If transformation had been successful despite use 
of the incorrect marker, the BASTA cassette should still have been present in the inserted 
DNA. Therefore the plants were deemed most likely non-transgenic and work was focussed 
on other strategies. 
  
157 
 
Chapter 5: CCaMK in planta 
 
 
Figure 5.5. Attempted development of stable M. truncatula CCaMK over-expression line. 
(A) Map for the binary vector (EC10265) which was used to transform M. truncatula R108 
for over-expression of CCaMK. Key features included a dsRED reporter gene, L. japonicus 
ubiquitin over-expression promoter and MtCCaMK coding sequence (lacking introns).  
(B) Image showing dsRed fluorescence of a representative dmi3-1 root transformed with 
EC10265 by hairy root transformation. 
(C) Potentially transgenic calli (transformed with EC10265) with developing embryos grown 
on kanamycin medium. Transformation was carried out by Matthew Smoker (TSL). 
(D) PCR analysis, using DMI3 primers, of a representative selection of potential 
transformants. The arrows mark four potentially transgenic plant lines with bands of the 
correct size for DMI3 cDNA (approx. 1.5 kbp), however subsequent PCR experiments were 
unable to replicate these bands. The last three lanes contain control PCR samples including 
a confirmed transgenic line (GFP-CCaMK-SBP 694/1), purified genomic DNA (gDNA) and a 
negative water control.  
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5.7 Testing of GFP-CCaMK-SBP stable line and subsequent purification attempts  
 
Since protein levels are extremely low in wt M. truncatula lines, alternative transgenic lines 
were explored. A stable line of M. truncatula had previously been produced in the Oldroyd 
lab although its successful transformation had not yet been confirmed. This line was 
generated in a dmi3-1 mutant background with a GFP-CCaMK-SBP construct (under the 
control of the native pDMI3 promoter). GFP was present at the N-terminus and SBP was a 
streptavidin-binding peptide tag present at the C-terminus. Seeds from the T1 generation 
were tested and 16 lines were selected on the basis of successful complementation of 
nodulation. They were also subjected to western blot analysis and probed with either αGFP 
or αMtCCaMK to identify lines with a good level of CCaMK protein. In particular, line 694 
showed good levels of the correct fusion protein (Figure 5.6A) with an observed size of 87 
kDa, as expected. A T2 progeny (denoted as 694/1) of this line was also confirmed to 
contain a single copy of the insertion by a TaqMan analysis carried out by iDNA genetics, 
which was sufficient for protein studies. This line was therefore selected for use in further 
experiments. 
 
Firstly, the previous approach of DEAE chromatography was trialled to see if it was effective 
for GFP-CCaMK-SBP since the predicted pI was very close to that for CCaMK (5.64 and 5.57, 
respectively). The chromatogram for this experiment shows an eluted protein peak which is 
 arked by a blue line  Figure 5.6B  which was tested by western blotting with αMtCCaMK 
(Figure 5.6C). Surprisingly, the eluted protein fractions did not contain the expected 
protein, however the protein was clearly visible in the crude extract used for this 
purification. In addition, no fusion protein was detected in the wash fractions for this 
purification when subjected to western blot with with αMtCCaMK  data not shown . 
Therefore it appeared that the 1 M NaCl elution step was insufficient to elute the fusion 
protein from the column, since the protein was clearly visible in the crude extract and the 
purification step would be a concentrating step. Due to the low availability of plant 
material for this line, other methods of purification were trialled instead of attempted 
optimisations for this purification method. 
 
Secondly, a Streptavidin Hitrap column was used to purify GFP-CCaMK-SBP based on the 
affinity of the streptavidin-binding peptide for streptavidin and utilising the biotin 
analogue, desthiobiotin, for elution. The chromatogram shows a potential protein peak 
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marked by a blue line (Figure 5.6D) which was tested by western blotting with αMtCCaMK. 
Despite the presence of a protein peak, again no GFP-CCaMK-SBP was detected with 
αMtCCaMK  data not shown  and therefore it see s likely that the concentration of 10 M 
desthiobiotin was not sufficient to elute the protein. An extraction was also trialled with 
harvested aerial plant material, since the transgene will be expressed throughout the plant. 
However, a crude extract blotted and probed with αMtCCaMK did not reveal an 
appropriate band, most likely due to low concentrations, and therefore this material was 
not used for further experiments. 
 
A final attempt was made with the all the remaining root tissue for this line (approximately 
10 g). This particular plant line did not grow as well as Jester so despite growing    4200 
seeds in a hydroponic system, a total yield of 14 g of root tissue was harvested and used for 
all trials. A CaM-Sepharose affinity column was used and the predicted protein containing 
fractions (Figure 5.6E) were pooled and applied directly to a pre-equilibrated size exclusion 
column (Figure 5.6F) to estimate the size of the oligomer. Despite the presence of a protein 
peak, a subsequent western blot probed with αMtCCaMK revealed no GFP-CCaMK-SBP 
protein was purified after using both columns. This is most likely because there was 
insufficient material for the lower affinity column, as opposed to tag-based purification 
systems. Therefore, the successful purification of this CCaMK fusion protein required 
further optimisation which was not possible due to limited availability of material. 
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Figure 5.6. Purification attempts of GFP-CCaMK-SBP from stably transformed M. truncatula 
line 694/1. 
(A) Crude protein extracts of GFP-CCaMK-SBP line 694/1 were analysed by western blots 
probed with αGFP and αMtCCaMK. The target protein of GFP-CCaMK-SBP is predicted to be 
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87 kDa and was detected at the appropriate size (see marked band). This figure is courtesy 
of Sylvia Singh.  
(B) Chromatogram for the attempted purification of GFP-CCaMK-SBP by ion exchange 
chromatography with a DEAE column performed at 4 °C. The potential protein-containing 
fractions which eluted from the column are marked on the chromatogram with a blue bar.  
(C) Eluted protein fractions from the attempted purification of GFP-CCaMK-SBP with a 
DEAE column (B) were subjected to a western blot and probed with αMtCCaMK. The 
fractions eluted from the column were present in lanes 1-10 while lane 11 contained crude 
extract. The target protein of 87 kDa is marked on the blot in the lane which contained 
crude extract.  
(D) Chromatogram for the attempted purification of GFP-CCaMK-SBP by affinity 
chromatography using a streptavidin Hitrap column performed at 4 °C. The potential 
protein-containing eluted fractions are marked with a blue bar.  
(E) Chromatogram for the attempted purification of GFP-CCaMK-SBP by affinity 
chromatography using a CaM-Sepharose column performed at 4 °C. The potential protein-
containing eluted fractions are marked with a blue bar.  
(F) The predicted protein-containing fractions from the CaM-Sepharose purification (E) 
were pooled, and subjected to size-exclusion chromatography with a Sephacryl S300 HR 
16/60 column.  The resulting chromatogram is shown and the potential protein-containing 
fractions are marked with blue bars.  
162 
 
Chapter 5: CCaMK in planta 
5.8 Discussion 
 
An investigation was undertaken to determine to what extent it is possible to purify CCaMK 
from M. truncatula. First, a purification strategy was established to generate significant 
quantities of root material for protein extraction. A hydroponic growth strategy was 
selected and was advantageous for several reasons including a high yield of root tissue, 
minimal cleaning of tissue so it was possible to freeze it quickly with low levels of root 
contamination. Therefore, a successful growth strategy was developed during this project 
that is optimal for protein purification from M. truncatula. 
 
Second, an antibody was generated against CCaMK using AI-VLD protein expressed in E. 
coli.  Testing of this antibody against E. coli-expressed constructs of CCaMK (MBP-CCaMK, 
AI-VLD and His-VLD) showed that it recognised both full-length and truncated forms of the 
protein strongly and specifically. Subsequent experiments with plant protein extracts 
demonstrated that the antibody also showed some cross-reactivity. However, use of the 
protein for IP experiments demonstrated that the antibody does specifically recognise 
MtCCaMK and was able to enrich the protein during IP so that it is within the detection 
li its of αMtCCaMK. I portantly, the IP experi ents de onstrated that these cross-
reactive proteins (including the oft-purified 48 kDa protein) could be distinguished from 
MtCCaMK (or MtCCaMK-derived proteins). This is because they were recognised by the 
antibody under denaturing conditions (e.g. SDS-PAGE) and not in a native environment (i.e. 
IP), and therefore the epitopes recognised by the antibody in these proteins were likely 
internal to the proteins. Overall, this de onstrates that αMtCCaMK is a useful tool for the 
detection of MtCCaMK in plant protein preparations. 
 
Purification of MtCCaMK was therefore possible, to an extent, because a single band was 
observed on a western blot probed with αMtCCaMK after IP. However, it was not possible 
to purify sufficient protein for biochemical experiments including oligomer-size 
determination and structural work. In an attempt to obtain sufficient protein yields, many 
different extraction procedures, buffers and protein purification methods were trialled, the 
most important of which are detailed in this Chapter. Extraction procedures which were 
trialled included the use of different tissue extraction machines namely a ball mill, liquid-
nitrogen cooled pulverisette, cell disruptor and blender. Only the cell disruptor showed 
improved extraction (data not shown) and therefore this was utilised in subsequent 
experiments. As detailed in this Chapter, both one-step and two-step affinity column 
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purification methods were utilised in an attempt to obtain the correct protein, including 
MonoQ, DEAE-Sepharose and CaM-Sepharose chromatography. However, these did not 
yield a sufficient quantity of the correct protein. This was due to the extremely low 
concentration of CCaMK in root tissue. This was determined because the protein was only 
detectable via western blot after enrichment using IP.  Furthermore, the use of over-
expression or transgenic M. truncatula lines for the purification of CCaMK was also 
unsuccessful. The over-expression line was unsuccessful due to the use of the incorrect 
antibiotic resistance marker; however the use of the GFP-CCaMK-SBP line for CCaMK 
purification was again unsuccessful due to low protein levels. Therefore, extensive trials 
were inadequate in this case to yield sufficient protein for biochemical work. 
 
Despite the low protein yield of CCaMK discussed above, the work described in this Chapter 
was necessary and important for several reasons. First, it was possible to establish that the 
48 kDa protein which was predominantly purified did not correspond to either a splice 
variant or degradation product of CCaMK. Furthermore, it was established that CCaMK was 
present in planta at the predicted and expected size of 58 kDa. Finally, procedures were 
developed during the course of these investigations which facilitated further investigations. 
These included the develop ent of the αMtCCaMK and the corresponding western blot 
technique for this antibody. Further ore, the IP procedure for αMtCCaMK was developed 
which allows cross-reactive proteins and MtCCaMK to be distinguished. These procedures 
were integral to the work described in Chapter 6. 
 
5.9 Summary 
 
Experimental work described in this Chapter detail the successful establishment of a large-
scale growth system for M. truncatula and the development and testing of an antibody for 
CCaMK, αMtCCaMK. MtCCaMK was deter ined to be the expected size when purified fro  
M. truncatula and was distinguishable by IP from cross-reactive proteins. It was not 
possible to purify sufficient MtCCaMK protein for biochemistry from either WT or 
transgenic M. truncatula lines. However, the techniques developed in this Chapter 
underpin some of the work carried out in Chapter 6. 
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6.1 Introduction 
 
Protein purification trials from M. truncatula Jester revealed a 48 kDa protein which the 
αMtCCaMK antibody strongly recognised and was detected when purified by several 
methods (Chapter 5). Whilst subsequent experiments demonstrated that this protein was 
not CCaMK-derived, the presence of multiple protein bands detected by western blot 
probed with αMtCCaMK raised the question of whether any of these proteins 
corresponded to alternative splice forms of CCaMK. Interestingly, preliminary data from 
Pierre-Marc Delaux indicate that splicing of DMI3 at the RNA-level may occur (Figure 6.2). 
In addition, alternative splicing is thought to be common in plants with over 60% of intron-
containing genes predicted to be alternatively spliced (Syed et al., 2012). Therefore work 
was undertaken to ascertain whether CCaMK is alternatively spliced in M. truncatula. 
 
An experiment was therefore devised to investigate whether alternative splicing of CCaMK 
occurs as part of its function in the nodulation and mycorrhization pathways. Previous 
experiments have shown that truncation of the protein can cause its auto-activation 
(Gleason et al., 2006) and spontaneous nodulation in the absence of rhizobia, therefore 
alternative-splicing of CCaMK is potentially biologically significant. Furthermore, alternative 
splicing has been demonstrated to have profound effects on CaMKII and the interpretation 
of calcium spiking. Changes within a linker region of different splice-forms of the β subunit 
affect the activation constant for CaM-binding. This affects the response of the protein to 
the frequency of calcium oscillations (Bayer et al., 2002). Splicing of CCaMK could therefore 
be extremely powerful, and could play a key role in the interpretation of the calcium 
spiking signal in the Sym pathway. Therefore, this Chapter details an experimental analysis 
of DMI3 cDNA and CCaMK protein during nodulation and mycorrhization in order to 
determine whether splicing of CCaMK plays a role in the Sym pathway. 
 
6.2 Exon structure of DMI3 
 
First, the exon structure of the DMI3 gene was determined (Figure 6.1). DMI3 is made up of 
7 exons, with a nucleotide sequence length of 1572 bp and a total predicted protein size of 
58 kDa. Primers were designed for RT-PCR experiments to characterise potential splicing, 
with the forward primer at the beginning of exon 1 and the reverse primer at the end of 
exon 7. This method would detect the main forms of splicing that retain the first and last 
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exons. These include exon skipping, intron retention, and alternative 5´ and 3´ splice sites 
at the exon/intron borders (Syed et al., 2012). Splice forms that lack the first exon would 
require the presence of alternate start sites, and similarly those lacking the final exon 
would require alternate polyadenylation sites which are difficult to predict due to the 
current under-development of bioinformatic tools for M. truncatula. In addition, 
exploration of these forms also dramatically increases the number of combinations that 
require testing. Therefore these experiments were carried out with primers spanning the 
full sequence to identify the main forms of splicing at the RNA level, if present. 
Furthermore, the use of a protein-level approach in addition would potentially identify all 
the different types of splice-forms discussed above, if present, and therefore this approach 
was comprehensive. 
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Figure 6.1.  Exon structure of M. truncatula DMI3. 
Exons 1-7 of the DMI3 gene are shown with the corresponding amino acid numbers shown at the bottom together with the predicted sizes of each exon. 
Key protein features are marked at the appropriate locations at the top (where EF = EF-hands). The location of the primers used for subsequent RT-PCR 
experiments are marked by horizontal arrows on exon 1 and 7.  
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6.3 Previous evidence of splicing 
 
RT-PCR data provided by Pierre-Marc Delaux suggested that splicing of the DMI3 gene may 
occur (Figure 6.2). An RT-PCR time-course analysis of DMI3 during nodulation in A17 was 
carried out with samples taken at one, two and three wpi with rhizobia, alongside a mock 
inoculated sample at each time-point (Figure 6.2A). A total of five different splice-forms of 
DMI3 were identified in addition to the full-length DMI3 gene (1572 bp). Interestingly, the 
full-length form of DMI3 was the least-abundant form detected at all time-points. The 
presence of different splice-forms also changed during the progression of nodulation. 
However, this was surprisingly also the case with the mock inoculated samples. The most 
predominant form detected at all time-points was 1173 bp and its expression altered over 
the three week experiment for both rhizobia- and mock-inoculated samples. Similarly the 
expression of a 993 bp form altered over time, and was detected only two wpi for both 
rhizobia and mock-inoculated samples. By contrast, a much smaller form of 498 bp only 
appears at a late stage of nodulation (3 wpi) and was not detected in any of the mock 
inoculated samples. 
 
Three of the most strongly expressed forms were also sequenced to identify which exons 
and partial exons of CCaMK were present (Figure 6.2B). The 1173 bp form consisted of a 
portion of the kinase domain and the entire VLD. It could be theorised that this form, if 
reflected at the protein level in planta, would be an auto-active form of CCaMK since the 
Thr271 residue, which negatively regulates the protein, is missing. In contrast the 993 bp 
form, which lacks a large proportion of the kinase domain, would be inactive for target 
phosphorylation because it lacked the active site of the enzyme. Finally, the function of the 
498 bp form, which contained a portion of the kinase domain and one EF-hand, is unclear 
since it lacks most of the regulatory elements of the protein and also the active site, so 
would therefore not encode a functional kinase. If reflected in the protein forms present 
the different forms of CCaMK detected in this experiment could perhaps be present to fine 
tune the progress of symbiosis signalling with a balance of an autoactive form and inactive 
forms. 
 
The data presented in Figure 6.2 came from a single experiment and therefore required 
verification. Three important questions were therefore invoked by these data: are the 
splice-forms detected real or artefactual, are they reflected at the protein level in planta 
169 
 
Chapter 6: Alternative splicing of MtCCaMK 
and are there alternative splice-forms present during mycorrhization? This chapter 
addresses these three questions. 
 
 
 
Figure 6.2. Characterisation of splice events in DMI3 (Pierre-Marc Delaux and Jean-Michel 
Ané, personal communication). 
(A) Time course of the expression of DMI3 full length and splice variants several weeks post 
inoculation (wpi) with S. meliloti (R) or a mock solution (C).  
(B) Schematic representation of the splice variants and the encoded protein domains 
present, as determined by sequencing. Red, green and blue squares indicate the kinase 
domain, the calmodulin binding domain and the EF-hands respectively. The vertical dashed 
lines in the kinase domain indicate the autophosphorylation site.  
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6.4 Experimental design 
 
A time-course analysis was devised to investigate alternative splicing of CCaMK during 
nodulation and mycorrhization. Three lines were selected for analysis: Jester, A17 and GFP-
CCaMK-SBP 694/1 (henceforth referred to as GFP). Jester and A17 were selected as wild-
type lines and the GFP line was selected as a control line, since this was generated with the 
coding sequence of DMI3 and therefore lacks introns which are necessary for splicing. 
Seedlings were grown on MOD FP agar for 10 days after stratification and replanted in 
terragreen/sand at Time 0. Seedlings were then inoculated with either rhizobia or 
mycorrhizal inocula at time 0, and an un-inoculated control for each line was harvested at 
this point. 
 
Time-points were selected for both symbioses at an early, middle and later stage of the 
interaction (Figure 6.3A). For nodulation, the time-points used were: four days (some 
nodule primordia visible), 10 days (small white nodules visible) and 21 days post 
inoculation (dpi) (fully-developed nitrogen-fixing nodules) (Figure 6.3 B). The progression of 
mycorrhization was established by ink and vinegar staining of representative Jester roots at 
appropriate time-points post-inoculation, as show in Figure 6.3C. At three and four dpi with 
mycorrhizal inoculum, no penetration of infection hyphae was visible. At seven dpi, stained 
Jester roots had either zero, one or two infection units (Figure 6.3C, left panel) per plant 
(Table 6.1). At 13 dpi, roots were scored with the gridline intersect method, and 
colonisation was approximately 20% (data not shown). At 21 dpi, six root samples were 
scored by the same method and total colonisation was approximately 24-46% (Table 6.2), 
with fully-developed arbuscules (Figure 6.3C, right panel). Therefore, roots were harvested 
for the mycorrhizal time-course at 7, 13 and 21 dpi. 
 
At each of the time-points, 20 roots were harvested, blotted and flash frozen in liquid 
nitrogen. They were then used for either RNA extractions and subsequent RT-PCR analysis 
or protein extractions and subsequent western blotting and IP with αMtCCaMK.  
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Figure 6.3. Experimental set up of time-course experiment for characterisation of CCaMK 
during nodulation and mycorrhization. 
(A) A schematic representation of the time-points investigated for the characterisation of 
CCaMK during nodulation and mycorrhization. Ten roots were harvested for each line (A17, 
Jester and GFP-CCaMK-SBP 694/1) at each of the seven time-points. Time 0: 10 day-old un-
inoculated roots, grown on Mod FP. Day 4, 10 and 21 nodulation: 4, 10 and 21 days post-
inoculation with rhizobia, transferred as 10-day old seedlings on day 0 from Mod FP to 
terragreen sand. Day 7, 13 and 21 mycorrhization: 7, 13 and 21 days post-inoculation with 
mycorrhizal inoculum, transferred as 10-day old seedlings on day 0 from Mod FP.  
(B) Images show representative Jester roots from 7 and 10 dpi with rhizobia, with 
approximate scale bars of 1 cm.  
(C) Images show representative Jester roots from 7, 13 and 21 dpi with mycorrhizal 
inoculum, with approximate scale bars of 1 mm.  
A
B
Day 10  Nod Day 21  Nod 
C Day 7 Myc Day 13 Myc Day 21 Myc
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Plant 
number 
Myc event per 
plant 
1 1 
2 2 
3 0 
4 1 
Table 6.1. Total number of mycorrhization infection events (scored by visual microscope 
analysis of ink and vinegar stained roots) at 7 dpi with mycorrhizal inoculum, in four 
representative Jester root samples. 
 
Plant 
number 
Percentage colonisation 
(%) 
1 38 
2 46 
3 24 
4 27 
5 27 
6 42 
Table 6.2. Percentage colonisation of six representative Jester root samples scored by the 
gridline intersect method (Giovannetti and Mosse, 1980), 21 dpi with mycorrhizal 
inoculum. Error is likely to be ±5-10%. 
 
6.5 RNA quality verification 
 
RNA was extracted from A17, Jester and GFP samples at each of the seven time-points for 
mycorrhization and nodulation (Figure 6.3A). RNA was extracted from approximately 100 
mg of tissue, which consisted of tissue from approximately 2-10 roots (depending on the 
age and size of roots harvested) from one experimental batch of plants. RNA quality was 
verified by gel electrophoresis for each sample (Figure 6.4A-C). RNA quality was sufficient 
for all samples because two strong rRNA bands (25S and 18S) were present at each time-
point for each line. 
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RNA was treated with DNase 1 to remove any contaminating DNA. This was verified by PCR 
analysis using DMI3 primers and a four minute extension time, in order to amplify genomic 
DMI3 at    4 kbp if present. There were no bands detected for any of the 21 samples (Figure 
6.4D-F) and a positive control with gDNA showed the 4 kbp amplification product as 
expected. Therefore all the RNA was deemed of sufficient quality for use in subsequent RT-
PCR experiments. cDNA synthesis was carried out with the Biorad iScript cDNA synthesis 
kit, which utilises a mixture of oligo(dT) and random primers. 
 
 
 
Figure 6.4. Quality verification for RNA extractions in time-course experiment. 
(A) RNA from samples of Jester roots at 7 time-points (Figure 6.3A) was analysed by gel 
electrophoresis. The two key bands detected for all samples at all time-points were 25S and 
18S rRNA and this indicates intact RNA extractions. 
(B) RNA from samples of A17 roots were analysed, as in (A). 
(C) RNA from samples of GFP-CCaMK-SBP 694/1 roots were analysed, as in (A). 
(D) DNA contamination was analysed for all RNA samples of Jester, treated with DNase, by 
PCR using DMI3 primers. No bands were detected at 4 kbp (genomic DMI3) and therefore 
no contaminating DNA was present.  
(E) A17 RNA samples were analysed for DNA contamination, as in (D). 
(F)  GFP-CCaMK-SBP 694/1 RNA samples were analysed for DNA contamination, as in (D). 
The final two lanes contained PCR samples for a positive control genomic DNA sample 
(gDNA) in which the 4 kbp genomic DMI3 was detected (marked with an arrow) and a 
negative control with water.  
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6.6 Full-length DMI3 is the predominant form during nodulation and mycorrhization 
 
An RT-PCR experiment was carried out for Jester, A17 and GFP cDNA from a time-course of 
nodulation and mycorrhization (Figure 6.3A).The cDNA synthesis was carried out using 
iScript cDNA synthesis kit and DMI3 primers with a two minute PCR extension time were 
used in order to amplify the full-length DMI3 gene (1.5 kbp) and any smaller splice-variants 
if present. At all time points for WT samples (Jester and A17) for nodulation and 
mycorrhization, the only band detected was 1.5 kbp corresponding to full-length DMI3 
(Figure 6.5A-B). This therefore showed no evidence of alternative splicing at these time-
points in either A17 or Jester. This was also the case for the control line GFP which cannot 
be spliced such that only a full-length DMI3 amplification product was detected at all time-
points, as expected (Figure 6.5C). No band was detected in the genomic DNA lane because 
the extension time was too short (2 minute extension time, instead of 4 min required for 
the 4 kbp gene), and a water control was negative as expected. An alternative reverse 
transcriptase (Superscript III) with oligodT primers was also trialled with representative 
samples (A17 and Jester, 21 dpi with nodulation/mycorrhization) to determine if splice 
variants were detected when an alternative cDNA synthesis strategy was used. Under these 
conditions, full-length DMI3 and no splice variants were detected (data not shown). 
Therefore, for all experiments presented, the iScript cDNA synthesis kit was used. 
 
RT-PCR with DMI3 primers was also carried out with an independent source of cDNA 
provided by Ben Miller to determine if alternative splice forms were present. cDNA 
corresponded to A17 roots at 0, 4 and 10 dpi with rhizobia and RT-PCR with these samples 
(and a two minute extension time) again showed full-length DMI3 and no alternative splice-
forms (Figure 6.5D). Therefore under these conditions no splicing of DMI3 occurs. 
 
In order to determine whether splicing occurred specifically during early stages of 
symbiosis signalling, an early time-course of nodulation was investigated. cDNA samples 
corresponding to Jester roots at 0, 2, 4, 8 and 16 hours post inoculation with a mock 
solution or rhizobia were used in an RT-PCR experiment with a two minute extension time 
(Figure 6.5E-F). Similarly, at all time-points tested and for both treatments the only form of 
DMI3 detected corresponded to a full length DMI3 amplification product and no alternative 
splice forms were detected. 
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In addition, an RNA-Seq analysis was undertaken for a comparison of un-inoculated and 
inoculated A17 root hairs (Martin Trick and Andrew Breakspear, personal communication). 
Under both conditions, the full-length form of DMI3 was detected with no detected splicing 
(data not shown).  Therefore, under these conditions no evidence of alternative splicing of 
DMI3 was detected. 
 
 
Figure 6.5. Full-length DMI3 cDNA is the predominant form detected during nodulation and 
mycorrhization. All panels depict RT-PCR experiments carried out with a 2 minute extension 
time.  
(A) RT-PCR using DMI3 primers for Jester samples at 7 time-points during nodulation and 
mycorrhization (Figure 6.3A). The only band detected was approximately 1.5 kbp, which 
corresponds to full-length DMI3.  
(B) RT-PCR for A17 samples, as in (A). 
(C) RT-PCR for GFP-CCaMK-SBP 694/1 samples, as in (A). A positive control with genomic 
DNA (gDNA) and negative control with water were included in the final two lanes.  
(D) RT-PCR was also carried out using DMI3 primers with A17 cDNA 0, 4 and 10 dpi with 
rhizobia as provided by Ben Miller. The only band detected at all time-points is marked and 
corresponds to 1.5 kbp.  
(E)  RT-PCR was also carried out using DMI3 primers with Jester cDNA 0, 2, 4, 8, and 16 
hours post inoculation with a mock solution as provided by Jodi Lilley. The only band 
detected at all time-points was also at 1.5 kbp.  
(F) RT-PCR for Jester cDNA 0, 2, 4, 8, and 16 hours post inoculation with rhizobia, as in (E). 
The only band detected at all time-points was also at 1.5 kbp. A negative control with water 
was included in the final lane (F). 
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6.7 Reduction of the PCR extension time reveals low levels of splice variants  
An RT-PCR experiment for Jester and A17 over a time-course of nodulation and 
mycorrhization revealed full-length DMI3 and no alternative splicing. However splice-
variants had previously been detected in A17 during the establishment of nodulation by 
Pierre-Marc Delaux (Figure 6.2). In order to determine if splice variants were present during 
the time-course of nodulation and mycorrhization but were not detected (Figure 6.5) due 
to low expression levels, the elongation time in the RT-PCR experiment was reduced to 
favour their amplification.  
 
Firstly, the elongation time was reduced to one minute (Figure 6.6), and RT-PCR was 
repeated for all time-points for Jester, A17 and GFP. Interestingly, low levels of potential 
splice variants were revealed by the reduction in the elongation time. The amplification 
product corresponding to full-length DMI3 was still the strongest for all lines and during 
every stage of nodulation and mycorrhization. However, in all Jester (Figure 6.6A) and A17 
(Figure 6.6B) samples an approximately 500 bp band was also present, which was not 
detected with the 2 minute extension time. However this 500 bp band was potentially also 
detected in one GFP sample at day 0, and therefore this may not correspond to a genuine 
splice-variant. In addition, in Jester day 0 and day 13 Myc, and A17 day 0 samples, another 
potential splice variant was detected at approximately 1 kbp. This 1 kbp band was absent 
from the GFP control line and therefore it appeared that this may be a genuine splice 
variant.  
 
In order to determine if weak potential splice-variants were also present during the early 
stages of nodulation, the elongation time was also reduced to one minute for the Jester 
cDNA corresponding to 0-16 hours post inoculation (Figure 6.6D-E). As in Figure 5.6A-C, the 
full-length DMI3 PCR product was still the most abundant at all time-points. Interestingly, 
the smaller amplification products that were detected were not the same as with the later 
time-course. Many very weak bands were detected in these samples and unexpectedly 
these were more prominent in the mock inoculated samples (Figure 6.6D) than in the 
rhizobia-inoculated samples (Figure 6.6E). These were extremely weak in comparison to 
those detected in the later time-course so it seems likely that they do not correspond to 
genuine splice-variants and instead may be artefacts of the PCR. They were therefore not 
considered further, and work instead focussed on those low-level splice-forms detected 
during later stages of nodulation and mycorrhization. 
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Figure 6.6. Potential splice-forms are enhanced with shorter extension times during RT-
PCR. All panels correspond to RT-PCR experiments carried out with a 1 minute extension 
time. 
(A) RT-PCR using DMI3 primers for Jester samples at 7 time-points during nodulation and 
mycorrhization (Figure 6.3A). The sizes marked in the ladder are in kbp. 
(B) RT-PCR for A17 samples, as in (A). 
(C) RT-PCR for GFP-CCaMK-SBP 694/1 samples, as in (A). A negative control with water was 
included in the final lane.  
(D) RT-PCR was also carried out using DMI3 primers with Jester cDNA 0, 2, 4, 8, and 16 
hours post inoculation with a mock solution as provided by Jodi Lilley. 
(E)  RT-PCR for Jester cDNA 0, 2, 4, 8, and 16 hours post inoculation with Rhizobia, as in (D). 
A negative control with water was included in the final lane.  
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6.8 Splice variants are further enhanced with a 30 second extension time 
In order to further enhance the potential splice variants detected in the RT-PCR with a one 
minute extension time, the RT-PCR was repeated with a further reduction of the extension 
time to 30 seconds. This was carried out for all Jester, A17 and GFP samples in the 
nodulation and mycorrhization time-courses (Figure 6.7). This experiment revealed further 
potential splice variants in both the Jester time-course (Figure 6.7A) and A17 time-course 
(Figure 6.7B) in addition to those previously detected. Consistent with the one minute 
extension time experiment, in all cases full-length DMI3 was the most predominant form, 
including the control GFP line (Figure 6.7C). The 500 bp band was again the second most 
abundant, and was present in all Jester and A17 samples and strangely five out of six of the 
GFP line samples. Therefore this amplification product corresponded to either a non-
specific PCR product or several different amplification products which were approximately 
500 bp. Therefore those products detected in the GFP line samples would correspond to a 
non-specific product, and those detected in the WT lines would likely correspond to a splice 
variant. 
 
In the Jester time-course, the 1 kbp amplification product was now detected at all time-
points. In addition, six out of seven of the A17 samples also possessed this amplification 
product. Furthermore, several Jester time-points also had additional potential splice-
variants; namely 4 dpi with rhizobia, and 7 and 13 dpi with mycorrhization. Similarly, the 
same three samples in the A17 time-course contained low levels of potential splice forms, 
and in addition 21 dpi with mycorrhization showed several potential forms. It was not 
possible from this particular experiment to determine the sizes of all the detected forms 
due to poor resolution of the DNA ladder and these potential splice-forms therefore 
required further characterisation. 
 
Therefore shorter extension times revealed several potential splice-forms in both Jester 
and A17. They were extremely low in abundance but, since several of these forms were not 
detected in the GFP control line samples, they were potentially genuine splice forms. 
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Figure 6.7. Potential splice forms are enhanced further by halving the elongation time 
during RT-PCR again. All panels correspond to RT-PCR experiments carried out with a 30 
second extension time. 
(A) RT-PCR using DMI3 primers for Jester samples at 7 time-points during nodulation and 
mycorrhization (Figure 6.3A). The sizes marked in the ladder are in kbp. 
(B) RT-PCR for A17 samples, as in (A). 
(C) RT-PCR for GFP-CCaMK-SBP 694/1 samples, as in (A). A negative control with water was 
included in the final lane. One PCR reaction did not work due to a potential pipetting error 
at 10 dpi with nodulation, however this does not reflect on the cDNA quality because this 
sample has been successfully amplified during other experiments (e.g. Figure 4.12C).  
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6.9 Cloning of splice variants 
 
In order to sequence the potential splice forms detected during the RT-PCR experiments, 
two PCR product samples were selected for cloning (Figure 6.8A). These two samples were 
from the 30 second elongation RT-PCR experiment, and corresponded to Jester at four dpi 
with rhizobia and seven dpi with mycorrhizal inoculum. They were selected because they 
contained the common potential splice-variants detected in all the A17 and Jester time-
points tested (500 bp and 1 kbp PCR products) and they also contained other potential 
splice variants, the size of which was unclear from preliminary experiments. 
 
These bands were cloned into the pDRIVE sequencing vector using the PCR Cloning Kit 
(Qiagen) and colonies were screened by colony PCR and subsequent gel electrophoresis 
(Figure 6.8B-C). A large proportion of the PCR products which were cloned corresponded 
with the full-length DMI3 amplification product at 1.5 kbp, as expected. However several of 
the potential splice-variants were also successfully cloned by this method. All amplification 
products which were either larger or smaller than full-length DMI3 and were therefore 
potential splice variants were sequenced. These are marked on Figure 6.8B-C. 
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Figure 6.8. Cloning of potential splice-forms of DMI3. 
(A) Two samples from the RT-PCR with a 30 second elongation step were selected for 
identification of splice variants due to the presence of distinct bands, which are marked by 
horizontal arrows. These were used for cloning and verified by colony PCR. 
The successfully cloned variants from Jester at 4 dpi with nodulation and 7 dpi with 
mycorrhization are shown in (B) and (C) respectively. The indicated bands were selected for 
sequencing, and the corresponding splice variants are named with roman numerals. The 
sizes marked in the ladder are in kbp. 
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6.10 Sequencing of splice variants 
 
The splice variants were sequenced (Figure 6.8) and this confirmed that they were all 
DMI3-derived, except for the variant marked X. All sequences which corresponded to band 
X were subjected to a BLAST analysis against the M. truncatula nucleotide database which 
revealed no matches. However, a BLAST analysis with the complete nucleotide database 
revealed band X corresponded to the cloning vector used (pDRIVE). This may have occurred 
due to the presence of primer dimers that were present in the PCR reactions, which were 
subsequently ligated into the cloning vector. These bands were therefore not considered 
further since they did not correspond to potential splice-variants. 
 
Two potentially full-length DMI3 bands at 1.5 kbp were selected from each sample (Jester 4 
dpi and 7 dpi with rhizobia/mycorrhizal inoculum respectively) and all four of these 
amplification products were confirmed as full-length DMI3 with all 7 exons present (Figure 
6.9 I). 
 
The other four potential variants that were successfully cloned corresponded with splice 
variants containing whole or partial DMI3 exons (Figure 6.9, II - V). From the Jester 4 dpi 
with rhizobia sample, three alternative splice forms were cloned and were marked as II, III 
and V. II corresponded to the first few amino acids of the kinase domain and the EF-hands, 
with a partial deletion at the beginning of exon 5 and exon 6 and 7 present in their entirety. 
A protein form containing these regions would bind calcium, however would not be a 
functional kinase because it lacks the vast majority of the kinase domain. However, this 
fusion was not in frame and therefore would likely not produce a corresponding protein 
form. Form III corresponded to a partial kinase domain (which possessed the ATP-binding 
site but not the active site) and a partial VLD (which included only the final two EF-hands). 
Therefore this protein would be able to bind ATP and calcium; but it would again not be 
active for target-phosphorylation due to the lack of a kinase domain. However, again, the 
fusion of the partial VLD was not in frame and therefore this would likely not be reflected in 
protein form. Form V corresponded to a partial kinase domain (containing the ATP-binding 
site but no active site) with the final EF-hand only. This potential protein would be able to 
bind ATP and calcium; but it would again not be active for target-phosphorylation due to 
the lack of a kinase domain. Interestingly, this fusion was in-frame and therefore could 
potentially be reflected at the protein level. 
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Splice form II was also cloned from the Jester 7 dpi with mycorrhization sample, and 
another novel form, IV, was also cloned. This form contained some of the kinase domain 
(including both the ATP-binding and the active site), the end of the auto-inhibitory domain 
(which lacked the CaM binding site) and all of the EF-hands. It is unclear how a protein 
containing these domains would function since it is possible it would be an active kinase 
because this splice-variant possessed the active site, in contrast with the other forms 
identified. However the Thr271 site was absent which negatively regulates the protein, and 
the CaM binding domain was also lacking which provides positive regulation of the protein. 
Therefore it is not clear whether a protein containing these regions would be active or 
inactive. However, this fusion was again not in-frame and so would likely not form a 
corresponding protein. 
 
Consequently, it is unclear if these splice forms are biologically relevant or if any of these 
forms, or those previously detected (Figure 6.2), are reflected at the protein level. 
Therefore, it was important to determine whether any splice variants are present at the 
protein level in planta. 
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Figure 6.9. Schematic representation of splice variants of DMI3. 
The splice variants detected during cloning (Figure 6.8) were sequenced and the corresponding complete or partial exons are shown in each. The total 
lengths of the splice-variants are indicated. Form I corresponds to the exon structure of the full-length DMI3 gene. 
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6.11 Western blotting of Jester nodulation and mycorrhization time-courses 
 
In order to determine if any splice forms were present at the protein level, a western blot 
analysis of Jester root samples was undertaken.  
 
First, to establish the optimum extraction method for the root samples, two buffers were 
trialled with un-inoculated Jester root samples (Figure 6.10A). Jester samples grown on 
plates for 7, 14 or 21 days with no rhizobial inoculation were extracted using either YS or Li 
buffer (for YS buffer see Materials and Methods, for Li buffer refer to (Li et al., 1996)). The 
same tissue for each time-point was divided equally by weight between each buffer. Under 
these conditions, six ain protein bands were detected by αMtCCaMK with each extraction 
buffer; however, the proportion of each band was different with the two treatments. Li 
buffer was selected for all further western blotting experiments due to a superior 
extraction of proteins, particularly of full-length CCaMK at 58 kDa. Although the weight of 
tissue used between 7, 14 and 21 days varied (1.1, 1.4 and 3.1 g, respectively) it was 
possible to conclude that the levels of each protein detected did not vary greatly with the 
age of the tissue. Since the level of protein extraction from plant tissue was extremely low 
(as detailed in Chapter 5) it was not possible to determine the identity of the six proteins 
identified with αMtCCaMK by ass spectro etry. Since there was previous evidence of 
cross-reactivity of this antibody, it was unclear if smaller proteins and the protein at 96 kDa 
corresponded to CCaMK-derivatives or to other proteins to which the antibody cross-
reacted. However it did seem likely that the band seen at 58 kDa corresponded to full-
length CCaMK. 
 
In order to determine if CCaMK protein splice-forms were present during nodulation or 
mycorrhization, Li buffer was used to extract Jester samples from one batch of plants for 
the time-course of nodulation and mycorrhization (Figure 6.10B). As seen in Figure 6.10A, 
six main proteins were detected with αMtCCaMK in ost sa ples  except Nod 4, 10 and 
21, which had seven). As before, there was insufficient protein to verify by mass 
spectrometry if those proteins detected corresponded to CCaMK, however it was likely that 
the band at 58 kDa corresponded to full-length CCaMK. It appeared that the 58 kDa protein 
stayed at the same level at each time-point, except 4 dpi with rhizobia. This analysis was 
somewhat quantitative because buffer was added to 2 ml/g of ground tissue but, due to 
the viscosity of the crude samples which potentially led to small variations in the volumes 
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pipetted, the results were not fully quantitative. Due to the known cross-reactivity of the 
αMtCCaMK antibody, it was not possible to deter ine if there were splice-variants present 
or if the 58 kDa band definitively corresponded to CCaMK from this experiment. 
 
   
Figure 6.10. Characterisation of CCaMK protein during nodulation and mycorrhization. Both 
panels are western blots developed with αMtCCaMK. 
(A) Two buffers were trialled to establish the optimal method for protein extractions for 
the plant root time-course samples. YS and Li buffers were used with M. truncatula Jester 
root samples grown on plates for 7, 14 or 21 days with no inoculation. Li buffer was 
selected for use in time-course western blot and immunoprecipitation (IP) experiments due 
to the better extraction of proteins, particularly full-length CCaMK (58 kDa).  
B) Western blot analysis of Jester samples at all 7 time-points studied (Figure 6.3A). Briefly, 
samples were ground to a fine powder in liquid nitrogen, extracted with 2 ml/g Li buffer 
and prepared for SDS-PAGE.  This extraction revealed several potential different forms of 
CCaMK in addition to full-length protein, but the antibody is known to cross-react with 
other proteins. 
 
 
6.12 IP reveals the full-length CCaMK protein form 
 
In order to determine whether proteins detected with αMtCCaMK corresponded to splice-
forms of CCaMK or were cross-reactive proteins, IP was carried out for the same Jester root 
samples. Since this procedure was more involved, it was only carried out for Jester samples 
at the seven time-points during nodulation and mycorrhization (and not for A17 or GFP 
samples). Interestingly, at all seven time-points the predominant protein that 
i  unoprecipitated with αMtCCaMK was present at 58 kDa and therefore most likely 
corresponded to full-length CCaMK (Figure 6.11A). The appropriate gel slice for each 
sample was analysed by mass spectrometry, and CCaMK was detected in six samples, 
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indicating that full-length CCaMK was likely immunoprecipitated by this method. This result 
coincided with the predominant form detected during RT-PCR experiments which was the 
full-length transcript at all time-points. Two smaller proteins were also detected by this 
method at approximately 43 and 30 kDa, however these contributed to a tiny percentage 
of the total protein detected and therefore were unlikely to be biologically significant. 
 
Due to the nature of the IP experiment the output bands were not quantitative and 
therefore it was not possible to determine if concentrations of full-length CCaMK protein 
changed during the symbiosis signalling process. It follows therefore that the weaker full-
length band of the day 13, mycorrhization sample does not necessarily suggest that levels 
of CCaMK were lower at this stage of signalling.  
 
The result of the IP experiment was in contrast to the western blot of crude protein extract 
with αMtCCaMK  Figure 6.10B , which showed six bands that potentially corresponded to 
CCaMK splice-forms. The IP result showed therefore that the five proteins (excluding full 
length 58 kDa) were most likely cross-reactive proteins, and the epitope(s) which was/were 
recognised by the antibody in each of these proteins may have been internal to the 
proteins. The epitope(s) would therefore be recognised by the antibody when the proteins 
were denatured, for example during SDS-PAGE and subsequent western blotting. However, 
the epitope(s) would not be detected when the protein was in a native state, for example 
during IP. Therefore, it can be concluded from the IP experiment that the predominant 
form of CCaMK protein during symbiosis signalling is full-length and no significant splice-
forms were detected. 
 
The input and flow-through fractions for each of these IP samples are shown in Figure 
6.11B-C. All five of the detected proteins from the western blot (Figure 6.10B) (excluding 
full-length CCaMK) were very weakly detected in the input and flow-through samples. This 
confirmed that these were cross-reactive proteins which did not bind to the antibody when 
in the native state, since they were detected before and after IP. The 58 kDa band is also 
detected very weakly in the wash and flow-through; this is either because binding to the 
antibody did not occur completely or there was another 58 kDa cross-reactive protein. 
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Figure 6.11. IP of CCaMK reveals full-length protein is the predominant form at key stages 
of nodulation and mycorrhization. All panels show western blots developed with 
αMtCCaMK. 
(A) The immunoprecipitates of Jester extracts at 7 time-points (Figure 6.3A) are shown. This 
was carried out using magnetic beads cross-linked to αMtCCaMK and the predominant 
band (marked with an arrow) corresponds with full-length CCaMK protein (approximately 
58 kDa).  
(B) The input samples from the IP of Jester extracts at 7 time-points (A) using magnetic 
beads cross-linked to αMtCCaMK are shown. 
(C) The flow-through fractions from the IP of Jester extracts (A) are shown.  
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6.13 Kinase domain antibodies do not reveal CCaMK splice-forms 
 
Since the αMtCCaMK antibody was produced against the AI-VLD antigen, protein splice-
variants could have been absent in the IP experiment if they contained only the kinase 
domain (33.3 kDa). Therefore antibodies with affinity to a region of the kinase domain were 
utilised with representative samples to determine if it was possible to detect other forms of 
CCaMK (Figure 6.12). Samples used for this experiment corresponded to the final time-
point in the time-course experiment for A17 and Jester, with mycorrhization or nodulation 
at 21 dpi. First, a western blot for the sa ples was carried out and probed with αMtCCaMK 
(Figure 6.12A). The resulting protein bands detected corresponded with the bands seen 
during a previous time-course extraction (Figure 6.10B) where subsequent IP showed that 
full-length protein was predominant. It can therefore be assumed that this form was also 
predominant in this extraction when detected with the antibody with affinity for the AI-
VLD. 
 
Two antibodies were tested with affinity to the kinase do ain of CCaMK. αpT271 
(previously used in Chapter 3) has affinity for the phospho-form of Thr271. The antibody 
annotated as αT271 corresponds to the non-specific fraction from the purification of the 
anti-phospho antibody, which has previously been demonstrated to bind to both the 
phospho- and non phospho-forms of CCaMK (data not shown). Therefore, using both of 
these antibodies would indicate if either phosphorylated or non-phosphorylated forms of 
CCaMK were present. The same A17 and Jester 21 dpi samples were subjected to western 
blotting and probed with either the αT271 or the αpT271 antibody. Figure 6.12B showed 
the western blot probed with αT271 and all sa ples possessed a single strong protein band 
at 48 kDa. This was most likely not a splice variant and instead corresponded to a cross-
reactive protein. This is because this protein was not pulled-down with the previous IP 
experiment (6.11A) and a kinase-only splice-variant would correspond to a size of 33.3 kDa 
or less. A BLAST analysis was carried out in order to identify potential candidates for this 
cross-reactive protein, with the peptide used for the production of this antibody 
(CSFYEKTWKGISQ). The three most likely candidates identified were: ERG2 and Sigma1 
receptor-like protein (NCBI Ref.: XP_013469825.1), tRNA pseudouridine synthase (NCBI 
Ref.: XP_003630601.2) and a B3 DNA binding domain protein. These candidates were 
identified because they contained more than four consecutive amino acids in common with 
the peptide. Of these, the most likely protein for cross-reactivity was the B3 DNA binding 
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domain protein (NCBI Ref.: XP_013466763.1), because it has a predicted size of 
approximately 48 kDa. This protein may correspond to the 48 kDa protein which was 
previously detected by αMtCCaMK, but this is unlikely since the epitopes of the antibodies 
which detected these proteins were different. 
 
Figure 6.12C corresponds to the same four Jester and A17 samples probed with the anti-
phospho specific antibody, αpT271. No bands were detected despite a long exposure ti e. 
This is ost likely because the affinity of the αpT271 antibody was too low to detect 
proteins at this concentration. Alternatively, CCaMK or splice-forms under these conditions 
were entirely un-phosphorylated at Thr271 and therefore were not detected. 
 
It was therefore not possible to determine if kinase-only forms of CCaMK are present 
during symbiosis establishment using these antibodies, but the RT-PCR and IP data taken 
together suggests that it is highly likely that the predominant form of CCaMK is full-length.  
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Figure 6.12.  Use of kinase domain antibodies does not provide further insight into CCaMK 
splicing. 
(A) A western blot using αMtCCaMK with A17 and Jester samples, 21 dpi with 
mycorrhization or nodulation as indicated. Samples were inoculated as 10 day old 
seedlings, and re-planted from Mod FP agar to terragreen sand.  
(B) A western blot using αT271 with the same A17 and Jester samples as (A), 21 dpi with 
mycorrhization or nodulation as marked. One main protein band was detected at 
approximately 48 kDa with αT271 however this is most likely not a CCaMK-derived protein.  
(C) A western blot using αpT271 with the same A17 and Jester samples as (A), 21 dpi with 
mycorrhization or nodulation as marked. Despite a long exposure time of the blot, no 
bands were detected.  
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6.14 Discussion 
An investigation was undertaken in order to determine if splicing plays a role in how 
CCaMK functions in the Sym pathway. Very low abundance splice-variants of DMI3 were 
revealed at the RNA level under short-extension time PCR conditions for both Jester and 
A17. Interestingly, only one of these forms, form V, could potentially be reflected at the 
protein level due to an in-frame fusion. This form contains a partial kinase domain and one 
EF-hand, EF-hand 3. Therefore, if this form was reflected in a corresponding protein form, it 
would not encode a functional kinase but it could bind ATP and calcium. The remaining 
three DMI3 splice-forms detected contained regions which were spliced out-of-frame and 
therefore would likely not be translated into corresponding protein forms. 
 
Surprisingly, none of the forms sequenced matched exactly to those detected previously by 
Pierre-Marc Delaux. Pierre-Marc detected three main splice forms: 1173, 993 and 498 bp. 
The 1173 bp form contained a partial kinase domain and the VLD (Figure 6.2). This form 
was most similar to form IV, and, if functional, it would most likely be a calcium-regulated 
kinase. However, the exact sequences present were different. The 993 bp splice-form had 
no likely counterpart in the experiments detailed in this Chapter. This form lacked key 
regions of the kinase domain necessary for functionality, but retained both the CaM 
binding domain and EF-hands. None of the forms detected in the studies subsequently 
presented in this Chapter retained both calcium-responsive elements of the protein. 
However, the 498 bp form is very similar to form V detected in these experiments. They 
both contain a kinase domain with only the ATP binding site, and one EF-hand of the VLD. 
Therefore, this protein could act as a calcium-binding protein only. Surprisingly though, the 
exact sequences encoding these similar splice-forms were different. The fact that none of 
the splice forms detected was identical to those previously identified suggests that they do 
not have key roles in the Sym pathway. 
 
Unexpectedly, it also appeared that one or more of these forms were present in the control 
GFP-CCaMK-SBP line. This line lacks splicing of DMI3 because it only possesses the coding 
sequence of DMI3. Therefore, these amplification products most-likely do not correspond 
to DMI3 splice-forms and are most likely non-specific bands or artefacts. 
 
Crucially, as demonstrated in this chapter, no significant splice-variants were reflected at 
the protein level for all nodulation and mycorrhization Jester time-points tested. This is 
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because the predominant protein form at all time-points corresponded to full-length 
protein. It seems likely that this is also the case for the A17 samples, because a similar 
pattern of amplification products was detected in the RT-PCR for this line and the most-
abundant of these was also full-length in all samples. In fact it could be predicted that the 
splice-variants would not be reflected in the predominant protein forms detected, because 
they reflect an extremely low proportion of the total DMI3 amplification products 
detected. In addition, several forms contained a premature stop codon and therefore 
would likely not be reflected at the protein level. One possibility is that the low abundance 
splice-variants detected at the RNA level correspond to errors that occur during normal 
mRNA processing. 
 
Under these conditions it therefore appears that alternative-splicing of CCaMK does not 
play a significant role in symbiosis signalling. Crucially, as demonstrated in chapter 5 and by 
others, for example (Shimoda et al., 2012), the coding sequence of DMI3 complements the 
dmi3-1 mutant for symbiosis establishment. Therefore any role of alternative splicing of 
CCaMK during symbiosis would be minor or of no significance. However, since some splice-
forms of DMI3 were detected, it is possible that the splicing of CCaMK could play a role in 
other signalling pathways or in other tissues. 
 
6.15 Summary 
 
The predominant form of CCaMK in nodulation and mycorrhization signalling is full-length, 
at both RNA and protein levels. Very low abundance splice-variants of DMI3 were revealed 
under specific PCR conditions but these did not match previously detected variants and 
were not reflected at the protein level. Therefore, it can be concluded that alternative 
splicing of CCaMK does not play a major role in symbiosis signalling. 
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The aim of this project was to characterise CCaMK in the symbiosis signalling pathway. In 
order to do this a multi-faceted study was undertaken in order to address key questions. 
This thesis has provided insight into how the protein responds to calcium in the nucleus, 
including the size of the oligomer and the likely mechanism of autophosphorylation at the 
important T271 site. Both of these factors impact on the kinetics of CCaMK function and 
potential modelling of the system. Furthermore, the conformational change when calcium 
binds was characterised and this provides insights into the possible roles this plays in 
CCaMK as a signal transducer. Finally the wider role of CCaMK in the pathway in planta was 
addressed by studying the changes in RNA and protein forms of CCaMK prior to symbiosis 
formation and during the progression of nodulation and mycorrhization. 
 
The CCaMK oligomer  
 
Autophosphorylation at T271 has recently been revealed to be crucial for the regulation of 
CCaMK function by the maintenance of the inactive state of the protein. This occurs via a 
hydrogen bonding network predicted to form between pT271 and two residues of the CaM 
binding domain at basal calcium levels (Miller et al., 2013). Autophosphorylation is also key 
to the regulation of the animal protein CaMKII and, in contrast to CCaMK, the mechanism 
by which this occurs is well characterised. Interestingly, phosphorylation in CaMKII occurs 
at T286 within the dodecameric oligomers at adjacent subunits when both of the subunits 
involved are bound to Ca2+/CaM (Hudmon and Schulman, 2002b). Therefore, in order to 
address how autophosphorylation occurs in CCaMK, it was first necessary to identify the 
oligomeric status of CCaMK which was currently unknown. By the use of three different 
methods described in Chapter 3, it was determined that MBP-CCaMK when purified from E. 
coli forms an oligomer. Furthermore, an estimate of the oligomer size was produced of 16-
18 subunits with a diameter of    31 nm. 
 
These data therefore show that CCaMK is capable of forming an oligomer similar to that of 
CaMKII. However, it could form an oligomer with more than 12 subunits. This corresponds 
to a large protein co plex of between    1600 – 1800 kDa, since each ono er of MBP-
CCaMK is    100 kDa. However, the mechanism by which this oligomerisation occurs is likely 
to be different to that of CaMKII. CaMKII possesses a C-terminal association domain 
required for the establishment of the oligomer (Hudmon and Schulman, 2002a); however 
CCaMK does not possess an analogous domain. There was also more variability detected in 
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the oligomer size of CCaMK. Whilst the SEC gave a single value for the oligomer size of 1607 
kDa due to the presence of a sharp elution peak, both the DLS and AFM data showed more 
variability. Variability is expected when using DLS with a polydisperse sample due to the 
measurement of the size of particles in solution where they are in Brownian motion. Some 
variability can be observed with AFM due to artefacts that form during the deposition of 
the protein. However, the variability in sizes detected during AFM is most likely indicative 
of the presence of different particle sizes. This is most likely due to larger aggregates of 
MBP-CCaMK which formed after purification, and therefore they were only detected in the 
AFM and occasionally during DLS. Whilst MBP-CCaMK was the best available non-
aggregating full-length construct of CCaMK, attempts to concentrate the protein led to 
aggregation. Therefore, it was not possible to carry out, for example, analytical 
ultracentrifugation to obtain a more precise oligomer size. Furthermore, techniques to 
obtain a more detailed image of the oligomer, for example cryo-EM, were not possible due 
to the aggregation observed with AFM. 
 
Despite the variability in the exact size of the CCaMK oligomers which were detected, the 
evidence shows that CCaMK is predominantly present as oligomers as opposed to 
monomers. Crucially, no evidence of MBP-CCaMK monomers was detected in any of the 
experiments. These experiments were carried out using an N-terminal MBP tag, and it 
could be theorised that the tag used could potentially affect the oligomeric state of the 
protein. However, the MBP-tag is widely used as a fusion tag to aid solubility and prevent 
aggregation, whilst also allowing ease of purification (Kapust and Waugh, 1999). 
Furthermore, there is little evidence of the MBP-tag actually causing this aggregation, 
because preliminary data regarding a tagless form of MtCCaMK also shows the presence of 
a large oligomer, before the onset of significant aggregation (Liang Zhou). The fact that 
CCaMK forms an oligomer therefore has implications for the common Sym pathway, 
namely on how CCaMK interacts with downstream proteins to relay the symbiotic signal. Of 
main interest is CYCLOPS, which is a key interacting protein of CCaMK. CCaMK interacts 
with CYCLOPS in the absence of symbiotic signalling and CYCLOPS is a phosphorylation 
target of CCaMK (Yano et al., 2008), suggesting that both the autophosphorylated inactive 
form of CCaMK and the form which is active for downstream phosphorylation interact with 
CYCLOPS. Furthermore, CYCLOPS has also been shown to form homodimers (Singh et al., 
2014). Together, this indicates that CCaMK-CYCLOPS may form a large hetero-complex 
before and during calcium spiking in order to detect and transduce the signal. However, the 
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number of subunits present in this complex is currently unclear. In addition, it is likely that 
CCaMK interacts with further target proteins, for example CIP73 and other as yet unknown 
proteins, and their role in this complex is also currently unclear. 
 
Intra-oligomeric autophosphorylation at T271  
 
The mechanism by which autophosphorylation at T271 occurs has previously been studied 
kinetically. Despite the presence of two different trends for the protein concentration-
dependence of autophosphorylation at T271, the authors concluded an inter-
monomeric/oligomeric mechanism in both studies (Sathyanarayanan et al., 2001), 
(Tirichine et al., 2006). The data from these two papers are contradictory, therefore, and 
required further clarification. In addition, the data presented in Chapter 3 showing the 
presence of CCaMK in oligomers has implications for the mechanism of 
autophosphorylation. Therefore it was necessary to undertake a thorough investigation to 
distinguish between the four possible mechanisms of autophosphorylation: intra-
monomeric, inter-monomeric, inter-oligomeric and intra-oligomeric.  
 
The data presented in Chapter 3 does not conclusively define the mechanism of 
autophosphorylation; but it does strongly indicate an intra-oligomeric mechanism. This is 
due to the reasonable elimination of the other possible mechanisms, rather than the 
positive detection of intra-oligomeric phosphorylation. First, intra-monomeric 
autophosphorylation was deemed unlikely due to the relative locations of the active site 
and T271 on a homology model, which concurs with findings from homology modelling 
carried out by Sathyanarayanan and colleagues (Sathyanarayanan et al., 2001). Second, 
three independent experiments showed no evidence of inter-oligomeric/monomeric 
autophosphorylation (Figures 3.6, 3.9 and 3.15), utilising three constructs of kinase dead 
CCaMK protein (GST-CCaMK K47E, MBP-CCaMK K47E and HisSUMO-CCaMK D192N). These 
were expressed separately, mixed with WT CCaMK, and then subjected to a kinase assay 
and a western blot probed with αpT271. These three experi ents therefore deter ined 
whether inter-oligomeric or inter-monomeric autophosphorylation were possible. This is 
because, whilst the majority of the proteins were present as oligomers, it is likely some 
protein was present as monomers too.  Furthermore, since three different fusion tags and 
two different kinase dead mutations were used it seems unlikely that these factors 
interfered with inter-monomer phosphorylation. The same experiment was used to 
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demonstrate that autophosphorylation of SYMRK occurs with an intermolecular 
mechanism (Yoshida and Parniske, 2005) therefore it seems likely that this experiment 
would allow inter-molecular autophosphorylation of CCaMK if possible.  As this is a 
negative result it cannot be unambiguously verified, however taken together it strongly 
suggests that inter-oligomeric/monomeric autophosphorylation at T271 in CCaMK does not 
occur. 
 
The remaining possible mechanism is intra-oligomeric autophosphorylation. In order to 
determine if this occurs in CCaMK oligomers, mixed oligomers were produced containing 
MBP-CCaMK K47E and WT CCaMK. These proteins were co-expressed and purified, and 
phosphorylation at T271 in each type of subunit was determined after a kinase assay using 
a western blot probed with αpT271. Whilst potential intra-oligomeric autophosphorylation 
was detected, a subsequent λ phosphatase treat ent did not re ove this signal. 
Therefore, it must be concluded that the signal detected was non-specific background. This 
background likely corresponds to the binding of αpT271 to non-phosphorylated protein 
occurring at a low level, and detected in this case due to the long exposure time used 
during the development of the western blot. However it seems likely that this indicates not 
that the hypothesis of intra-oligomeric autophosphorylation is wrong, instead that the 
strategy used gave an ambiguous result.  
 
This strategy has previously been utilised to determine the mechanism of 
autophosphorylation for CaMKII, which was demonstrated to occur in an inter-subunit 
intra-oligomeric manner (Mukherji and Soderling, 1994). There are several reasons why this 
method may not have worked in this particular experiment for CCaMK. First, as discussed 
above, the way in which CCaMK forms oligomers is likely different to CaMKII due to the lack 
of an identified analogous association domain. It could be possible in this case that the 
presence of a kinase-dead mutation could have caused a conformational change and 
therefore aberrantly affected the way in which the mixed oligomers formed, preventing 
cross-phosphorylation. Furthermore, the MBP-tag is a large fusion tag of approximately 40 
kDa (Terpe, 2003) and it is possible that the presence of the tagged and un-tagged version 
of the protein when assembled into a complex do not form a favourable conformation 
permitting trans-phosphorylation. Alternatively, perhaps ATP must bind to both the donor 
and recipient to allow inter-oligomeric phosphorylation, and, if this is the case, the kinase-
dead mutation would also prevent its own autophosphorylation. In addition, the kinase 
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dead mutation could prevent the phosphorylation of inactive subunits perhaps by a 
structural change in the protein, which would affect both the inter- and intra-oligomeric 
experiments. Such effects of the kinase-dead mutations cannot be ruled out. 
 
These data taken together therefore suggest, but do not conclusively prove, an intra-
oligomeric mechanism of autophosphorylation at T271. This is similar to the intra-
oligomeric mechanism observed for CaMKII; however, there are also substantial 
differences between the two mechanisms. Whilst CaMKII is autophosphorylated at T286 by 
Ca2+/CaM-binding, CCaMK is instead autophosphorylated in response to Ca2+ ions binding 
to the EF-hands. In addition, autophosphorylation appears to regulate the proteins in 
opposite ways: CaMKII is activated by phosphorylation at T286 and CCaMK is inactivated by 
phosphorylation at T271 (Miller et al., 2013). Furthermore, it has been shown that it is 
necessary for Ca2+/CaM to bind to adjacent subunits in CaMKII in order for this 
autophosphorylation to occur (Hanson et al., 1994). Therefore, there are key differences 
between these two mechanisms. 
 
An intra-oligomeric mechanism of autophosphorylation at T271 has implications for the 
wider mechanism of CCaMK regulation and activation. First, it suggests that 
autophosphorylation occurs in a concentration-independent manner with first order 
kinetics. This would be favourable because it is more robust than a concentration-
dependent reaction, due to a lack of CCaMK-gene expression and protein level effects. As 
previously discussed, CCaMK is thought to be autophosphorylated at T271 at the basal, 
inactive state (Miller et al., 2013). The presence of a stable, inactive state of CCaMK is 
important because it allows tight regulation of symbiosis. Downstream components leading 
to nodule organogenesis, for example, must be carefully regulated so that they are only 
induced in response to the correct signal, i.e. nuclear calcium spiking which peaks at 625-
800 nm nuclear calcium (Ehrhardt et al., 1996). Therefore, the favourable kinetics of the 
intra-oligomeric autophosphorylation reaction would help to enhance this inactive state 
stabilised by the hydrogen bond network, and therefore boost the stringent regulation 
observed during symbiotic signalling. 
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CCaMK undergoes a calcium-dependent conformational change 
 
To study the conformational change that CCaMK undergoes when calcium ions bind to the 
EF-hands of the VLD, two complementary approaches were undertaken. The VLD construct 
was used for SAXS, which showed an elongation of the domain in the presence of calcium. 
Furthermore, the conformational change was also analysed using the full length MBP-
tagged version of CCaMK. This revealed that a hydrophobic patch is exposed when calcium 
binds to the VLD. These data are consistent with previous data regarding the 
conformational change; however it also extends our understanding of this occurrence. The 
conformational change was initially characterised by mobility shift assay (Takezawa et al., 
1996), (Shimoda et al., 2012) however there are potential errors with this method including 
the loss of bound calcium ions during gel electrophoresis. The conformational change was 
further analysed by Swainsbury and colleagues (Swainsbury et al., 2012) who confirmed 
that it corresponded to a change in tertiary structure that also reveals a hydrophobic cleft. 
However, these data were obtained using constructs lacking either the kinase domain or 
both the kinase and AI domains, and therefore could only be assumed to apply to the 
protein as a whole. Therefore, the data in this thesis confirm the previously detected 
conformational change. Furthermore, it was demonstrated that the hydrophobic patch is 
exposed in the full-length protein and corresponds to an elongation of the VLD. 
 
The conformational change has important potential implications for the function of CCaMK 
in the symbiotic pathway. First, this conformational change can be rationalised in terms of 
the function of the protein proposed by Miller and colleagues (Miller et al., 2013) (Figure 
1.9). Binding of calcium to the EF-hands has been shown to induce autophosphorylation at 
T271 (Takezawa et al., 1996), and it follows that this could be facilitated by the 
aforementioned calcium-induced conformational change. This conformational change likely 
facilitates a structural rearrangement in the full-length protein that is required for intra-
oligomeric autophosphorylation at T271. The phosphorylated form corresponds to the 
basal state of the protein. At higher calcium concentrations, it seems likely that the protein 
undergoes a further conformational change when Ca2+/CaM binds to the protein, which 
disrupts the hydrogen bond network and allows activation for downstream signalling 
(Miller et al., 2013). This would be a separate conformational change to that which was 
characterised above and future work would be required to determine the structural 
changes involved. 
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Furthermore, the exposure of a calcium-dependent hydrophobic cleft in the full-length 
CCaMK protein has important consequences for downstream signalling. Hydrophobic 
patches generally function in the binding of target proteins and this is observed in, for 
example, CaM binding to target proteins (Bhattacharya et al., 2004). Since this patch 
exposure is observed with full-length CCaMK, it is likely that it does not facilitate 
interaction of CCaMK monomers. This evidence, combined with the data presented in 
Chapter 3, suggest the formation of an oligomer of CCaMK which is not modulated by 
calcium binding. This follows because the oligomeric state of MBP-CCaMK was addressed in 
the presence of EDTA, and the exposure of the hydrophobic patch in the presence of 
calcium suggests that the conformational change does not mediate further calcium-specific 
CCaMK:CCaMK interactions. Thus, the hydrophobic patch likely functions in target protein 
binding. One protein which binds to CCaMK is CaM itself, and theoretically the hydrophobic 
patch exposure could enhance CaM binding. This could explain how binding of CaM is 
observed to be 8-fold stronger after calcium-induced autophosphorylation 
(Sathyanarayanan et al., 2000), a phenomenon which is thought to prime the protein for 
activation. However, CaM has a well-defined binding site in the CaM binding domain of 
CCaMK, and both the conformational change and hydrophobic patch exposure have been 
observed when only the VLD is present (Swainsbury et al., 2012). Furthermore, this 
phenomenon was still observed, albeit reduced from 8-fold to 5-fold, when a peptide of 
CCaMK lacking the VLD was used (Sathyanarayanan et al., 2001). Therefore if seems likely 
that the hydrophobic patch exposure does not contribute significantly to this phenomenon, 
even if the conformational change itself facilitates CaM binding.  
 
Another binding protein of CCaMK is CYCLOPS. CYCLOPS has been shown to bind to CCaMK 
in the absence of symbiotic signalling and it is also a phosphorylation target of CCaMK 
(Yano et al., 2008). Since calcium-induced autophosphorylation occurs in the basal state of 
the protein, the patch would therefore be exposed at basal calcium. Therefore the function 
could be to bind to CYCLOPS, because it is currently unknown as to whether CCaMK can 
bind in the absence of calcium. There are also other interaction proteins of CCaMK, for 
example Cip73, and there are likely to be more identified in the future. Therefore it is also 
plausible that the function could be to bind one of these target proteins. 
 
Whilst the data obtained in this project regarding the calcium-dependent conformational 
change are robust, the SAXS envelopes are not ideal. This is because there are regions in 
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the SAXS envelope which lack density from the fitted homology model, showing that they 
are not a perfect match. The SAXS data is further limited because it provides an envelope 
structure only and doesn’t show ato ic-level resolution. It is important for this reason and, 
crucially, for the understanding of CCaMK during signalling, that a high resolution crystal 
structure of the protein is obtained. It would be ideal to obtain a crystal structure of the 
full-length protein; however previous work with CCaMK showed aggregation which would 
adversely affect its ability to crystallise (Swainsbury et al., 2012). Furthermore, attempts to 
concentrate a full-length construct of CCaMK which shows minimal aggregation, such as 
MBP-CCaMK, were unsuccessful and so  could not be used for crystal trials at this time. 
Therefore crystal trials were carried out for the VLD and a central peptide containing T271 
and the CaM binding domain (Chapter 4). 
 
Despite extensive attempts to produce crystals of these two constructs, none were 
obtained. Crystallisation of a protein requires the formation of precise inter-molecular 
interactions which allows the formation of a crystalline lattice. There are therefore a 
 yriad of different factors which can affect a protein’s ability to crystallise including, but 
not limited to, the temperature, precipitant, pH, buffer components, sample purity and 
homogeneity, metal ions, co-factors or ligands, aggregation and concentration used (Russo 
Krauss et al., 2013). Whilst it was possible to vary some of these (e.g. metal ions and 
precipitants) it was obviously not possible to vary all possible factors which may have 
affected the constructs used. Therefore, under the conditions tested, it was not possible to 
crystallise constructs of CCaMK and this remains an important future goal. 
 
Characterisation and purification trials of MtCCaMK 
 
A study was undertaken in order to determine to what extent it is possible to extract and 
purify CCaMK from M. truncatula. A growth strategy for the commercial M. truncatula WT 
line, Jester, was first developed in order to obtain as much root tissue as possible. This 
hydroponic growth method was based on a method used to purify an unrelated oxalate 
oxidase from Hordeum vulgare (Requena and Bornemann, 1999) which yielded sufficient 
protein for biochemical studies. This method proved successful for the growth of large 
quantities of M. truncatula (20 000 seeds = 800 g root material) and furthermore roots 
were shown to be capable of forming nodules, suggesting that growth in this system was 
sufficiently similar to a terrestrial environment. In addition, it was also possible to develop 
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an antibody with strong affinity to CCaMK constructs expressed in E. coli, by using the AI-
VLD protein as the antigen for immunization. This facilitated the evaluation of different 
purification strategies. 
 
Many different purification strategies were tested in an attempt to yield MtCCaMK protein 
for characterisation. The first aim was to purify sufficient protein to obtain a clear band on 
a western blot when probed with αMtCCaMK to confir  the size of CCaMK in planta, which 
was first determined as approximately 56 kDa in L. longiflorum (Patil et al., 1995). 
Subsequent experiments were attempted to determine if it is possible to purify sufficient 
CCaMK protein for biochemical experiments. The first purification strategy tested was 
based on that which was used in (Requena and Bornemann, 1999), however this strategy 
was for an apoplastic protein and did not prove successful for CCaMK (data not shown). It 
was therefore determined that a strategy which specifically included nuclear extraction 
would likely be more successful, due to the nuclear localisation of CCaMK (despite the lack 
of a canonical nuclear localisation signal) (Smit et al., 2005), (Takeda et al., 2012). 
 
There are two main ways in which nuclear-localised proteins can be purified: isolation of 
nuclei and subsequent purification or whole cell extract purification. Both methods were 
trialled for the purification of MtCCaMK, with methods based on (Palma et al., 2007) and 
(Backstrom et al., 2007) respectively. The isolation of nuclei prior to purification did not 
produce a good protein yield with respect to CCaMK, as verified by western blotting, and 
therefore was not trialled further (data not shown). The final purification method utilised 
was based on the method utilised in (Backstrom et al., 2007), with buffers derived from (Li 
et al., 1996). This was chosen because the extraction was superior to those previously 
tested (including RIPA buffer, shown in Figure 5.3A) and because some CCaMK protein has 
been reported to be also present in the cytosol (Sylvia Singh, personal communication). In 
addition, buffers including non-ionic detergents were included in order to maintain protein-
protein interactions, in case these stabilised the purification of CCaMK.  
 
After these extensive purification trials, it was determined that it is possible to obtain a 
protein band on a western blot probed with αMtCCaMK after IP, which corresponds to full-
length CCaMK protein at 58 kDa. This corresponds with the previously observed size of 
CCaMK. Further attempts to purify CCaMK, and obtain a corresponding protein band on 
SDS-PAGE stained with coomassie, were unsuccessful including the use of overexpression 
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plant lines. This is most likely due to the presence of CCaMK at extremely low levels in 
planta, which is consistent with detection of the full length protein during western blotting 
only after enrichment with IP and not in crude plant extracts. 
 
Alternative splicing of CCaMK 
 
Analysis of CCaMK at a variety of key developmental stages during the establishment of 
nodulation and mycorrhization revealed very low levels of splicing at the RNA level which 
were not reflected in corresponding protein splice forms. This suggests that whilst CCaMK 
is capable of being spliced this does not play a major role during symbiosis. This result was 
unexpected, because previous data from Pierre-Marc Delaux showed the detection of at 
least three different splice forms of DMI3 during nodulation (Figure 6.2). Furthermore, the 
full-length DMI3 transcript was less abundant than the three main alternatively spliced 
forms which were detected. There are several potential reasons for this discrepancy 
including the plant growth conditions, the reverse transcriptase and the particular PCR 
conditions used. It may, indeed, be a combination of these factors. However, for this 
project, a range of time-points during nodulation and mycorrhization were tested, with two 
WT lines (A17 and Jester), two different reverse transcriptases, different PCR conditions 
and different sources of cDNA. Crucially, the IP experiment showed that the splice variants 
which were detected at low levels at the RNA level were not reflected at the protein level 
for Jester (Figure 6.11A). Therefore, it seems likely that if significant splice variants were 
present during symbiosis they would have been detected by these methods and this 
indicates that splicing of CCaMK does not play a key role in symbiosis.  
 
One potential type of splice variant which could have been missed during the experiments 
at the protein level is a variant containing the kinase domain only, which would be 33.3 kDa 
or smaller. This form would not have been detected during experiments at the RNA-level 
due the primers used. Attempts to utilise kinase domain-specific antibodies  αT271 and 
αpT271, Figure 6.12B-C) did not identify any kinase splice variants, and further did not 
identify the predominant, full-length CCaMK protein. It seems most likely that this is due to 
low affinity of the antibodies coupled with the low levels of the proteins in crude extract. A 
further possibility is that no full-length protein was detected with the αpT271 antibody 
because all the protein present was not phosphorylated at T271. This is a possibility 
because all samples were taken from roots at 21 days post infection, and therefore CCaMK 
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may have been fully de-phosphorylated and active for signalling at this point (Miller et al., 
2013). Alternatively, phosphorylation could have been removed by the action of a 
phosphatase during purification. Therefore, even if low levels were phosphorylated, these 
may have been below the threshold for detection by the αpT271 antibody. However, both 
the phosphorylated and non-phosphorylated forms of T271 should have been detected by 
the αT271 antibody, and therefore the ost likely explanation is that the detection li it 
was too low for both antibodies. Hence, whilst it is not possible to rule out the presence of 
kinase only protein forms, the RT-PCR and IP data taken together strongly point to the 
presence of the predominantly full-length form of CCaMK at these symbiotic stages. 
Furthermore, these data were corroborated by RNA-Seq analysis which detected only the 
full length form in un-inoculated and roots inoculated with rhizobia. Finally, the coding 
sequence of DMI3 has been shown to complement the dmi3-1 mutant for symbiosis by 
myself (Chapter 5) and others including (Shimoda et al., 2012). Therefore, the conclusion 
that splice variants do not play a major role during symbiosis is robust from the data 
presented. 
 
In addition, the potential biological roles of the low-level splice forms detected are unclear. 
Form V, the only in-frame alternative transcript detected during the new nodulation and 
mycorrhization experiments, lacked a functional kinase domain but retained one EF-hand. 
Therefore, if present at the protein level this splice-form would not be an active kinase 
protein. It is possible, however, that it could play a role in calcium buffering in the nucleus, 
thereby potentially affecting the calcium spiking signal perceived by functional CCaMK. The 
other three splice-forms detected (II, III and IV) contained out-of-frame regions and 
therefore would likely not have a function at the protein level. Further evidence that the 
weakly expressed splice variants would not play a major biological role during symbiosis 
signalling is that the RNA forms detected and sequenced from the PCR with short extension 
times do not exactly match those previously sequenced by Pierre-Marc Delaux. It follows 
that if splice variants were essential for particular roles, it is likely that there would be 
evolutionary pressure to maintain them. Therefore the existence of a variety of splice 
variants does not suggest this evolutionary pressure.  
 
Despite the lack of clear symbiotic roles of these low-level splice forms detected during 
symbiosis they could potentially have biological roles which were not identified from this 
study. For example, two of the main roles of alternative splicing are transcript regulation 
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or, if they are reflected in protein forms, they can act as dominant negative protein 
regulators which repress full-length CCaMK (Reddy et al., 2013), (Staiger and Brown, 2013). 
Therefore, the splice forms identified could play a role in the fine-tuning of CCaMK 
regulation during symbiosis signalling even if they do not have clearly identifiable biological 
functions as discussed above. For example, the three forms identified with premature 
termination codons could be degraded by nonsense-mediated decay and therefore 
function in the regulation of transcript levels. However, crucially, in these particular 
experiments they were only detected at very low levels implying a non-essential function 
during symbiosis.  
 
Interestingly, one reason why alternative splice-forms of CCaMK could have been detected 
at low levels is due to the dilution effect introduced by including multiple tissue types 
within each sample. For example, CCaMK has been shown to play roles in both infection 
and cell division during the establishment of nodulation, which occur in the epidermis and 
cortex respectively (Rival et al., 2012). An attractive possibility is that differential splicing of 
CCaMK in different cell types could facilitate different cellular processes. This would be 
analogous to splicing seen in CaMKII, where differential splice for s of the β for  which 
vary in linker length facilitates different responses to calcium spiking frequency in different 
cell types (Bayer et al., 2002). However, none of the splice variants identified showed clear 
evidence of these subtle differences in the ability of CCaMK to perceive the calcium spiking 
signal, so this theory is speculation only. 
 
A further possibility is that whilst splicing of CCaMK does not play a role in symbiosis 
signalling, it instead plays a role in the regulation of the protein in other pathways. For 
example, CCaMK was first identified in the anthers of L. longiflorum and N. tabaccum. 
CCaMK was detected throughout the development of anthers, from the pollen mother cells 
to the tetrad stage of meiosis, where protein levels peaked (Poovaiah et al., 1999). 
Therefore, it is possible that the ability of CCaMK to be spliced could be crucial in alternate 
tissue types e.g. flowers instead of roots. Furthermore, other roles for CCaMK have recently 
been described, in particular during ABA signalling in O. sativa, Z. mays and Triticum 
aestivum (Shi et al., 2014), (Ma et al., 2012), (Yang et al., 2011). In wheat, for example, the 
D-genome CCaMK was shown to contain upstream ABA-responsive elements, and was 
predominantly expressed in root tissue. In addition, ABA down-regulated CCaMK 
expression which indicates a potential role for CCaMK in stress responses (Yang et al., 
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2011). It is therefore theoretically possible that the ability of CCaMK to be spliced in root 
tissue in fact enables it to function optimally in alternative pathways, for example stress 
responses.  
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This project has addressed key questions relating to the function of CCaMK in the Sym 
pathway using a combination of approaches. An investigation into the autophosphorylation 
of CCaMK revealed that CCaMK forms an oligomer that likely facilitates intra-oligomeric 
autophosphorylation at T271. This study could be extended in a number of ways. First, 
since the oligomeric state was determined using MBP-tagged and E. coli-expressed CCaMK, 
it would be pertinent to validate this finding in planta. Extensive attempts to carry this out 
during this project as detailed above were unsuccessful, so this is not a trivial undertaking. 
An alternative to a purification strategy is to utilise fluorescence correlation spectroscopy, 
perhaps with a GFP-tagged CCaMK form, to determine the oligomeric state in planta. One 
of the best courses of action seems to be the exploration of alternative overexpression 
lines, however this has the additional risk that the overexpression of the protein may 
influence the oligomeric state of the protein by potentially causing aggregation. A further 
possibility, which is less attractive is the use of plant expression systems, for example N. 
benthamiana. However, the HyperTrans plant transient expression system has been 
previously attempted for CCaMK by Nicola Gilberthorpe and was unsuccessful. 
 
Further interesting areas for future oligomeric state research regarding CCaMK include 
unpicking the involvement of CYCLOPS in the oligomer structure and identification of the 
residues necessary for oligomerisation. The interaction with CYCLOPS could be investigated 
by co-expression and co-purification by SEC. Identification of the CCaMK residues involved 
in the oligomerisation process present a challenge. However, we have evidence that the N-
terminus may be involved because the AI-VLD is present as a monomer (Swainsbury et al., 
2012) and data by Liang Zhou showed that removal of the first five amino acids in the N-
terminus disrupted oligomer formation. Furthermore, the kinase domain has been 
implicated in the interaction between CCaMK and CYCLOPS (Yano et al., 2008). Therefore, 
future work should focus on the kinase domain for the identification of residues 
responsible for oligomerisation.  
 
The data presented in this thesis strongly suggest that autophosphorylation at T271 occurs 
intra-oligomerically. However, this was not conclusively demonstrated due to the 
presumably unfavourable conformation formed in the oligomers of tagged and tagless 
protein. In order to determine if this is the case, the co-expressed mixed oligomer 
experiment could be repeated utilising different tags on the kinase dead protein. For 
example, this could be carried out using His-SUMO-CCaMK D192N protein instead of MBP-
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CCaMK K47E. Alternatively, the question could be addressed kinetically by assessing the 
degree of autophosphorylation at T271 as a function of time and protein concentration, 
analogous to the experiments carried out in (Tirichine et al., 2006) and (Takezawa et al., 
1996). The results from these experiments could be used to test mathematical models of 
the reaction to determine the mechanism. However, these experiments are challenging 
because they require precise control of the calcium concentrations in order to reach 
physiologically relevant calciu  concentrations lower than 10 μM. 
 
One of the most crucial experiments remaining for CCaMK is the elucidation of a complete 
structure. The importance of this has been mentioned in many recent studies, including 
work presented by Miller and colleagues (Miller et al., 2013) and Shimoda and colleagues 
(Shimoda et al., 2012). The challenge that this presents, however, cannot be overstated. 
There are obviously many, many different strategies which could be undertaken to attempt 
to produce crystals of CCaMK but some alternatives present more attractive options. For 
example, in order to obtain the crystal structure of the complete CaMKII oligomer, point 
mutations were made at key functional residues for example the autophosphorylation site 
and kinase-inactivating sites (Chao et al., 2011). A similar strategy could be taken for 
CCaMK, and other potential mutation sites include inactivating mutations affecting the EF-
hands and CaM binding domain. However, crystal trials utilising full-length CCaMK with 
strategic mutations have been initiated by Sylvia Singh, and have so far been unsuccessful. 
A further possibility for exploration is cryo-EM, which has been used recently for high 
resolution structures with no size-limit (Frauenfeld et al., 2011). In addition, alternative 
truncations of the protein could be explored, perhaps for NMR structural determination 
(provided they are smaller than 40 kDa), which also yields atomic level resolution. 
However, the ultimate goal remains a structure of the full-length protein. Furthermore a 
characterisation of the conformational changes that the full-length protein undergoes by 
SAXS, in the presence of calcium and CaM, would be ideal. However, there are currently no 
suitable full-length candidate constructs. 
 
Interestingly, whilst the data obtained for this thesis indicated that alternative splicing is 
not required for symbiosis, it does appear that low levels of CCaMK splice variants are 
produced at the RNA level. As previously suggested these could correspond to the function 
of CCaMK in different pathways, for example in ABA signalling. Therefore a similar study 
could be undertaken in different tissue types, during different developmental stages or 
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during stress responses in M. truncatula in order to determine if splicing of CCaMK is 
important in different contexts. However, since there is currently no strong evidence for 
this involvement this is unlikely to be a priority for future work.   
 
In addition to the topics covered in this thesis, there are more unanswered questions 
relating to CCaMK. For example, certain elements of the model of CCaMK function 
described in (Miller et al., 2013) remain to be confirmed in planta, for example that the 
basal and inactive state of CCaMK is with phosphorylation at T271. Furthermore, the roles 
of the other phosphorylation sites in CCaMK (including S343 and S344) require further 
clarification in planta. The hydrogen-bonding network has thus-far been identified by 
homology modelling alone, despite its crucial predicted role in the mechanism of CCaMK 
inactivation. Therefore, structural confirmation of the relative positions of the amino acids 
involved in this network is necessary to confirm its importance. In addition, since 
phosphorylation is crucial to the mechanism of CCaMK function, it follows that one or more 
phosphatases may be involved in the system, which have yet to be identified. Finally, it 
seems likely that further interaction proteins of CCaMK exist which perhaps serve to 
specifically transduce the signal to produce either nodules or arbuscules. Therefore this will 
also be an important goal. A wider question regarding the Sym pathway, and potentially 
CCaMK, remains as to how specificity is conferred in the production of either arbuscules or 
nodules. This could potentially be mediated by CCaMK; but other possibilities include a 
parallel pathway and downstream pathway elements. 
 
CCaMK is, and remains, an extremely important but challenging protein for study. A full and 
thorough understanding of CCaMK will become increasingly important as we progress 
towards the goal of engineering nitrogen-fixing crop plants. However, it is also a protein 
worthy of study in its own right due to the important role it plays in this pathway and the 
fascinating complexity surrounding its mode of action. 
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